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Abstract
Osteochondral defects in the knee can be disabling causing persistent pain, 
giving way, locking, catching and swelling and a reduction in activities including 
sport. Traditionally symptomatic defects were treated with marrow stimulation 
techniques such as drilling, abrasion and microfracture of the subchondral bone 
which have had limited success with usually the production of a fibrocartilage 
repair. This repair tissue tends to be soft and degenerates over a period of 
time. Autologous chondrocyte implantation (ACI) has produced hyaline or 
hyaline-like repair tissue in experimental models and in the clinical setting in 
early studies, with the potential for permanent regeneration of articular 
cartilage, thus preventing early onset osteoarthritis.
This study reviews the clinical results of 3 techniques of autologous 
chondrocyte implantation (AGI): the more traditional periosteum covered AGI 
(AGI-P) implant, the collagen-covered AGI (AGI-G) and the matrix carried 
autologous chondrocyte implantation (MAGI). Single cohort studies of AGI-P 
and AGI-G over a 4 year period were made together with the provisional results 
of the MAGI procedure at 1 year. Then 2 prospectively randomized studies 
were performed to compare AGI-G with AGI-P and MAGI with AGI-G. Finally a 
small series of patients were reviewed who had a chondrocyte implantation 
combined with other surgical techniques such as an anterior cruciate ligament 
reconstruction or tibial osteotomy.
A review of these patients revealed a significant improvement in their clinical 
scores over 4 years for the AGI-G and AGI-P technique in keeping with
previously published data and also for the MAGI technique at 1 year.
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Interestingly, a large number of the ACI-P patients developed graft hypertrophy 
which required arthroscopic debridement since patients complained of pain and 
catching. However, the ACI-C and MACI patients rarely developed this 
problem. The prospectively randomised study did not show any difference in 
terms of clinical and histological assessment at 2 years between the ACI-C and 
ACI-P patients. The early results for the MACI technique are also comparable. 
Based on this data it is proposed that collagen-covered ACI is the present ‘gold 
standard’ in chondrocyte implantation rather than periosteum-covered ACI.
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CHAPTER 1: INTRODUCTION
A REVIEW OF ARTICULAR CARTILAGE DEFECTS OF THE KNEE AND 
THEIR MANAGEMENT
The Problem with Articular Cartilage
Articular cartilage covers the ends of bones and by its structure and function, 
acts as a shock absorber as well as an extremely slippery surface for joint 
movement. It is essentially a type II collagen meshwork supported by water, 
which is held in place by the osmotic pressure of the proteoglycans produced 
by the chondrocytes (figure I). It is a tough, resilient substance, able to 
withstand very high levels of mechanical stress. But despite its toughness, it is 
susceptible to trauma and disease. If damaged, it loses its water content and 
degenerates. This may result in a spectrum of cartilage lesions varying from 
superficial lacerations to large defects extending down to the subchondral 
bone. A conservative estimate suggests 10,000 individuals damage their knee 
joint cartilage due to various injuries each year in the UK (Bentley 2000, 
Personal Communication).
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Figure I. Schematic representation of the spatial relations between 
collagen, proteoglycans and chondrocytes in cartilage 
(Courtesy of G. Bentley and BMJ
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Figure II. Photomicrograph of normal 
articular cartilage showing the superficial (SZ), 
middle (MZ), deep (DZ) and calcified zones 
(CZ). The tidemark is also indicated (TM).
(Courtesy of G. Bentley)
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Articular Cartilage Structure and Function
Articular cartilage possesses many unique characteristics, it provides a low 
friction surface allowing the smooth running of a joint and also enables it to 
transmit loads across and dissipate areas of high mechanical stress to the 
underlying bone.
These unique properties can be attributed to the way that chondrocytes are 
organized into layers and the extracellular matrix that they produce. The 
constituents that make up the extracellular matrix include collagen, 
proteoglycans and water, which envelop the relatively sparse population of 
chondrocytes. Water makes up 65-80% of the total weight of cartilage  ^ the 
proteoglycans constitute 12% and chondrocytes 2%, and the remainder 
represents the collagen fibres
It has been estimated that 90-95% of collagen in articular cartilage is type II 
The remaining 5-10% is made up of type V, VI, IX, X and XI The structure of 
type II collagen constitutes a triple helix, which gives the cartilage its excellent 
tensile strength and robustness and provides the scaffolding of articular 
cartilage.
The ability of chondrocytes to divide usually ends once skeletal maturity has 
been achieved. Mankin demonstrated the ability of chondrocytes to divide in the 
skeletally immature.  ^®. The almost complete inability of adult chondrocytes to 
divide and repair damaged articular surface is an important characteristic and is 
responsible for considerable morbidity.
Articular cartilage is one of a few tissues that does not possess nerve fibres so 
that injuries to its surface does not result in pain. It is only when the underlying 
bone is exposed that pain is felt.
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Conventionally articular cartilage has been divided into layers or zones, the 
superficial, middle, deep and calcified (figure II). In the superficial zone the 
collagen fibrils are highly organised and have a preferential direction parallel to 
the articular surface; in the middle zone the fibrils have no real preferential 
direction and appear to have a random arrangement; and finally, the deep zone 
where fibrils are again highly organised and prefer a direction perpendicular to 
the subchondral bone. This is also known as the 'Benninghoff arcade model' ® 
The three dimensional structure of articular cartilage was demonstrated using 
the scanning electron microscope by Jeffrey et al in 1991 (figure III) This 
revealed that in the middle and superficial zones there is a series of closely 
packed layers or leaves. Each of the leaves is composed of a fine meshwork of 
collagen fibrils and are bound to other leaves by bridging fibrils. In the calcified 
and deep zone, the fibrils are arranged in vertical bundles and are also bound 
to each other with fibrils. The leaves formed in the middle zone then arch over 
to form the horizontally orientated leaves of the superficial zone. A similar close 
association between the horizontal leaves exists with numerous 
bridging/interconnecting fibrils.
As well as differences in its three-dimensional structure, each zone possesses 
many other distinctive characteristics. Cells found in the superficial zone are 
characteristically flattened due to the shearing forces that they are exposed to 
and secrete a lubricant called lubricin. Lubricin is a glycoprotein found in 
synovial fluid and prevents direct surface to surface contact at an articulation. 
The thickness of this layer varies between 1 and 100 nm. Lubricin is secreted 
by other cells such as the synovial lining cells and enables the smooth running 
of the joint as well as preventing wear. The synovium also secretes hyaluronic 
acid, proteinases, collagenases and prostaglandins. These constituents are
23
added to an ultrafiltrate of blood plasma, which together make up the synovial 
fluid. As well as lubricating the joint, the synovial fluid also provides 
nourishment for the articular cartilage.
Cells in the superficial zone secrete an extracellular matrix containing a large 
aggregating proteoglycan (aggrecan), similar to cells found in other zones. This 
molecule is able to bind large amounts of water and is responsible for the 
resilience of cartilage to compressive forces. Cells in the superficial zone are 
exposed to the greatest shearing forces and it is here that the greatest 
concentrations of collagen fibrils are found Infact their ability to resist 
compressive forces is of less importance, which is why this zone possesses the 
lowest concentration of aggrecan.
24
Figure III. Electron micrograph of articular cartilage after freeze 
fracturing, demonstrating the collagen leaves (A) which curve over in the 
middle zone to lie in the horizontal plane, parallel to the articular surface 
(AS) in the superficial zone. (B) indicates the isolated chondrocyte 
lacunae within the leaves (Courtesy of the British Journal of Bone and 
Joint Surgery).
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Type II Collagen fibrils in the superficial zone are narrower than those found in 
the deeper zones (diameter 20 nm compared with >100 nm) and are arranged 
parallel to the surface of the cartilage to a depth of 50 -  100i|m The 
comparatively low concentration of aggrecan and the parallel arrangement of 
numerous narrow collagen fibrils in the superficial zone contribute to its high 
tensile strength and has been likened to as a tough skin or rind that overlies the 
rest of the cartilage.
The middle zone (or transitional zone) is thicker than the superficial zone and 
contains more rounded chondrocytes with wider type II collagen fibrils that lie in 
a random arrangement. The matrix found in this zone, which envelops the 
fibrils, also contains a higher concentration of aggrecans.
The deep zone (or radial zone) contains the highest concentration of aggrecans 
and it is here that the collagen fibrils with the greatest diameter are found. The 
collagen fibres are arranged in a parallel fashion perpendicular to the joint 
surface. The middle and deep zones are largely responsible for the resilience of 
cartilage to compressive forces due to the large concentration of aggrecans, 
but provide little resistance to shearing forces due to the low concentration of 
collagen fibrils unlike the superficial zone.
Chondrocytes of the deep zone are characterized by being spheroidal in shape 
and arranged in a columnar orientation. This zone is also unique in that it is part 
calcified and becomes the calcified zone. The tidemark is a calcification front 
where non-calcified cartilage meets calcified cartilage. Chondrocytes found in 
the calcified zone are able to calcify their extracellular matrix and are rich in 
alkaline phosphatase. The collagen fibrils are inserted into the calcified 
cartilage ensuring that it is securely anchored to the underlying subchondral
26
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Figure IV. Electron micrograph of a chondrocyte in 
its lacuna. Some of the organelles can be seen clearly in 
this picture including the nucleus (N) and the Golgi 
apparatus (G). (Courtesy of J.A. McNulty, Loyola 
University Chicago Stritch School of Medicine).
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bone. As cartilage degenerates as seen in osteoarthritis the calcified zone may 
progress further into the deep zone. This may result in two tidemarks being 
seen. The more superficial tidemark represents the extension of the zone of 
calcification and the deeper one being the original tidemark Clearly, if the 
matrix of the deep zone becomes calcified its ability to ‘spring back’ after being 
exposed to a compressive force is considerably reduced.
Thus, chondrocytes from different zones differ in size, shape and metabolic 
activity.
The proteoglycan monomers (aggrecans) consist of a central protein core with 
many sulphated gylcoaminoglycans (GAG’s) bound to it (figure V and VI). The 
GAG chains have numerous negative charges and are therefore able to bind 
cations and are hydrophilic. As a result the glycoaminoglycan chains are able to 
bind water molecules tightly within cartilage. This is a key characteristic of 
gylcoaminoglycans and is responsible for the robust structure of articular 
cartilage.
Also by having numerous side chains with negative charges, they repel each 
other, so the proteoglycan aggregates tend to spread out. In native cartilage 
aggrecans are only partially hydrated due to the compressive forces that are 
exerted on them by the collagen framework made up of type II collagen fibrils. 
Thus if the collagen framework is destroyed, aggrecans absorb water and 
expand (as seen in chondromalacia patellae) and early osteoarthritis.
Articular cartilage can be viewed as a type of sponge, although considerably 
more resilient due to its integrity being maintained by the strong hold that the 
aggrecans have for water and the collagen framework which holds it altogether 
under tension.
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As well as the differences mentioned above between each zone, there is also 
considerable variability within each zone. Surrounding each chondrocyte there 
is relatively little collagen but high concentrations of aggrecans (pericellular 
matrix). Enveloping this region, surrounding the cells and the pericellular matrix 
there is a web of thin collagen fibrils, which may provide some protection for the 
cells (territorial matrix). The area found between the territorial matrixes is called 
the interterritorial matrix. Here, the organisation of the cartilage is dictated by its 
mechanical function, and the collagen fibrils are arranged as previously 
described for the various zones.
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Figure V. A schematic diagram demonstrating the structure of 
aggrecans. Each monomer consists of a central protein core with many 
sulphated glycoaminoglycans (e.g. Keratan sulphate and chondroitin 
sulphate) bound to it. (Courtesy of the University of Texas).
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Figure VI. An electron micrograph showing the structure of an aggrecan. 
Branching off hyaluronate (A) are many core proteins (B) with numerous 
sulphated glycoaminoglycans attached (Courtesy of the University of 
Kuopio).
The Chondrocyte
Chondrocytes are responsible for synthesizing all the constituents of the extra­
cellular matrix and therefore play a major role in directing possible regenerating 
processes following injury to the articular cartilage surface. This synthetic 
activity is mainly driven by anaerobic means due to the distance of 
chondrocytes from oxygenated blood. The ability of chondrocytes to synthesize 
the extra-cellular matrix is affected by chemical factors as well as mechanical 
influences. Soluble mediators such as interleukins and growth factors play a 
role as well as the composition of the matrix itself. Therefore there is a form of 
feedback mechanism between the matrix and the chondrocytes. Hydrostatic 
pressures are also thought to influence the metabolism of chondrocytes.
In the osteoarthritic patient there is evidence to suggest that chondrocytes are 
able to synthesize new matrix but many of these molecules are degraded by 
proteolysis
In the young growing child, damage to the articular cartilage also stimulates the 
synthesis of new type II collagen fibres as well as proteoglycan.These new 
fibres are not destroyed by proteolysis and may account for the fact that 
symptoms can resolve following an injury in a growing child. Hence 
considerable work has been done to investigate possible antagonists to the 
proteolytic agents that occur in osteoarthritis. Some success has been seen 
with antagonists to Interleukin-1 (IL-1) and tumour necrosis factor-a which are 
known to suppress type II collagen and aggrecan synthesis (Kobayashi, M. et 
al: unpublished data). There may be further scope for this therapeutic option in 
future research.
Another important characteristic of articular cartilage in the young is that 
chondrocytes are able to proliferate, however once skeletal maturity is reached
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the cells rarely divide under normal conditions although cell division is seen in 
osteoarthritis
The fact that cartilage is relatively acellular means that its ability to repair itself 
is impeded and as cartilage ages the number of cells reduces due to apoptosis, 
further impairing its ability to synthesize new matrix.
The interplay between chondrocytes and the extracellular matrix they produce 
together with their arrangement into zones explains the unique characteristics 
of articular cartilage.
These unique characteristics together with the inability of articular cartilage to 
repair itself have posed a significant clinical problem for many years. The 
observation made by William Hunter is just as relevant today as it was 260 
years ago and it strikes at the core of the problem of the management of 
osteochondral defects.
‘From Hippocrates down to the present age, we shall find, that an ulcerated 
cartilage is universally allowed to be a very troublesome disease; that it admits 
of a cure with more difficulty than a carious bone; and that, when destroyed, it 
is never recovered'
W. Hunter 1743 14
Repair of Articular Cartilage
Full thickness articular cartilage defects are never restored to normal cartilage 
by natural methods Damaged articular cartilage may repair itself with 
fibrocartilage, but this requires vascular in-growth from the subchondral bone.
Fibrocartilage may restore the joint surface to a functional level, but often this
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result is ‘short-lived’ since it is less resilient than hyaline cartilage so that 
continued trauma to the articular surface eventually leads to its degeneration 
This is due to the relative preponderance of type 1 and 111 and the absence of 
type II collagen. Even so there are several treatment methods currently used 
that encourage vascular in-growth and subsequent repair by fibrocartilage 
formation for which good clinical results are claimed
The poor ability of articular cartilage to regenerate, contrasts with bone, which 
has an excellent ability to regenerate despite the fact that both cartilage and 
bone share the same progenitor cells. So why can bone regenerate and 
cartilage cannot?
Caplan et al ^  in their review of cartilage repair and regeneration address this 
issue. The key to bone healing is the arrival of numerous progenitor cells to the 
fracture site. These progenitor cells and other repair cells together form a 
blastema which goes on to form a callus and then through a process of 
remodelling forms new bone over the old fracture site. Unlike bone, cartilage 
has no blood supply of its own, so progenitor cells and other repair cells are 
unable to migrate to the site of damage.
Avascularity may be one factor that is responsible for the inability of cartilage to 
heal, also the immobility of the chondrocytes trapped in the extracellular matrix 
and the limited ability of mature chondrocytes to divide and increase their 
synthetic activity, also plays a role Hence a logical way to repair such 
defects with hyaline cartilage is to artificially deliver chondrocytes to the site of 
injury where they may form new matrix. The first reported case of a repair of an 
osteochondral defect in a human subject by the siting of cultured autologous 
chondrocytes underneath a periosteum cover was reported in 1984 by Brittberg 
et al ^  in Sweden.
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Aetiology of cartilage defects
For the purposes of this review, the aetiology of the various defects has been 
classified into those of traumatic origin, those attributed to osteochondritis 
dissecans and those due to chondromalacia patellae.
Traumatic Cartilage Defects
By far the largest group are those patients whose defects are of traumatic origin 
and are commonly found on the medial femoral condyle.
Knee trauma is common in high performance athletes such as soccer players, 
reportedly accounting for 20% of all their injuries This high incidence maybe 
explained by the high velocities and repetitive high impact twisting movements 
that occur within the knee when kicking a soccer ball or by contact injuries 
placing extreme stresses on the articular cartilage
Traumatic chondral injuries are believed to occur through two distinct 
mechanisms. The largest group arises through abrasive wear, which results in 
superficial fibrillation. Often at this stage the lesion is asymptomatic until 
erosion progresses to the subchondral bone.
The second type of lesion occurs because of disruption to the deep cartilage 
ultra-structure by large shear forces. Ateshian ^  demonstrated that shear 
stress is concentrated at the junction of the uncalcified and calcified cartilage, 
which may produce damage to the cartilage above the tidemark but also to the 
subchondral bone. Levy et al confirmed this when they performed biopsies of 
the base of osteochondral defects in soccer players at the delamination border 
revealing that the calcified cartilage remained with the subchondral bone.
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Osteochondritis Dissecans
Osteochondritis dissecans is a localized disease and involves the separation of 
a fragment of the subchondral bone and overlying cartilage (hence dissecans). 
It is found most commonly in the ankle, elbow and knee. However the knee is 
the most frequent site, affecting 75% of patients From the name it could be 
assumed that an inflammatory process is responsible for the development of 
such a condition ,however, Nagura in 1960 demonstrated the absence of 
inflammatory cells in histological sections of excised osteochondral fragments 
None the less, the name osteochondritis endures. As well as a possible 
inflammatory process other aetiologies have been suggested such as indirect 
trauma ischaemia as well as defects of ossification and genetic 
causes However, to this day little is known about how this disease process 
develops and it has been surmised that the factors responsible vary according 
to the specific joint involved and on the specific site within the joint 
The condition has been subdivided into the juvenile and adult form. Children 
and adolescents between the ages of five years and fifteen years who still have 
open physes have the juvenile form Older children with closed physes and 
adults, have the adult form. The condition is rare in those aged 10 years or less 
and those more than 50 years old It had been suggested that although adult 
osteochondritis may arise de novo, it is more likely that such patients initially 
had an asymptomatic juvenile osteochondritis dissecans, which failed to heal 
and later developed into a symptomatic defect
Patients with osteochondritis dissecans often present in a fashion similar to 
those with traumatic defects. Patients may complain of pain, swelling, locking 
and giving way. Often the symptoms are intermittent and are related to the level
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of activity of the patient. If there is a cartilaginous or osteochondral loose body 
present, the symptoms may be more constant with locking, pain and swelling. 
The lesion commonly affects the weight-bearing area of the lateral aspect of the 
medial femoral condyle However, it can affect both weight bearing and non­
weight bearing areas of the joint
Children with open growth plates have the best prognosis and are best treated 
with conservative management. Schenck and Goodnight concluded on the 
basis of their review of the literature that children with symptomatic lesions 
should be managed initially with reduction in activities until they no longer have 
symptoms. They advocated protected weight-bearing to allow healing of the 
subchondral bone and to prevent further damage. Clearly it can be difficult to 
limit the activities of a child so they suggested using a knee immobiliser or a 
splint. These patients should be carefully followed up in the orthopaedic clinic 
with regular clinical examinations and serial radiographs and possibly serial 
MRI’s. They advocated operative treatment only if there are loose bodies 
present, or if symptoms persist for 6-12 months, or if healing is deemed unlikely 
based on observations of the radiographs that show fragments that are 
completely separated from the articular surface and are displaced. Children 
who are symptomatic despite a trial of non-operative treatment and who are 
approaching skeletal maturity may be considered for operative management.
Older patients often become symptomatic and without treatment may progress 
to osteoarthritis. There are various treatments available for this patient group 
such as curettage and drilling of the base of the defect or chondrocyte 
transplantation.
This line of management is supported by Linden’s work that described the 
natural history of osteochondritis dissecans in fifty-eight patients with a mean
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follow up of 33 years. He observed that children with open physes with defects 
attributed to osteochondritis dissecans did not go on to develop secondary 
degenerative changes, however 38 of 48 patients who had first developed the 
condition after closure of the physes had progressed The treatment of 
osteochondritis dissecans continues to be a controversial subject and the 
aetiology remains unclear. However, in treating this condition it is important to 
differentiate between the juvenile form of the condition and the adult form.
Chondromalacia Patellae
Chondromalacia patellae or softening of the articular cartilage of the patella is a 
common finding at arthroscopy and is most commonly found in patients aged 
15 to 35 years Normal healthy articular cartilage is bluish-white, smooth, 
glistening and resilient. With chondromalacia patellae the earliest change is that 
the cartilage becomes a dull, yellowish-white and is soft and swollen Usually 
this area of abnormal cartilage is found in the medial patellar facet on the most 
medial or ‘odd’ facet “  and is approximately 1 -  2 cm in diameter. With time, 
irregular fissures develop and the area becomes a mass of frond-like material 
attached to the subchondral bone. The affected area tends to increase in size 
and its centre becomes eroded down to the underlying subchondral bone. As 
the size of the affected area gets bigger the lateral facet may become 
incorporated into the defect so that the whole retropatellar surface may be 
involved but in 30-50% of individuals the condition appears not to progress. 
There have been many theories of the aetiology of chondromalacia patellae in 
the past, including a direct or indirect injury to the patella or a generalised 
constitutional problem. At present the most likely cause is thought to be due to 
chronic or recurrent overload of the retropatellar surface. This may be due to
the fact that the patella and femoral joint surfaces are not congruent or to
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abnormal tracking of the patella during flexion and extension. However, Dowd 
and Bentley ^  showed that chondromalacia could occur without any joint 
instability suggesting that in some cases it may be genetic. Chondromalacia 
patellae is very common; Outerbridge observed in 196 cases of medial 
menisectomy that 101 patients showed evidence of the condition This 
pathological state can be associated with retropatellar pain and other 
symptoms including joint swelling and giving way, this can lead to considerable 
disability with associated restrictions of activity
However not all patients are symptomatic, explaining the relatively high 
incidence at arthroscopy and low numbers of patients presenting with the 
condition in the Orthopaedic Clinic® .^ Also, approximately 50 percent become 
asymptomatic with time which could indicate spontaneous healing of the 
cartilage^. None the less there remains the concern that patients with 
symptomatic chondromalacia patellae may go on to develop osteoarthritis, 
although at present there is little in the literature to support this.
Response to injury in connective tissue
The avascular nature of articular cartilage poses a significant problem in its 
response to injury The response of the majority of organs to trauma usually 
follows a similar path. This sequence of events can be divided into 3 distinct 
phases: necrosis, inflammation and repair
Necrosis is set in motion as soon as the injury occurs. The extent of this phase 
is dependent on a number of factors including the type and severity of trauma 
and the vascular supply. The vascular supply is important for three reasons. 
Different organs have varying sensitivities to the interruption of their local blood
supply. The heart and brain are extremely sensitive to any interruptions of their
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blood supply whereas skin is more resilient. Also some organs have a far richer 
blood supply than others and some have the potential to open up a rich 
collateral circulation. Therefore tissues that are subjected to a severe injury, 
with a poor vascular supply, with little ability to open up a collateral circulation 
and are made up of cells that are extremely sensitive to ischaemia undergo 
extensive necrosis.
Following necrosis there is a phase of inflammation. In this phase the 
vascularity of the organ again plays an important part. Blood vessels are able to 
dilate resulting in increased blood flow to the injured tissue. When the vessels 
dilate the pore size between the endothelial cells which make up the capillary 
walls enlarge, and as a result, become more permeable allowing the migration 
of cells from the capillary lumen to the extracellular space. Fibrinogen also 
leaks out and following an enzyme driven cascade forms a fibrin meshwork, 
which also contains numerous inflammatory cells that mop up any cell debris. 
Towards the end of this phase the fibrin meshwork becomes organised and 
forms a scaffold and the next phase then commences.
The third and final phase is often the longest phase. The repair phase starts 
with the neovascularisation of the fibrin scaffolding that was formed during the 
inflammatory phase. The newly formed vascular supply conducts cells to the 
site of injury that are needed for repair. Fibroblasts found within the fibrin 
meshwork lay down a fibrous matrix that later develops into a scar. Rather than 
repairing the site of injury with scar tissue some tissues are able to replace like 
with like. For example with a fracture, bone is able to repair itself with new bone 
and in the case of the liver it is able to regenerate itself. Clearly with articular 
cartilage repair the response is impaired by the avascular nature of cartilage.
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During the first phase of healing, the extent of necrosis is less than one may 
expect compared with other organs.
Being part of an avascular structure chondrocytes are relatively insensitive to 
hypoxia resulting in less necrosis following trauma. The inflammatory phase is 
non-existent in the healing of articular cartilage since there are no blood 
vessels. This has considerable implications for the final phase, since there are 
no vessels to conduct cells to the site of injury that are needed for repair. 
Hence a superficial injury that significantly disrupts the chondrocytes and 
extracellular matrix but does not breach the subchondral bone has very little 
capacity to heal The only possibility for repair in superficial lesions is from 
the chondrocytes near the edges of the defect which undergo transient 
proliferation
Although the above description is true for superficial injuries to articular 
cartilage, deep injuries that involve the subchondral bone follow a different 
course. Subchondral bone is perfused with numerous blood vessels and if this 
area is involved in the injury then the inflammatory phase of healing is able to 
play a role.
For the purpose of this review a deep injury is considered as a defect that 
breaches the tidemark and penetrates the subchondral bone. Such an injury 
will precipitate bleeding and the formation of a haematoma, which subsequently 
becomes organised into a fibrin clot. Cells trapped within the fibrin clot include 
undifferentiated cells from the marrow and endothelium and white blood cells, 
which differentiate into primitive fibroblasts. Together with the ingrowth of new 
capillaries from the subchondral bone, the fibrin clot ultimately becomes 
granulation tissue. Meanwhile, at the base of the lesion new bone forms and 
grows towards the joint. The new bone formation only continues until it fills the
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bony defect and stops at the boundary between the calcified cartilage and 
subchondral bone. Therefore at this stage the deep part of the defect is 
restored with new bone and the cartilage part of the defect is filled with 
granulation tissue. The granulation tissue is fused to the underlying new bone 
and unites with the adjacent cartilage found at the rim of the defect. 
Chondrocytes found at the rim of the defect undergo a minimal response to the 
injury similar to what occurs following a superficial lesion. Meanwhile the 
granulation tissue residing within the defect becomes gradually replaced by 
fibrocartilage which contains type I and type III collagen mainly.
However, research by Salter et al in 1980 showed that continuous passive 
motion appeared to influence the healing of cartilage following a deep 
laceration. Their results showed that by subjecting the injured joint to 
continuous motion the defect healed more rapidly and the repair tissue had 
features of hyaline cartilage rather than fibrocartilage.
Mankin concluded from his review of the literature that superficial lesions 
undergo minimal healing but deep lacerations that penetrate the bone 
stimulates a full blown healing response and may result in a mixed hyaline / 
fibrocartilage repair. He also suggested that depending on the size of the defect 
that such an injury may lead to a focus for osteoarthritis Further reviews 
have suggested that repetitive loading injuries to the cartilaginous surface that 
exceed a certain threshold may result in damage to the chondrocytes and 
underlying bone leading to features of osteoarthritis
The Natural history of Osteochondral defects
Full thickness chondral injuries secondary to work related and sporting activities 
are common with an incidence of between 5%-10% of acute haemarthrosis
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Despite this high incidence very little is known of the natural history of 
osteochondral defects, which poses a difficult problem of when to treat such 
injuries.
Animal models have been used to explore the natural history of osteochondral 
defects however their cartilage often possesses different properties from those 
of human cartilage and the lesions created rarely resemble those seen in 
human knees.
Messner and Maletius performed a study of a population of 28 young athletes 
who had previously been diagnosed with severe isolated chondral damage in 
the weight-bearing areas of their knees They noted that at 14 years, only 7 
patients still performed at their pre-injury activity level. The remaining 21 
patients showed a reduction in activities during the follow-up period. These 
patients also had knee radiographs repeated at 14 years which showed that 12 
patients had no radiographic signs of arthrosis in the injured knee, 4 patients 
had Grade 1 arthrosis, 11 had grade 2 and 1 patient had Grade 3. This 
suggested that along with a clinical deterioration there was a permanent 
deterioration seen on the knee radiographs following a cartilage injury.
Curl et al concluded from their review of 31,516 arthroscopies where 19,827 or 
63% had chondral lesions, that significantly injured articular cartilage is never 
spontaneously restored to normal articular cartilage’
Hernborg and Nilsson described the course of events in untreated knee 
arthrosis This study was based on non-weight bearing radiographs of knees 
taken at the time of presentation 10 to 18 years earlier. At subsequent follow-up 
a clinical examination was made and weight-bearing radiographs were taken 
which showed that greater than half had deteriorated both clinically and 
radiographically.
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Similar research by Spector et al, found that 33% of their patients deteriorated 
during an average of 11 years
A number of factors have been found which exacerbate this deterioration. Such 
factors include obesity, meniscal tears, sport activities and certain occupations. 
Also, there has been shown to be an increasing prevalence with age 
Sahlstrom and colleagues looked for joint space narrowing on weight bearing 
radiographs of the knee in their review of patients with knee arthrosis. They 
observed that 70% of knees with Ahlback Grade 1 or higher, deteriorate over a 
20 year period (Ahlback Grade 1 ; sharpening of the edges, the beginning of 
osteophytes, sclerosis and flattening of the condyles and joint space narrowing 
up to 50%
In the case of the natural history of osteochondritis dissecans, patients with 
juvenile osteochondritis frequently heal. However, those lesions that do not 
heal and continue after closure of the physes rarely heal with non-operative 
management It has been hypothesized that in both the juvenile and adult 
forms of osteochondritis dissecans that the articular cartilage softens as it loses 
its anchorage to the subchondral bone. If the disease process is allowed to 
proceed unhindered, some minor trauma may then knock off an osteochondral 
fragment resulting in a crater in the articular surface and a loose body in the 
joint. With separation of the fragment from the underlying bone, healing 
becomes unlikely. If the lesion involves a weight bearing surface, the 
incongruity of the articular surface predisposes the joint to more advanced 
changes as seen with degenerative joint disease.
There is still much to discover about the natural history of osteochondral 
defects from whatever cause and the majority of studies document the
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deterioration of early osteoarthritis rather than discrete osteochondral defects 
as can be seen from the above. A large number of isolated chondral injuries are 
discovered incidentally at arthroscopy although not all patients complain of pain 
as their main symptom. Although there are techniques available that can 
restore the articular surface, surgical intervention may not always be indicated. 
From a review of the literature the best guide for the management of 
osteochondral defects is the Surgeons’ best judgment in ascertaining that the 
patient’s symptoms are explained by the presence of the defect. Once the 
surgeon is confident that the defect is responsible for their symptoms then 
surgical intervention is probably indicated.
Diagnosing articular cartilage defects 
Clinical Assessment
The management of any clinical problem always starts with the history and 
examination.
Pain is the most common presenting complaint of a patient who has sustained 
an articular cartilage injury. Ochi et al and Brittberg et al ^  have reported 
symptoms such as locking, pain, swelling and retropatellar crepitus. Peterson et 
a! described them as severe symptoms with pain at rest. Hangody et al 
defined them as pain, pain with activity, swelling and locking.
In Levy et al’s study of chondral delamination of the knee in soccer players, 
patellar and trochlear lesions were associated with reports of pain during 
jumping, deceleration and the extension phase of kicking. Anterior condylar 
lesions produced pain during the extension phase of kicking. Central condylar 
lesions produced pain during pivoting and lateral movements. Posterior
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condylar lesions were painful during the flexion phase of kicking and during 
planting of the non-kicking leg to the ground.
Often patients report that the affected knee gives way when walking or when 
going down stairs. On further questioning these patients often recall that 
immediately preceding the knee giving way they notice an intense sharp pain 
from within the knee.
This episode of intense pain may coincide with the osteochondral defect 
coming into contact with the opposing joint surface during the weight-bearing 
phase of walking. The giving-way is therefore a response to the intense pain. 
Giving-way may also occur independent of pain. In this situation the instability 
maybe explained by the presence of quadriceps wasting or an anterior cruciate 
ligament (ACL) rupture.
Occasionally the patients may complain of locking similar to the presenting 
complaint of a meniscal tear. In the case of an osteochondral defect being the 
cause, this may be attributed to an osteochondral fragment that has broken off 
from the joint surface impairing the smooth running of the knee.
The patient should have a thorough examination of gait, alignment of the lower 
limbs and evidence of generalised joint laxity should be sought. One should 
look for the presence of an effusion and evidence of joint instability due to 
ligament damage and patello-femoral maltracking.
Localised bone or joint line tenderness maybe the only positive finding found on 
examination. Some authors have reported as high as a 94% incidence of a 
specific mechanism of injury and joint line tenderness with chondral lesions in 
mixed populations and an 83% incidence of an effusion, although others have 
noted no correlation between clinical signs and articular cartilage damage
45
Clearly a finding of joint line tenderness may also be found with other knee 
pathologies such as a meniscal tear.
The examination findings together with information obtained from the history 
may suggest the presence of an osteochondral defect. This can be confirmed 
with the use of imaging and arthroscopy.
Investigations
There are a number of investigations that are used to assess the presence of 
an osteochondral defect and exclude other pathologies. Often large defects 
show up on a plain radiograph (figure VII), smaller defects may be detected on 
an MRI scan (figure VIII).
Plain Radiographs
Weight-bearing anteroposterior (AP) ideally full length and lateral radiographs 
of the knee with tangential views of the patello-femoral joint in 30 degrees of 
flexion should be taken. As well as identifying possible defects an assessment 
of joint alignment can be made.
Radiographs of osteochondritis dissecans may show the lesion as a well - 
circumscribed area of sclerotic subchondral bone separated from the remainder 
of the epiphysis by a radiolucent line. Old traumatic lesions often have a similar 
appearance on a plain radiograph.
In the case of osteochondritis dissecans of the knee a number of systems have 
been devised to evaluate radiographs. Harding described a system where 2 
lines are drawn on the lateral radiograph, the first along the posterior femoral 
cortex and the second along the Blumensaat line (corresponds to the 
intercondylar notch). The articular surface between these two points represents
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Figure Vila. AP radiograph 
demonstrating an osteochondral defect
(A) of the medial femoral condyle.
Figure Vllb. MRI (T1 weighted) of the 
same knee as in figure Vila (sagittal 
view) demonstrating an osteochondral 
defect (A) of the medial femoral 
condyle with underlying bone bruising’.
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Figure VIII. Lateral radiograph of the knee 
demonstrating the Blumensaat line (A), and a 
line drawn along the posterior femoral cortex
(B). Between these 2 lines Harding found a high 
incidence of osteochondritis dissecans (C).
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the most common site for osteochondritis dissecans lesions on the medial 
femoral condyle (figure VI11)^®.
However in the majority of cases osteochondral defects of whatever cause are 
hard to identify on a plain radiograph 
Magnetic Resonance Imaging
Magnetic Resonance Imaging is currently the most useful non-invasive imaging 
technique for evaluating the knee figure Vllb. A study by Dipaola et al found 
that the observations made from magnetic resonance images of osteochondritis 
lesions correlated closely with those made from an arthroscopy but correlated 
poorly with plain radiographs
The International Cartilage Repair Society Magnetic Resonance Imaging 
Committee met in 2000 and suggested a fat saturated T1 weighted GRE 
(Gradient Recalled Echo) sequence using a 1 Tesla magnet or greater as one 
of the best sequences at imaging cartilage. The advantage of this sequence is 
the excellent contrast between the cartilage, which appears bright, and fluid, 
bone and fat which appears dark. This sequence has been shown to be very 
accurate in detecting cartilage defects The defects are seen as contour 
defects unlike fast spin echo sequences that appear as signal abnormalities. 
The use of fat suppression increases the dynamic range of signal intensities 
within the articular cartilage allowing the detection of more subtle changes in 
signal intensity. Also fat suppression eliminates the chemical shift artifact and 
reduces the motion-induced ghosting artifact from extra-articular fat signals
With increasing the strength of the magnet the resolution of the image improves
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The environment within the joint also influences the detection of defects by 
MRI. Kramer et al noted that detecting lesions using an MRI scanner was made
% t  t
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easier in the presence of an effusion due to the orthographic effect of free fluid 
in the joint on T2-weighted images The detection of detached osteochondral 
fragments are also made easier in the presence of free fluid such as an 
effusion
As well as detecting specific defects in the articular surface current MRI 
techniques are looking at the characteristics of cartilage itself. The water 
content of cartilage can be deduced using an MRI. This relatively new 
application of MRI could be extremely useful, since it is thought that increased 
hydration is an early indicator of disease, however these changes are small (< 
5%) and therefore difficult to detect Another possible avenue for 
development is the use of contrast agents. Magnevist or Gadolinium-DTPA^' 
(Diethylene Triamine Penta-Acetic Acid) is an ionic agent that has a negative 
charge and that is able to penetrate cartilage. This contrast agent works since 
glycoaminoglycans (GAG’s) also have a negative charge so areas within 
cartilage that have a high GAG content will have low concentration of Gd- 
DTPA^* and areas with a low GAG content will have a high concentration of Gd- 
DTPA^ From the distribution of Gd- DTPA^, areas of high and low GAG 
concentration can be determined. This technique is called delayed Gadolinium 
Enhanced MRI of Cartilage’ (dGEMERIC) and is illustrated in (figure IX). The 
results of this technique are encouraging when compared to the gold standard’ 
of estimating GAG content biochemically and histologically This agent also 
appears to increase the detection rate of defects as apposed to using an MRI 
with a non-ionic contrast such as Prohance (Bracco Diagnostics, Princeton, 
New Jersey) Using the dGEMERIC technique one cannot make an absolute 
measure of the GAG content, but it provides a baseline with which disease 
progression and therapeutic measures can be monitored.
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The techniques described above enables the detection of abnormal cartilage 
before it breaks down to form a defect within the articular surface. With early 
detection of ‘problem areas' of cartilage possible preventative or disease 
reversing techniques could be introduced. As yet these novel MRI techniques 
are not being used in routine clinical practice.
Along with detecting defects in the articular surface, a number of useful 
observations can be made of the bone underlying the lesion. The degree of 
penetration into the subchondral bone can be estimated and the presence of 
bone oedema can be observed. The presence of bone oedema can be useful in 
monitoring the success of therapeutic measures and disease progression. MRI 
can exclude other intra articular pathologies such as ligamentous disruption or 
meniscal tears.
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Proton Density Gd(DTPA)2 - Gd(HPD03A)
Figure IX. This sequence of magnetic resonance images illustrates how 
dGEMERIC imaging can visualize the glycosaminoglycan composition of 
articular cartilage.
IXa, Shows a proton density image of articular cartilage.
IXb, Following administration of a charged ionic contrast agent (Gd- DTPA^*), 
the distribution of which is dependent on the concentration of 
glycoaminoglycans (GAG’s). Areas of high concentration of GAG’s take up less 
of the contrast due to there negative charge and areas of relatively low GAG 
content will take up more of the contrast.
IXc, When the same patient is given a nonionic agent (Gd(HPD03A) the 
cartilage appears homogenous. This suggests that the selective uptake of the 
ionic contrast agent seen in IXb is due to charge and hence indicates the GAG 
distribution (Courtesy of the American Journal of Bone and Joint Surgery
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At present although there are many exciting developments in the imaging of 
cartilage using MRI, their chief use is in detecting defects and assessing the 
integrity of implants post cartilage transplantation.
Arthroscopy is at present the most useful diagnostic tool enabling the 
investigator to visualise the joint surface. In the case of a suspected 
osteochondral defect the procedure is performed using the standard technique 
through lateral and medial parapatellar portals. The site of the defect can be 
noted as well as the size and depth of the defect. At this stage the extent of the 
lesion can be graded (from 1 to 4) according to the International Cartilage 
Repair Society (ICRS) Grading System (table I). Using a probe introduced 
through one of the portals the integrity of the cartilage surrounding the defect 
can be assessed. It is also important to assess the rest of the knee for similar 
defects in the articular surface and other potential causes for the patient's 
symptoms should be excluded.
In summary the management of a suspected osteochondral defect should 
include a detailed history and examination together with plain radiographs of 
the knee and an MRI scan. Following these investigations, the presence of an 
osteochondral defect can be fully assessed by performing a knee arthroscopy.
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Management of chondral and osteochondral defects in the knee 
Non-surgical Treatment
As mentioned earlier in this review, children with osteochondral defects no 
larger than 2-3 cm in diameter with open physes are best managed 
conservatively for the first six to twelve months since the majority of their 
defects will heal. In the case of adult patients with symptomatic defects, non- 
surgical, conservative management probably has a limited role. Non-surgical 
options include a period of protected weight bearing following an acute injury 
and a course of non-steroidal anti-inflammatories. Physiotherapy may help 
regain range of motion after an injury and improve quadriceps strength.
This line of management is probably best reserved for superficial injuries that 
do not penetrate the tidemark and are asymptomatic. Long-term follow-up 
studies of superficial injuries have not demonstrated progression to 
degenerative disease ^.However there remains the concern that significant 
injury to the articular surface may progress leading to increasing pain and 
disability especially in athletic individuals. For this reason surgical options 
should be considered in adult patients with full thickness defects who are 
symptomatic.
Surgical Treatment
Over the years many techniques have been tried and tested with varying 
degrees of success. These include arthroscopic lavage and debridement of 
damaged articular cartilage, techniques that penetrate the subchondral bone, 
osteotomies, periosteal or perichondral grafting, autogenous osteochondral 
grafting (mosaicplasty), massive osteochondral allografts, autologous 
chondrocyte transplantation and the use of mesenchymal stem cells. Synthetic 
implants have also been used, such as carbon fibre pads.
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The main difficulty in comparing these various techniques is the lack of 
established criteria for determining a successful result. Many publications quote 
success in terms of excellent, good, fair and poor results but based on different 
classification systems The difficulty at present is developing a reliable and 
reproducible classification system with no inter- or intra- observer error which 
also takes into account additional factors such as site, size, depth and location 
of defect, together with other co-existing injuries.
TECHNIQUES
Arthroscopic Lavage and Debridement
The benefit of simple lavage was discovered by chance by Burman in 1935 but 
it was Jackson and Bauer who pioneered arthroscopic lavage for incomplete 
lesions of articular cartilage However a possible placebo effect has been 
noted in the literature The symptomatic benefit from this technique is thought 
to be due to the removal of loose articular debris and inflammatory mediators 
known to be produced by the synovial lining of damaged joints. Evans et al ^  
demonstrated in their study that the intra-articular injection of allogenic 
cartilaginous particles into rabbit knees resulted in synovitis and stiffness with 
concomitant destruction of articular cartilage which explained the beneficial 
effects sometimes observed in patients after lavage. Jackson et al showed 
that lavage could benefit patients with symptomatic defects with 45% of 
patients reporting an improvement at 3% years. Better results were seen when 
debridement (removal of loose fragments of cartilage) was performed as well 
as lavage. In a review of 137 patients, 88% experienced improvement with 68% 
continuing to have some benefit at 3 years.
Hubbard reported in a prospective randomised trial comparing arthroscopic 
debridement with washout that at 1 year the mean improvement in a modified
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Lysholm score was 28 for the debridement group but only 5 for the washout 
group. At 5 years the mean Improvement for the debridement group was 21 but 
only 4 for the washout group. In this report Hubbard does not mention the 
defect size and all defects were located on the medial femoral condyle, an area 
of the knee that responds well to treatment. He does not comment on whether 
the defects progressed in terms of joint space narrowing on follow-up 
radiographs or at follow-up knee arthroscopies.
Debridement and washout at best only gives short term relief without 
addressing the underlying pathology. There is the concern that damage to 
articular cartilage be extended by the debridement and may progress in an 
active patient who continues to perform high impact loading through the site of 
injury. For this reason this treatment has little role in the management of 
isolated full thickness defects in articular cartilage in the young active patient.
Techniques that penetrate the subchondral bone -  * marrow stimulation’
There are various techniques of subchondral bone penetration, which are used 
to encourage a repair of the defect. By penetrating the subchondral bone 
numerous pluripotential mesenchymal stem cells are released together with 
some bleeding into the defect. The resulting blood clot fills the defect and with 
time differentiates into a fibrocartilaginous repair.
1. Subchondral Bone Drilling
Pridie observed in the late 1950’s that patients who had had drilling to the base 
of a cartilage defect had developed a smooth fibrocartilage cover over the base 
of the defect on subsequent re-exploration The procedure is still very much 
in use today. At arthroscopy once the lesion has been identified and debrided,
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Figure X. Drilling of an osteochondral defect following 
debridement of a defect over the medial femoral condyle (Courtesy 
of the British Journal of Bone and Joint Surgery).
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a 2 mm Kirschner wire is used to drill multiple holes into the highly vascularised 
subchondral bone (figure X). This encourages a bleeding response that 
ultimately results in healing by fibrocartilage. In placing the multiple drill holes, 
adequate spacing between the holes must be made to ensure that no fracture 
occurs between them®®.
Mitchell et al used this technique in treating defects that had been artificially 
created by scraping away the cartilage using a scalpel in mature rabbits. In one 
knee the defect was drilled with 20-30 holes of 1 mm in diameter through the 
subchondral bone. The cartilage in the other knee was removed in a similar 
fashion but was not drilled and was used as a control, interestingly at 2 and 4 
months after the drilling the repair material resembled hyaline cartilage but at 
12 months the repair more closely resembled fibrocartilage. In contrast the 
controls did not develop any reparative tissue in the defects.
Pridie’s experience with the procedure was reported in 1967, 46 (77%) out of 
60 patients felt that the operation was a success. However fourteen patients 
were not happy and reported that they would not have the operation again, 
although some admitted that they had noticed a slight improvement. Of the 
group that said that they were not happy, five said their symptoms were in fact 
worse after the procedure
Tippet reported on 133 osteoarthritic knees that had a combined osteoplasty
and osteotomy. The osteoplasty was performed by removing the damaged
cartilage and then drilling multiple holes 3-4 mm deep and 2-3 mm apart. Tippet
advised drilling at a slight angle to increase the surface area for forming
cartilage as well as offering some sort of protection to the fibrous clot from
disruption when the knee flexes and extends. The results at a mean of sixty-two
months follow up revealed that 70.8% had excellent results, 15.4% good, 6.9%
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fair and 6.9% poor, with complete pain relief in 68.5%. These results were 
reported as superior to that of osteotomy alone
Childers et al reviewed 25 patients with chondromalacia patellae who had a 
partial chondrectomy and drilling to the defect following failed conservative 
treatment. The damaged articular cartilage over the retropatellar surface was 
excised down to the subchondral bone and then multiple small holes were 
drilled into the defect. Patients were allowed to partially weight bear with two 
crutches as soon as comfort allowed. Twenty-two of the 25 patients achieved 
good or excellent results at a mean follow up of 24 months. The authors noted 
that two of the three failures were over thirty years of age.
In 1978 Bentley reported 56% satisfactory results following cartilage excision 
and drilling of he subchondral bone for grade II defects (Outerbridge 
attributed to chondromalacia patellae. The mean follow up was seven years. 
Lesions that were more extensive than grade II, produced unsatisfactory results 
in this patient group.
In summary, short-term results appear good in patients noticing an 
improvement in their symptoms especially with small lesions but long-term 
follow up results are disappointing
2. Abrasion Chondroplasty
The abrasion technique involves using a motorised burr to abrade through the 
full thickness of the damaged cartilage down to the subchondral bone to 
precipitate bleeding and the release of mesenchymal stem cells from the 
marrow.
Kim et al performed a study using a rabbit model to compare chondral 
shaving with abrasion chondroplasty. With chondral shaving a motorized
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shaver was used to excise an area of cartilage leaving as smooth a surface as 
possible (partial thickness). The results revealed that none of the defects that 
were produced by shaving filled with repair tissue at 4 or 12 weeks. However, in 
the case of abrasion chondroplasty using a motorized burr to abrade through 
the full thickness of the cartilage down to subchondral bone, repair tissue was 
found to fill the defect in 17 out of 19 animals at 4 weeks and 18 out of 20 at 12 
weeks. This study also assessed the effects of continuous passive motion. It 
was observed that the animals in the abrasion group who had continuous 
passive motion had defects that completely filled with repair tissue and those 
that had intermittent active motion the defects only partially filled. The nature of 
the repair tissue following abrasion ranged from fibrous to hyaline like cartilage 
at 12 weeks.
Concerns have been raised that the use of a rotary burr to abrade cartilage 
may cause thermal necrosis of the underlying bone although abrasion did 
not appear to effect the repair in Kim’s study.
Johnson reported on a series of 95 patients with a mean age of 60 years, 
who had changes on knee radiographs consistent with degenerative arthritis. At 
a minimum of 2 years post abrasion chondroplasty, 74 patients said they were 
better, 15 said they were worse, 7 were the same and 3 failed to answer. At the 
same follow-up, 64 patient knees had comparisons made between their pre and 
post-operative standing AP radiographs. Half were reported to have wider joint 
space, which was attributed to a fibrocartilage repair. Johnson did not report on 
those patients who had a wider joint space on their postoperative radiograph, 
whether they noted an improvement in their symptoms. The author concluded 
that this procedure was best reserved as a palliative technique in patients with 
rest or night pain who were not particularly active.
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Friedman et al published results following a retrospective study of 
arthroscopic debridement and abrasion chondroplasty. He found a 60% 
improvement in patients post surgery at a mean follow up of 12 months and 
found the best results in patients under 40 years. From their experience of the 
technique they noted an advantage over other techniques in that difficult to 
reach areas such as the patellofemoral joint using the drilling technique can be 
readily accessed by the abrader.
Bert and Maschka performed a retrospective review of 126 patients who had 
abrasion arthroplasty plus arthroscopic debridement or arthroscopic 
debridement alone. Mean follow-up was 60 months. In the group treated with 
abrasion, 51% had good or excellent results, 16% fair and 33% poor results. 
The remaining patients who had arthroscopic debridement alone 66% had good 
to excellent results, 13% had fair and 21% poor results. The interesting 
observation made in this study was there appeared to be little correlation 
between the patients' symptoms in terms of pain and disability with the extent 
of the patients’ pathology. A prime example was a patient who had a good 
cover of fibrocartilage following an abrasion chondroplasty yet clinically 
complained of intense pain and required a prosthetic joint replacement. Hence 
the results of this technique appear unpredictable. Bert went on to conclude 
that although debridement of defects can reduce symptoms, abrasion 
arthroplasty does not appear to benefit patients who have osteoarthrosis of the 
knee and may even increase their symptoms.
The majority of long-term follow up studies for abrasion chondroplasty have 
been performed on patients with osteoarthritis rather than isolated 
osteochondral defects. The unpredictable results mentioned above are almost 
certainly due to the co-existing factors of diffuse knee joint involvement, which
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occur with arthritis. Johnson considered this procedure as palliative in 
patients with a degenerative knee condition who are not particularly active. 
There are better alternatives to the technique in the management of patients 
with discrete osteochondral defects with no evidence of arthritis.
3. Spongialization
Ficat et al described an extension of the technique that Pridie pioneered 
although not too dissimilar from the abrasion technique described above. This 
entailed resecting en block all of the diseased cartilage with its underlying 
subchondral bone, leaving a completely exposed cancellous bony bed. The 
authors called this technique ‘spongialization’ since it exposed the spongiosa’ 
found beneath the subchondral bone. They considered it necessary to remove 
the entire subchondral bone underneath the damaged cartilage since it too was 
abnormal. By removing the highly innervated subchondral bone associated with 
the damaged articular cartilage, they supposed that the pain would be 
alleviated. They felt that the depression created by the technique was important 
since it created an area, which could be filled with repair tissue without affecting 
the mechanics of the joint. They reported on 85 patients who underwent the 
procedure for chondromalacia patellae, 79% had a good or excellent result at a 
mean follow up of 15 months. However despite these encouraging results there 
are no long term follow-up reports in the current literature.
4. Microfracture
This technique has similarities to the subchondral bone drilling described by 
Pridie in that the aim is to penetrate the subchondral bone provoking 
bleeding and healing by fibrocartilaginous repair. An arthroscopic awl (figure
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XIa) is used to make the microfractures (figure Xlb). This procedure for 
repairing defects is thought to cause less thermal necrosis of the underlying 
bone and surrounding tissues compared with a motorized burr for example. As 
previously described, the area of damaged cartilage should be removed before 
microfracturing commences There have been reports that this technique is 
able to generate repair tissue, which is made up of a mixture of hyaline and 
fibrocartilage and found to completely fill the defect .
Steadman et al reported pain relief at 3 to 5 years in 75% of patients, 
although 20% remained unchanged and 5% were worse. An assessment of 
activities of daily living revealed an improvement in 67% of patients with no 
changes in 20%, the remaining 13% were made worse. Patients who played 
sports and other high activity pursuits noted an improvement of 65%.
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Figure XIa. Photograph of arthroscopic awls with 
conical shape angulations of 30°, 45° and 90° 
^°^.(Courtesy of the American Journal of Bone and Joint 
Surgery).
Figure Xlb. Picture taken at arthroscopy showing 
the microfracture technique to a defect over the medial 
femoral condyle^(Courtesy of the American Journal of 
Bone and Joint Surgery).
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Carbon Fibre Matrix Support Prostheses
Muckie and Minns reported the use of a woven carbon fibre pad as a 
scaffold for supporting fibrocartilaginous repair tissue in the repair of 
osteoarthritic cartilage. Following the identification of a suitable defect the 
damaged cartilage is removed and the area is debrided down to the 
subchondral bone. The edge of the defect is then probed and if unstable is 
debrided back to stable, healthy cartilage. The defect is drilled to provoke 
bleeding and a patch of woven carbon fibre that has previously been cut to size 
is positioned within the defect. Care is taken to position the edges of the patch 
beneath the rim of the surrounding cartilage. No fixation is required since the 
carbon fibre pad is a press-fit ‘ and becomes impregnated with blood clot within 
a few minutes of tourniquet release, securing the pad to the defect. Muckie and 
Minns reported that both animal and clinical studies showed that the carbon 
fibre pads became filled with strong fibrous tissue made up of predominantly 
type I collagen. They observed that endochondral ossification occurred within 
the pad adjacent to the subchondral bone, ensuring a secure fixation for the 
graft. They demonstrated that this technique was able to produce a smooth 
conforming surface, which was continuous with the adjacent articular cartilage. 
Results from this study revealed that 77% of patients had a good or excellent 
clinical response at 3 years with no synovitis
Bentley et al reviewed a series of 79 patients at a mean follow up of 6 years 
post surgery. In patients that had a femoral condylar repair 77% had a good or 
excellent result with 93% good or excellent for those with medial femoral 
condyle defects. However, repairs to patellar defects were less successful with 
only 49% with good or excellent results and 20% who required patellectomy. A 
study by Meister et al reported on 27 patients with painful articular defects of
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the patella who underwent this technique. The mean age of the patients (8 
male, 19 female) was 29.8 years with a mean defect size of 2.1 cm .^ There 
were 4 excellent, 3 good, 7 fair and 13 poor results. Nine patients subsequently 
had a patellectomy for persistent pain at a mean of 27 months after surgery. 
Patient satisfaction was 41%. On review of the grafts at arthroscopy the results 
were encouraging with good incorporation of the carbon fibre pads. However, 
the poor clinical outcome together with seeding of the joint with carbon fibre 
debris and histiocytic giant cell reaction in the synovium were cause for 
concern.
This repair is thought to give a firmer repair than more traditional procedures 
such as drilling, abrasion chondroplasty and microfracture. Although initial 
results were encouraging there are concerns about the long- term viability of 
such a repair.
Osteotomy
Osteotomies can be performed alone or with other techniques in the treatment 
of osteochondral defects or unicompartmental osteoarthritis.
Limb malalignment is a significant predisposing factor for the development of 
osteochondral defects. Maquet et al showed with varus knees, loads 
through the medial compartment were greater than those through the lateral 
compartment. Thus, genu varum may cause progressive articular cartilage 
damage. It was reasonable to assume that correcting the varus deformity would 
stop this progression. Re-alignment surgery to correct a varus or valgus 
deformity can redistribute load bearing through intact articular cartilage rather 
than through the damaged area. Osteotomies can be performed either above or
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below the knee in the form of an opening or closing wedge distal femoral 
osteotomy or high tibial osteotomy. The choice of osteotomy depends on the 
site of the deformity.
Jackson and Waugh were the first to publish results of the upper tibial 
osteotomy. In total 11 patients with a mean age of 60 years were reviewed over 
a 6 year period, with a mean follow up of 31 months. The indications for surgery 
in all patients was a disabling pain attributed to osteoarthritis unrelieved by 
conservative treatment, a valgus/varus deformity and a range of knee flexion 
greater than 90®. Of the 11 patients, 7 had a valgus and 4 had a varus 
malalignment. The osteotomy was performed through cancellous bone at the 
level of the tibial tubercle. The fibula was also divided through a separate 
incision over its middle third. Initially, the tibial osteotomy was outlined by a 
series of drill holes and was competed with a gouge. The soft bone allowed 
easy angulation and no internal fixation was used. The leg was immobilised 
post operatively in a long leg plaster cast. Post-operative radiographs were 
performed to confirm satisfactory alignment and the plaster was wedged if 
necessary. Weight bearing was allowed after 4 to 6 weeks. At 8 to 10 weeks 
the knee was mobilised and most patients achieved 90° of flexion at 2 to 6 
weeks from the time the plaster was removed. All patients reported
considerable improvement in their pain, with all but 1 patient gaining 
satisfactory range of movement. I patient died in the first year due to unrelated 
causes.
Coventry advocated this approach since it involved bone that would heal 
rapidly, allow early motion of the knee and early weight bearing and allowed 
exploration of the knee at the time of the osteotomy if required. Coventry’s early 
results from 1 to 4 years after surgery reported 12 out of 22 patients had
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satisfactory results, 1 patient who died of unrelated causes, 6 patients who had 
been operated on too recently to be evaluated and only 3 patients who reported 
an unsatisfactory result
Subchondral bone, which is highly innervated, becomes sensitive to pressure if 
the overlying cartilage is softened or damaged. Osteotomies may relieve pain 
by reducing the pressure on damaged articular cartilage and so reduce the load 
transmitted to the underlying bone.
Bergenudd et al reported on 19 patients with degenerative disease of the 
medial compartment of the knee. A proximal tibial closing wedge osteotomy 
was performed using a metal staple fixation (Figure XII) on the lateral side 
aiming for 4® of valgus over correction. A biopsy was made after a mean follow 
up of 26 months, 9 of the 19 patients showed signs of a fibrocartilage repair, 8 
patients did not show any change and 3 showed evidence of deterioration. A 
clinical evaluation at 2 years revealed 14 patients had good or excellent results.
There was no correlation between the finding of a fibrocartilaginous repair and 
relief of symptoms. There was also no correlation between the clinical result 
and radiographic observations and the post operative varus-valgus angle.
Ivarsson, Myrnerts and Gillquist reported on 81 knees at a mean follow up of 
5.7 years and 65 knees at a mean follow up of 11.9 years that underwent a 
closing wedge tibial osteotomy with staples, for medial compartment 
osteoarthritis of the knee. At 5.7 years, 57% of patients reported a good result 
and 78% acceptable. At 11.9 years, 43% reported a good result and 60% 
acceptable. There was deterioration of 20 knees. In most cases the 
deterioration occurred between 8 and 9 years post surgery. They also reported 
that overcorrection of 3-7° valgus gave the best results based on observations
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Figure XII. AP Radiograph taken whilst the patient was standing following a 
lateral closing wedge osteotomy of the right knee (patient previously had an 
anterior cruciate ligament reconstruction)
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at 5 years post osteotomy.
An opening wedge high tibial osteotomy has also been described. Hernigou et 
al and Moroni et al have reported favourable results with this technique in 
patients with medial compartment osteoarthritis. More recently Puddu et al 
made a modification to this technique which was later described by Fowler et al 
Pre-operatively, long leg, weight bearing radiographs were obtained so that 
the degree of correction could be estimated (Figure Xllla). The osteotomy was 
performed through a vertical incision centred between the anterior tibial 
tubercle and the posteromedial border of the tibia. Once the proximal tibia was 
exposed under fluoroscopic control a guide pin was drilled through the proximal 
tibia from medial to lateral. The guide pin was positioned so that it was 4cm 
below the medial joint line and 1 cm below that lateral joint line. An oscillating 
saw was used to cut the medial cortex only and was positioned immediately 
below and parallel to the guide pin to help prevent an intra-articular fracture. 
Using small flexible osteotomes the osteotomy site was gradually opened up. A 
calibrated wedge was advanced into the osteotomy site until the osteotomy had 
been opened sufficient to correct the malalignment. This was further evaluated 
using an extramedullary alignment guide. A 4 hole Puddu plate (Arthrex, Inc, 
Naples, FL.) was inserted into the osteotomy site, and with the leg in extension 
it was secured with 2 cancellous screws proximally and 2 cortical screws 
distally (figure Xlllb). The majority of authors recommend bone grafting 
osteotomies greater than 7.5mm to prevent delayed or non union. Patients with 
an intact lateral cortex can partially weight bear in a cast brace from day 1, then 
fully weight bear at 6 weeks. Noyes et al reviewed a total of 55 patients over
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Figure Xllla Figure Xlllb
Figure XIII Pre-operative (a) and post-operative radiographs (b) of a left knee 
showing a correction of a varus malalignment using an open wedge, medial, 
high tibial osteotomy with a Puddu plate (Arthrex, Inc, Naples, FL.)
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a mean follow up period of 20 months where the osteotomy united in all 
patients, although 3 patients had a delayed union and 1 patient required 
revision since he mobilized fully weight bearing from the start resulting in the 
plate failing.
There has been some success with combined procedures. Tippet reviewed 
133 patients who either had a combined osteotomy and subchondral drilling or 
osteotomy alone. The combined group did better, although this was for 
unicompartmental osteoarthritis and not focal osteochondral defects. More 
recently osteotomies have been combined with chondrocyte transplantation 
techniques as a one stage procedure with encouraging results (unpublished 
data, RNOH).
The majority of studies have been published on osteotomies for osteoarthritis 
as apposed to discrete osteochondral defects and the long-term studies have 
been disappointing i20;i2i
However, with limb malalignment being one of the predisposing factors for the 
development of focal defects in articular cartilage, a corrective osteotomy can 
be useful in the management of these patients as noted by Minas and Nehrer 
in their review of articular cartilage defects and their management.
All the techniques mentioned so far may result in the defects being filled with 
repair tissue that is predominantly fibrocartilage. It has been well established 
that the mechanical and biochemical properties of fibrocartilage are inferior to 
that of hyaline cartilage. It has poor resilience to compressive forces, poor wear 
characteristics and tends to breakdown with time. With this in mind 
considerable research has been undertaken to develop techniques that can fill
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a defect in the articular surface with hyaline cartilage that can alleviate 
symptoms and give a long lasting repair.
Perichondria! and periosteal grafting
This technique takes advantage of the fact that the cambium layer of 
periosteum or perichondrium possesses multipotent mesodermal cells. Rubak 
et al 2^3:124 showed that free periosteal grafts transplanted to defects surgically 
created over the femoral condyles in rabbits could result in hyaline-like repair 
tissue that closely resembled the surrounding articular cartilage. Rubak 
concluded that the repair tissue generated was not only like normal articular 
cartilage but originated from the periosteum. Interestingly, the post-operative 
rehabilitation proved crucial on the nature of the repair. Immobilisation 
appeared to inhibit the development of a hyaline-like repair and mobilisation a 
stimulatory effect In the clinical setting there has been some success with 
this technique in treating degenerative metacarpophalangeal joints with rib 
perichondrium The problem with larger joints such as the knee for example 
is being able to attach the graft securely.
Early results for this technique using either rib perichondrium or periosteum 
from an area adjacent to the tibial tuberosity were encouraging. However, more 
long-term follow-up has not been as encouraging. Augerman et al reported 
that 9 out of 14 patients had severe or consistent pain at 8 years follow-up 
having had a periosteal graft. Arthroscopic or MRI assessment revealed that 
less than half of the defects were % filled. Other studies have also documented 
similar poor long-term results
The use of perichondrium has a significant limitation in the fact that it is largely 
found covering the cartilage between the sternum and the ribs. This limits the
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graft size and often several ribs must be stripped to obtain sufficient 
perichondrium. Long-term problems encountered with perichondrium include 
endochondral ossification and delamination of the cartilage from the underlying 
bone For these reasons the role of perichondral or periosteal grafts alone in 
the treatment of osteochondral defects is limited.
Osteochondral Allografts
Osteochondral allografts tend to be used in the repair of large defects such as 
trauma cases, osteonecrosis or following excision of tumours The great 
advantage of using an allograft is that the shape of the graft can be matched to 
the exact contour of the recipient site, since the graft can be taken from the 
same location on the donor as the recipients’ defect (orthotopic grafting). This 
overcomes the difficulty of trying to restore the normal contour of the articular 
surface by other means and also avoids the morbidity associated with 
harvesting large quantities of articular cartilage from the patient as in the case 
of a mosaicplasty.
With this technique comes the risk of transmission of infectious diseases such 
as HIV and Hepatitis B and C from the donor tissue. Before any allograft 
transplantation the donor is screened although the risk of disease transmission 
cannot be completely eliminated
Another factor to consider with an osteochondral allograft is the possible 
reaction of the recipients’ immune system. Articular cartilage is considered an 
immunologically privileged tissue This can be attributed to two reasons. The 
fact that articular cartilage is avascular isolates it from the immune system and 
although antigens are found on chondrocytes they are protected from exposure
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to the recipient by their surrounding matrix If articular cartilage could be 
transplanted from donor to recipient without the attached subchondral
bone then no immunologic considerations would have to be made. However 
allografts must be transplanted with bone attached to secure them to the host 
bone Subchondral bone possesses many antigens, which could precipitate 
an immunologic rejection. Although freezing has been used to reduce this 
response it also reduces the number of viable chondrocytes in the graft
The limited availability of fresh material for osteochondral allografting has 
resulted in considerable efforts in improving the viability of chondrocytes post 
freezing. Damage to cells through freezing is thought to occur as intra and 
extra-cellular water converts to ice crystals. This tends to occur between 0® and 
-40®. By gradually cooling cells at a rate slow enough to allow water to 
equilibrate across the cell membrane should ensure a minimum amount of 
intra-cellular ice to form. Following slow freezing down to -40®, more rapid 
freezing can then occur down to -80®
Various agents have been used in an attempt to protect the chondrocytes from 
the effects of freezing with limited success. Dimethylsulfoxide (DMSO) is able 
to protect isolated chondrocytes but poorly penetrates the extracellular matrix of 
articular cartilage and so offers protection to cells in the superficial zone only
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Mahomed et al reported on 91 patients who had fresh small fragment 
allografts for defects sustained following trauma in the knee. In this study, 
patients who required correction of a malalignment also had an osteotomy. At 5 
years post-transplantation 75% of cases were reported as a clinical success, 
64% at 10 years and 63% at 14 years. Unipolar grafts, involving only one
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surface of the compartment had a lower failure rate compared with bipolar 
grafts and younger patients (less than 60 years) did better.
A study by Chu et al reported on 55 patients of 45 years or less with a mean 
follow up of 75 months. Following unipolar grafts 76% had a good or excellent 
result and 50% for bipolar grafts.
Newman ^  in his review of the subject concluded that there were a number of 
factors important for the success of an osteochondral allograft: 1/ That the graft 
should be orthotopic, matching the exact surface contour and height of the 
recipient site and fixed firmly. Any unevenness in the surface is associated with 
a bad outcome; 2/ Young donors are preferable; 3/ Resorption of bone in the 
graft carries a poor prognosis.
Regarding the last point, in the majority of instances the bone underlying the 
cartilage in an allograft is dead and it has been postulated that the recipients' 
bone replaces the necrotic bone of the graft by ‘creeping substitution’, during 
the period of non-weight bearing post-operatively. Gross et al reported on 9 
transplantations, that showed that the grafts united with replacement of the 
bony part of the graft by host bone with minimal collapse in only one case
In summary there maybe an indication for osteochondral allografts as an 
alternative to prosthetic joint replacement in the management of young patients 
with large unipolar defects who lead an active life. However concerns remain 
about the long-term viability of the donor chondrocytes and the risks of the 
transmission of infection.
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Autogenous osteochondral Grafting
A study by Outerbridge H.K. et al reported on a small series of patients who 
had osteochondral defects over a femoral condyle repaired by plugs of cartilage 
and bone harvested from the patella. Once the defect had been identified at 
arthrotomy, the damaged area of the articular cartilage was excised down to 
cancellous bone using a narrow osteotome. The defect was shaped so that it 
had 4 walls perpendicular to the surrounding articular cartilage surface with 
bleeding cancellous bone at the base. The base of the defect was drilled with 5- 
10 holes of 2 mm in diameter and one of the walls of the defect was 
undermined. Using a saw a corresponding plug of cartilage with its attached 
subchondral bone was excised from the lateral facet of the patella and shaped 
to the contours of the defect and gently pushed into the defect. The surface of 
the graft was made flush with the rest of the articular surface. Post operatively 
the patients were placed on a continuous passive motion machine and were 
allowed brief periods of partial weight bearing. At a mean follow up of 6% years 
post transplantation all 10 patients who were reviewed reported an 
improvement in their knee function and relief of their symptoms.
Hangody described a technique in 1997 involving the transplantation of 
multiple osteochondral plugs for the treatment of symptomatic full thickness 
defects affecting the femoral or tibial condyles. At arthrotomy the damaged area 
of articular cartilage is located and excised and the surrounding cartilage is 
debrided back to a stable rim. The base of the defect is lightly abraded to 
promote fibrocartilage filling between the osteochondral plugs. A calculation is 
made based on the size of the defect to assess the number of plugs required to 
fill the defect. In the case of large defects multiple osteochondral plugs can be 
harvested. Using special instruments grafts are harvested from the extreme
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medial or lateral aspects of the trochlea from the non- weight bearing area of 
the articular surface. Multiple drill holes are made in the base of the defect 
ensuring that they are perpendicular to the joint surface. The holes should be 2 
mm deeper than they need to be to ensure that the grafts do not sit proud of the 
articular surface.
Smaller holes can be drilled between the larger ones taking care to leave 
enough intact bone between them. With the knee in flexion the plugs are 
guided into place by gentle impaction so that the surface of each graft lies flush 
with the rest of the articular surface (figure XIV).
Smaller grafts can be impacted between the larger ones. Once the surgeon is 
happy that the grafts are seated correctly the knee can be closed in the 
standard fashion. Patients spend up to 10 days with the knee immobilised in 
extension in a plaster cast Some authors advocate a period of non-weight 
bearing post surgery whereas others recommend partial weight bearing 
from day 1
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Figure XIV. An intra operative photograph following the 
transplantation of multiple osteochondral plugs to a defect over the 
medial femoral condyle.
(Courtesy of G. Bentley)
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Hangody reported encouraging results on 113 patients with more than 3 
years follow-up. At a second look arthroscopy the donor sites had healed with 
fibrocartilage, none of the grafted cartilage plugs had displaced and biopsies 
showed that the plugs retained their hyaline character.
More recently Noras reported on 20 patients treated with this technique, 16 
had a lesion on the medial femoral condyle and 4 on the lateral femoral 
condyle. Seventeen patients reported substantial improvements at 2 years 
follow-up.
Hangody reported on his recent results on patients reviewed over a 10 year 
period, 92% reported good to excellent results for defects over the femoral 
condyle, 87% for tibial plateau defects and 79% of those who had repairs to 
patellar or trochlear defects. Unfortunately Hangody does not mention the size 
of the defects repaired although does say the ideal diameter of the defect 
should be between 1 and 4 cm .^ Although the patients were followed up over a 
10 year period there is no mention of the mean follow-up time.
In a randomized, controlled, clinical trial Bentley et al ^  reported on 42 patients 
who underwent a mosaicplasty to defects with a mean defect size of 4.66cm^, 
29 (69%) had good or excellent results at 1 year, although they appeared to 
deteriorate with time. Arthroscopic examination revealed fair or poor results in 
66% of patients. Five patients had mosaicplasty to the retropatellar surface, 
none of which had a good result. It was suggested that the poor results in the 
case of the patellar defects could be attributed to the differing thicknesses of 
donor and recipient articular cartilage.
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The inherent weakness for this technique is that the gaps between the 
osteochondral plugs heal by less resilient fibrocartilage. In all cases in this 
study the harvest sites had healed with a fibrocartilage repair.
The majority of studies published to date have a short follow-up with only a few 
long-term studies. With the concerns of donor site morbidity and poorer results 
for patellar defects this technique may have a limited role in the management of 
small defects over the femoral and tibial condyles.
Bentley et al reported on patients with a mean defect size of 4.66 cm*, Hangody 
mentioned that the ideal defect size should be between 1-4cm* but didn’t 
mention the mean defect size in his results. This suggests mosaicplasty 
probably does not have a role in the management of defects of 4 cm* or larger.
This technique should probably be avoided in patients with bipolar lesions 
affecting both joint surfaces due to the concerns of the grafts dislodging as they 
catch one another with flexion and extension of the knee.
Autologous chondrocyte implantation in the knee
The aim of any cartilage repair technique is to relieve the patients’ symptoms, 
restore the articular surface and prevent progression to early osteoarthritis. 
Articular hyaline cartilage has many unique characteristics that enable it to 
withstand very high compressive forces and shearing stresses. Therefore any 
substitute for articular cartilage must possess characteristics as close to that of 
hyaline cartilage as possible. A number of techniques have already been 
described which endeavour to replace the defect with hyaline cartilage such as 
osteochondral allografts and autogenous osteochondral grafts. There has been 
some success with these techniques but concerns such as disease
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transmission in the case of allografts and harvest site morbidity in the case of 
autogenous grafts remain.
The origins of autologous chondrocyte implantation can be traced back to 1965 
following the isolation of adult articular chondrocytes in suspension by Smith 
In 1968 Laurence and Smith demonstrated that isolated epiphyseal 
articular chondrocytes survived when implanted into fractures in rabbits^^®. 
Bentley and Greer went on to show that isolated chondrocytes could be 
used for repairing defects of the articular surface in an animal model. In this 
study chondrocytes were taken from rabbits before they had reached skeletal 
maturity because of the ability shown by Mankin  ^® that these chondrocytes 
were able to divide. However, once past skeletal maturity chondrocytes more or 
less lost this ability. Bentley and Greer demonstrated that both isolated 
epiphyseal and articular chondrocytes could be used to repair articular cartilage 
defects.
The next stumbling block was to be able to expand the number of chondrocytes 
ensuring that the cultured cells retained their ability to produce type II collagen. 
Green described a technique of culturing chondrocytes after they had been 
isolated from the extracellular matrix by enzymatic digestion. During the 
expansion, the cells gradually dedifferentiate and lose their ability to 
manufacture type II collagen, however they regain this ability once exposed to 
agarose gels Aston and Bentley showed that by growing chondrocytes at 
high density the phenotype was preserved and the cells produced type II 
collagen jh e  ability to expand the numbers of adult chondrocytes in a 
monolayer culture proved a significant advance in the treatment of 
osteochondral defects using autologous cells. Peterson et al reported on 
the repair of defects in skeletally mature rabbits with autologous or homologous
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cultured chondrocytes. Cartilage plugs were removed from the mid patellae and 
enzymatically digested and grown in a monolayer culture for 2 weeks. Then 
pellets of chondrocytes were implanted into artificially created defects and 
covered with either a layer of fascia, synovium, blood clot, tendon or 
periosteum. Results were encouraging with a total reconstitution of full 
thickness 3 mm defects with hyaline cartilage. In 1987 Grande et al reported 
on an animal study using autologous chondrocytes grown in vitro, 82% of the 
defect was reconstituted with repair tissue compared with 18% in the ungrafted 
controls. To keep the chondrocyte suspension within the defect the cells were 
injected under a periosteal flap, which had been sutured to the rim of the 
defect. Using autoradiography it was established that the repair tissue had 
labeled cells incorporated within it. From these results it could be concluded 
that the implanted cells had a part to play in the formation of the repair tissue. 
Brittberg et al reported on 23 patients treated with this technique. None of the 
defects extended beyond the subchondral bone. Patients’ symptoms included 
pain, locking, swelling and retropatellar crepitus. The mean age of the patients 
was 27 years and the mean defect size was 3.1 cm .^ The procedure is divided 
into 2 stages. At the first stage 300-500 mg of cartilage is harvested 
arthroscopically from a minor load bearing area of the upper medial femoral 
condyle of the damaged knee. Care should be taken to ensure that a full 
thickness piece of cartilage is removed without damaging the deep layers of the 
specimen and not to violating the subchondral bone The specimen is then 
removed from the knee via one of the arthroscopy portals. The cartilage biopsy 
is then put into a sterile container and transferred to a laboratory. In the 
laboratory the specimen is enzymatically digested releasing the chondrocytes, 
which are then grown in a monolayer culture. The patient is readmitted 21-28
83
days following the harvest of cartilage and the second stage of the procedure is 
performed. To ensure a bloodless field a tourniquet is applied and a medial or 
lateral parapatellar arthrotomy is performed depending on the location of the 
defect. Intravenous antibiotics are administered over the peri-operative period 
as prophylaxis against infection. Once the defect is identified it is debrided back 
to a stable rim of normal cartilage. The base of the defect is also debrided down 
to the subchondral bone, taking care not to make it bleed (figure XV a). A 
periosteal flap is harvested from the proximal medial tibia and sutured with 5 0 
Dexon sutures to the rim of the defect.
The cultured chondrocytes are then injected underneath the periosteal flap into 
the defect (figure XV b). The knee is then closed in the standard way. In 
Brittbergs' original study the patients' knee was placed in a small elastic 
bandage and active movement without weight bearing was initiated 2-3 days 
post surgery. Weight bearing was introduced gradually with exercises to 
strengthen the quadriceps mechanism over the 8 week period post surgery.
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iFigure XVa Figure XVb
Figure XV. a. Photograph showing an osteochondral defect over the 
medial femoral condyle post debridement, b. Photograph of defect 
immediately following an autologous chondrocyte implantation with 
periosteum cover (A) secured with multiple sutures (B).
(Courtesy of The Center for Orthopaedics & Sports Medicine ,1211 Johnson 
Ferry Rd., Marietta, G.A.)
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Subsequent studies have revealed that up to 50 times the original number of 
cells can be cultured Le Baron and Athanasiou performed a study 
seeding a manufactured scaffold with chondrocytes, they reported that 
scaffolds with less than 10 million cells/ml resulted in poor cartilage formation. 
Puelacher et al noted that scaffolds seeded with 20-100 million cells/ml 
resulted in cartilage formation when implanted subcutaneously into nude mice. 
However in normal articular cartilage there is only 10,000 cells/mm*. Possible 
reasons for the relatively high concentration of cells needed for a successful 
repair may be because a large number of implanted cells undergo apoptosis 
once they are implanted into the defect or perhaps it is the physical crowding of 
the cells that is needed for them to redifferentiate into type II secreting 
chondrocytes. Brittberg et al in their recent review advocated using 30x10® 
cells/ml in the clinical setting.
Brittberg classified the patients clinical outcome as excellent (no pain, 
swelling or locking with strenuous activity), good (mild aching with strenuous 
activity but no swelling), fair (moderate pain with strenuous activity and 
occasionally swelling but no locking) or poor (pain at rest, swelling and locking). 
Of those patients with repairs to condylar defects, 14 of the 16 patients had 
good or excellent results. When these patients had a second look arthroscopy, 
the grafts were level with the surrounding articular cartilage and were firm to 
probing. Biopsies taken of the grafts from the good/excellent group revealed on 
histological analysis the appearance of hyaline cartilage in 11 of the 15 patients 
biopsied. Immunostaining for type II collagen in biopsy specimens from 5 
patients were positive. In common with other repair techniques the patellar 
defects did not do so well with only 2 out of 7 patients reporting a good or 
excellent result. The authors suggested that the poor outcome for patellar
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defects maybe due to additional pathology such as abnormal patellofemoral 
joint mechanics that were not corrected at the time of the procedure.
Encouraged by these results variants of autologous chondrocyte implantation 
have been tried in approximately 1 0 ,0 0 0  patients worldwide 
In 2002 Peterson and Brittberg et al reported on the long-term durability of 
autologous chondrocyte implantation. They evaluated 61 patients who had 
been treated for isolated cartilage defects over the femoral condyle or patella, 
with a mean follow up of 7.4 years. Defects ranged from 1.3 to 12.0 cm .^ After 2 
years 50 of the 61 patients had good or excellent results. When reviewed again 
at 5-11 years later, 51 of the 61 patients had good or excellent results. These 
results suggested that long-term symptom relief could be achieved with this 
technique. In general other techniques that aim to resolve patients symptoms 
associated with lesions of the articular cartilage are not as durable. Hubbard et 
al reported 80% success at 1 year following debridement but this reduced to 
59% at the 5 year mark Similarly, defects repaired by fibrocartilage following 
arthroscopic abrasion arthroplasty tended not to last beyond the 4 year mark 
Several hypotheses have been identified to explain the mechanism of cartilage 
repair in autologous chondrocyte implantation. Minas and Nehrer suggested 
three possible mechanisms. The first is that the implanted chondrocytes re­
populate the area of the defect and synthesize a new cartilage matrix. The 
periosteal patch acts simply as a watertight seal ensuring the cells stay within 
the defect. The second mechanism is that growth factors secreted by the 
periosteum stimulate the cultured chondrocytes to divide. Finally, the third 
possible explanation is that the implanted cells and periosteum stimulate 
chondrocytes in the adjacent cartilage, in the subchondral bone or in the
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AFigure XVI. Photograph of a type I/Ill collagen membrane secured to the 
rim of an osteochondral defect located over the medial femoral condyle. A 
cannula has been introduced through a small opening underneath the 
membrane so that the suspension of cultured chondrocytes can be injected 
into the defect. (Courtesy of G. Bentley).
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periosteum itself to enter the defect and repair it. The last suggestion can 
probably be excluded due to the relatively poor results seen in periosteal patch 
repair of defects in the animal model and in the human subject Lindahl et 
ai performed a study in which dead periosteum (periosteum which had been 
snap frozen in liquid nitrogen) was sutured to the rim of the defect and a 
chondrocyte suspension was injected into the defect underneath the 
periosteum. Only 1 out of 8  rabbits developed good repair tissue. This 
suggested that the periosteum and chondrocytes work together to repair the 
defect. In using both periosteum and chondrocytes there appeared to be a 
chondroprotective effect on the surrounding cartilage since the number of 
apoptotic cells was reduced by 60% compared with an untreated defect 
This has not been seen in human subjects but the results seen in rabbits have 
led the Swedish Bone and Cartilage Research Group to favour periosteum over 
collagen membranes.
This reciprocal arrangement between the periosteum and chondrocytes alluded 
to by Lindahl is not supported by studies using alternatives to the periosteal 
flap. Bentley et al reported encouraging data using a biodegradable type I/Ill 
collagen membrane (figure XVI) to contain the chondrocytes within the defect. 
In this study 53 patients had autologous chondrocyte implantation with a type 
I/Ill collagen membrane and 5 had a periosteum cover as part of a 
prospectively randomised study comparing AGI with mosaicplasty. The mean 
age of the patients was 31.6 years and the mean defect size was 4.66 cm .^ Out 
of the AC I group, 51 (8 8 %) had a good or excellent result. The mean follow up 
was 19 months. This confirmed that comparable results could be obtained 
using a type I/Ill biodegradable membrane rather than periosteum and favoured 
the hypothesis that the membrane/periosteum acts purely as a watertight seal.
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Concerns have been raised about some aspects of autologous chondrocyte 
implantation with periosteum or collagen covered techniques They included 
the co-morbidity associated with the harvesting of the periosteal flap, the 
unequal distribution of chondrocytes after injection, with the added possibility of 
cell leakage beyond the periosteal flap or membrane. Reservations have also 
been expressed about the placing of multiple sutures in the rim of healthy 
cartilage to anchor the periosteum or membrane. With these concerns in mind 
a new technique of implanting the cells into the defect has evolved. The Matrix 
carried autologous chondrocyte implantation (MAGI; Verigen, Leverkusen, 
Germany) technique uses a similar porcine derived type I/Ill collagen 
membrane but is seeded with chondrocytes on one surface. The membrane 
has special properties that make it a suitable scaffold for supporting the 
cultured chondrocytes. One surface has a smooth appearance since it has a 
relatively high density of collagen fibres resulting in a relatively low friction 
surface and represents the articular cartilage surface. On the reverse the 
surface appears coarse since it has large gaps between the collagen fibres 
seen at a microscopic level and is able to harbour cells such as chondrocytes 
The chondrocytes are able to anchor themselves to the collagen fibres and 
form multiple layers on the surface of the membrane.
Implantation of the membrane is preceded by an arthroscopy 4-6 weeks earlier 
to harvest a sample of cartilage which is enzymatically digested to release the 
chondrocytes which are then expanded in a monolayer culture. The cultured 
cells are then seeded onto the membrane at approximately 3 weeks (refer to 
Genzyme corporation). Similar to the AGI technique the MAGI is implanted into 
the defect via an arthrotomy although there has been some success implanting 
it arthroscopically
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Using the open approach the incision tends to be smaller than that used for the 
ACI technique. Once the defect has been exposed it is debrided as described 
for the ACI technique. The membrane is then cut to size and fixed using fibrin 
glue to the bottom of the defect with the cells facing down (figure XVII). Firm 
pressure is applied for approximately 30 seconds and the glue is allowed to set 
for a further 1-2 minutes. The knee is then manipulated to ensure that the graft 
is stable. If there are concerns about graft stability, Wood et al 
recommended using 4 tacking sutures at 12, 3, 6  and 9 0' clock. The knee is 
closed in the standard fashion and the patient is rehabilitated as for the ACI 
technique.
Previous studies have shown that fibrin glue was detrimental to chondrocytes 
resulting in apoptosis Following this study Wood et al performed 
preclinical studies to assess whether chondrocytes could migrate from a 
collagen membrane through fibrin glue and anchor themselves to the base of 
the defect. They demonstrated using an in vitro study that at 2 weeks, cells 
were seen migrating through the fibrin glue towards the putative subchondral 
bone.
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Figure XVII. Schematic diagram illustrating the MACI 
technique of implanting chondrocytes. Initially the defect is 
debrided and then the membrane seeded with chondrocytes 
is cut to size. The membrane is then secured to the base of 
the defect with fibrin glue. (Courtesy of Verigen UK)
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Animal studies in mice have shown that 50% of the membranes disappeared by 
21 days following implantation. The extent of membrane degradation appears 
to be dependent on the degree of crosslinking of the collagens and elastin 
content
Zheng and Wood reported on a study in which rabbits had 3 mm defects 
artificially created over the femoral condyle treated with the MACI technique. At 
1 2  weeks, histological assessment revealed that the defects had filled with 
hyaline cartilage and the collagen membrane had disappeared 
Following this encouraging animal work Fabian reported on the early clinical 
results of the MACI technique on 18 patients with a mean age of 28.2 years. 17 
patients had repairs to knee defects and 1 patient had an ankle defect repaired. 
In a number of cases more than one defect was repaired and sizes varied from 
2cm^ to 8 cm .^ In this small series of patients the results were very encouraging 
at 1 year. As well as the knee (figure XVII la), attempts at repairing talar dome 
osteochondral defects in the ankle have also been made with the MACI 
technique (figure XVIIIb).
There is currently a prospectively randomised multi-centre study comparing the 
MACI technique with the ACI technique based at the Royal National 
Orthopaedic Hospital, Stanmore.
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Figure XVIIIa. Osteochondral
defect of the medial femoral 
condyle following a MACI repair.
Figure XVIIIb. Osteochondral 
defect of the talus (A) following a 
MACI repair. Defect exposed via a 
medial malleolar osteotomy (B). 
(C) shows the proximal medial 
malleolus.
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Assessment following autologous chondrocyte implantation 
Although improvement in the clinical status following autologous chondrocyte 
implantation is a very important parameter in assessing the success of a repair, 
more direct methods can also be used. Traditionally, plain radiographs have 
been used to assess joint space, which represents an indirect measure of the 
thickness of the cartilage. However these observations are more useful in 
patients with frank osteoarthritis rather than discrete osteochondral defects. 
Magnetic Resonance Imaging has been used extensively for the imaging of 
cartilage. Using contrast agents such as Gadolinium enables an assessment of 
the proteoglycan content to be made Arthroscopic examination provides an 
opportunity to determine whether the lesion is completely filled, how well it is 
integrated to the surrounding cartilage and the macroscopic appearance of the 
graft can be assessed. These parameters form the basis of the International 
Cartilage Repair Society Grading system (table I).
At the time of the second look check arthroscopy, a biopsy specimen can be 
taken to assess the repair histologically. Briggs et al ^  reported on 14 implant 
biopsies taken from patients who had previously had an autologous 
chondrocyte implantation with a collagen membrane. In the case of 8  patients 
the defect was sited over the medial femoral condyle, lateral femoral condyle in 
4 patients, trochlea in 1 patient and patella in 1 patient. The mean defect size 
was 2.46 cm .^ Arthroscopic examination in all cases showed that the repair 
tissue was level with the surrounding cartilage and was firm to probing. 
Histological examination of 6  biopsies had hyaline cartilage only, 2 had foci of 
hyaline cartilage within fibrocartilage, 4 had fibrocartilage only and 2 fibrous 
tissue. Type II collagen was identified in all 8  patients with hyaline cartilage and 
3 of the cases that were fibrocartilage. In situ hybridisation revealed that all
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samples had the potential to express both type lia and type lib collagen. Type 
lia collagen is present in a chondroprogenitor cellular phenotype usually found 
in developing skeletal tissue and type lib is expressed in mature chondrocytes. 
It has been suggested that immature chondroprogenitor cells may be essential 
for the development of repair tissue seen in autologous chondrocyte 
transplantation. Type X collagen is normally located near the osteochondral 
junction. Immunostaining for type X and type II collagen revealed that their 
distribution was similar to that of normal articular cartilage.
This study confirmed that the implantation of cultured chondrocytes into a 
chondral defect underneath a type I I/I 11 collagen membrane could result in a 
hyaline repair. This would suggest that a periosteum cover is not essential for 
the development of such a repair.
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DOES THE GRAFT FILL THE DEFECT?
SCORE
Is it level with surrounding cartilage 4
Is there 75% repair of defect depth 3
Is there 50% repair of defect depth 2
Is there 25% repair of defect depth 1
Or is there 0% repair of defect depth 0
HOW WELL INTEGRATED IS THE GRAFT TO THE BORDER ZONE?
SCORE
Complete integration with surrounding cartilage 4
Demarcating border <1mm 3
% of graft integrated, % with notable border >1mm width 2
% of graft integrated with surrounding cartilage, % with a 
notable border >1 mm
1
From no contact to % of graft integrated with surrounding 
cartilage
0
MACROSCOPIC APPEARANCE
SCORE
Intact smooth surface 4
Fibrillated surface 3
Small, scattered fissures or cracks 2
Several, small or few but large fissures 1
Total degeneration of grafted area 0
TOTAL SCORE OUT OF 12
ICRS Grade 1 Normal 1 2
ICRS Grade II Nearly normal 1 1 - 8
ICRS Grade III Abnormal 7-4
ICRS Grade IV Severely abnormal 3-1
Table I The International Cartilage Repair Society Grading system for the 
assessment of chondral and osteochondral defects.
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Summary
The treatment of discrete osteochondral defects has proved a challenging clinical 
problem for a considerable number of years. The inability of cartilage to repair itself 
has led to the development of a number of novel techniques to manage the 
symptoms of articular cartilage damage. The early techniques used methods to 
penetrate the subchondral bone such as drilling and abrasion arthroplasty, which 
can generate a fibrocartilage repair. Unfortunately this repair tissue lacks the 
resilience of hyaline cartilage due to important differences in its structure and 
physiology. As a result long-term studies have not been entirely encouraging for 
these techniques. Some success has been achieved with osteochondral allografts 
but these are probably best reserved for large traumatic osteochondral defects and 
concerns remain regarding disease transmission and immunological rejection.
It has been shown that autologous chondrocyte implantation can result in a durable 
hyaline repair in the treatment of some focal chondral defects. This can be 
achieved using cultured chondrocytes together with a membrane to retain the cells 
and does not require a periosteal flap for the development of a satisfactory repair. 
With the advent of mesenchymal stem cell technology and the development of 
biodegradable matrices to act as a conduit for implanting cells, further advances 
should be forthcoming in this challenging field of Orthopaedic Surgery.
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CHAPTER 2:
THEORETICAL JUSTIFICATION FOR THIS WORK
Damage to knee joint cartilage due to various injuries is a common problem with 
some estimates of more than 10,000 individuals affected each year in the UK 
(Bentley 2000). From the previous section it can be seen that a number of surgical 
techniques have been used to address this problem. However a possible problem 
with traditional techniques such as microfracture or drilling is that they generate 
fibrocartilage repairs. Although in the short term such repairs can alleviate the 
patients’ symptoms there are concerns as to its durability. It is proposed that with 
time the fibrocartilage repairs degenerates’ resulting in a return of the patients’ 
symptoms and progression to osteoarthritis. Techniques such as mosaicplasty 
tried to address this issue by replacing the exposed subchondral bone with 
autologous osteochondral plugs. However gaps remain between the plugs which 
ultimately fill with fibrocartilage and also some of the plugs may delaminate, 
subside or protrude causing catching and eventual breakdown.
More recently autologous chondrocyte implantation has been proposed as a 
technique which could enable the repair of a defect with hyaline or hyaline-like 
cartilage. The advantage of this technique over mosaicplasty is that it does not 
require the harvesting of osteochondral plugs from the periphery of the knee joint 
and instead a small sliver of cartilage is taken and then cultured. The ACI 
technique also enables a more even distribution of chondrocytes over the defect 
and there are no difficulties of subsidence so that the repair tissue is more likely to 
restore the normal contours of the articular surface.
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The majority of the data to date has been on the periosteum covered AC I and has 
originated from centres in Gothenburg and the United States. The aim of this study 
is to assess both clinically and histologically a group of patients over a 4 year 
period who have undergone the periosteum covered AC I and then to compare this 
group of patients with other patients who have undergone collagen covered AC I or 
the MACI technique at a single specialist centre. The results of this study may also 
help to determine whether periosteum covered AC I is the true gold standard in 
chondrocyte implantation.
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CHAPTER 3:
RESULTS OF THE AGI TECHNIQUE FOR THE TREATMENT OF 
OSTEOCHONDRAL DEFECTS OF THE KNEE USING A PERIOSTEAL COVER
Introduction
Since the early 1980’s Peterson et al have been using autologous articular 
chondrocytes for the repair of focal articular cartilage defects 36;i5i;i56 w^h this 
technique a small sample of cartilage is taken from the non-weight bearing part of 
the injured knee. The chondrocytes are then isolated from their extracellular matrix 
and grown in a monolayer culture. The cultured cells are then implanted into the 
defect underneath a periosteal patch.
Following Peterson et al's encouraging results with this technique 36;72;9i;i65 ^ 4  
year review of patients who have had chondral or osteochondral defects repaired 
with autologous chondrocyte implantation using a periosteal cover was made.
Patients and Methods
The South East Multi-Centre Research Ethics Committee and The Joint Research 
and Ethical Committee of the Royal National Orthopaedic Hospital Trust gave its 
approval before commencing this study (G. Bentley 2002 -  personal 
communication).
Patients reviewed at 1 year after operation
A total of 33 patients were reviewed at 1 year with a mean age of 30.58 years 
(range 15 to 52 years) with symptomatic articular cartilage defects and undenvent 
the ACI technique using a periosteal cover. There were 15 men and 18 women.
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The mean defect size was 4.66 cm  ^(range 1 to 9.89 cm )^ with 18 having defects in 
the right knee and 15 in the left. Of the 33 patients, 8  (24.2%) were on the medial 
femoral condyle, the patella in 54.6% (12, single facet and 6  multiple facets), the 
lateral femoral condyle in 3 (9.1%), the trochlea in 3 (9.1%) and 1 patient had 
multiple defects repaired (table II). The aetiology of the lesions included 13 (39.4%) 
patients who had post-traumatic defects, 15 (45.5%) who had chondromalacia 
patellae, 4 (12.1%) had osteochondritis dissecans and 1 patient who had a defect 
of unknown aetiology, although was most probably post traumatic (table III). Not all 
patients had a straight fonward ACI technique, 3 had a combined ACI and lateral 
release, 2 had a combined ACI and mosaicplasty to defects to the trochlea, 1 
patient had a combined ACI and drilling to the harvest site with a K wire, lhad an 
ACI and division of a medial plica and 1 patient had a staged anterior cruciate 
ligament (ACL) reconstruction and ACI technique 6  months later. The mean 
duration of symptoms was 7.3 years (range 1 to 27 years) and all patients had 
undergone a previous arthroscopy, the mean number of further operations was 
1.91 (range 1 to 4).
Patients reviewed at 2 years after operation
A total of 30 patients were reviewed at 2 years with a mean age of 31 years (range 
17 to 52 years). There were 13 men and 17 women. The mean defect size was 
4.73 cm  ^(range 1 to 9.89 cm )^ with 16 having defects in the right knee and 14 in 
the left. Of the 30 patients, 6  (20%) were on the medial femoral condyle, the patella 
in 18 (60%) (12, single facet and 6  multiple facets), the lateral femoral condyle in 3 
(10%), the trochlea in 2 (6.67%) and 1 patient had multiple defects repaired (table 
II). The aetiology of the lesions included 11 (36.67%) patients who had post-
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traumatic defects, 15 (50%) patients who had chondromalacia patellae, 3 (10%) 
had osteochondritis dissecans and 1 patient who had a defect of unknown 
aetiology (table III). A number of the patients reviewed at 2 years had combined 
procedures including, 2 patients who had a combined ACI and lateral release, 2 
patients who had a combined ACI and mosaicplasty to defects over the trochlea, 2 
patients who had an ACI and also required drilling to the harvest site, 1 patient who 
had a medial plica divided at the time of the ACI and 1 patient who had a staged 
ACL reconstruction followed by an ACI 6  months later. The mean duration of 
symptoms was 7.4 years (range 1 to 27 years) and all patients had undergone a 
previous arthroscopy, the mean number of further operations was 2 (range 1 to 4).
Patients reviewed at 3 vears after operation
A total of 17 patients were reviewed at 3 years with a mean age of 30.5 years 
(range 20 to 39 years). There were 7 men and 10 women. The mean defect size 
was 3.99 cm  ^(range 1.5 to 8.75 cm )^ with 9 having defects in the right knee and 8  
in the left. Of the 17 patients, 5 (29.4%) were on the medial femoral condyle, the 
patella in 8  (47%) (7, single facet and 1 multiple facets), the lateral femoral condyle 
in 2 (11.8%), the trochlea in 1 (5.9%) and 1 patient who had multiple defects 
repaired (table II). The aetiology of the lesions included 8  (47.1%) patients who 
had post-traumatic defects, 6  (35.2%) who had chondromalacia patellae, 2 (11.8%) 
who had osteochondritis dissecans and 1 patient who had a defect of unknown 
aetiology (table III). A number of patients reviewed at 3 years had combined 
procedures including 1 who had a combined ACI and mosaicplasty to a defect over 
the trochlea, 1 patient who had an ACI and drilling to the harvest site with a K wire, 
1 patient who had and ACI and lateral release and 1 patient who had a staged ACL
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reconstruction followed by an ACI 6  months later. The mean duration of symptoms 
was 6.9 years (range 1.5 to 23 years) and all patients had undergone a previous 
arthroscopy, the mean number of further operations was 1.8 8  (range 1 to 4).
Patients reviewed at 4 vears after operation
A total of 7 patients were reviewed at 4 years with a mean age of 31.9 years 
(range 23 to 39 years). There were 5 men and 2 women. The mean defect size 
was 3.64 cm  ^(range 1.5 to 8.75 cm )^ with 4 having defects in the right knee and 3 
in the left. Of the 7 patients, 1 (14.3%) was on the medial femoral condyle, the 
patella in 4 (57.1%) (all single facet) and the lateral femoral condyle in 2 (28.6%) 
(table II). The aetiology of the lesions included 4 (57%) patients who had post- 
traumatic defects and 3 (43%) who had chondromalacia patellae. One patient had 
a combined ACI and mosaicplasty to a defect over the trochlea and 1 patient who 
had an ACI and drilling to the harvest site with a K wire. The mean duration of 
symptoms was 5.4 years (1.6 to 18 years) and all patients had undergone a 
previous arthroscopy, the mean number of further operations was 1 .8 6  (range 1 to 
4).
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ANATOMICAL
DISTRIBUTION
NUMBER
OF
PATIENTS 
AT 1 YEAR
NUMBER
OF
PATIENTS 
AT 2 YEARS
NUMBER
OF
PATIENTS 
AT 3 YEARS
NUMBER
OF
PATIENTS 
AT 4 YEARS
Medial Femoral 
Condyle
8 6 5 1
Lateral Femoral 
Condyle
3 3 2 2
Patella-single
facet
1 2 1 2 7 4
Patella-multi
facet
6 6 1
Trochlea 3 2 1
Multiple defects 1 1 1
Total 33 30 17 7
Table II. Anatomical site of the defects found in 33 patients at 1 year, 30 at 2 
years, 17 at 3 years and 7 at 4 years.
AETIOLOGY 
OF DEFECTS
NUMBER 
OF 
PATIENTS 
AT 1 YEAR
NUMBER 
OF 
PATIENTS 
AT 2 YEARS
NUMBER 
OF 
PATIENTS 
AT 3 YEARS
NUMBER 
OF 
PATIENTS 
AT 4 YEARS
Trauma 13 11 8 4
Osteochondritis
dissecans
4 3 2
Chondromalacia
patellae
15 15 6 3
Other 1 1 1
Total 33 30 17 7
Table III. Aetiology of the defects found in 33 patients at 1 year, 30 at 2 years, 
17 at 3 years and 7 at 4 years.
105
The indication for surgery in all cases was pain associated with a chondral or 
osteochondral defect, other symptoms included swelling, giving way, catching and 
locking.
Surgical Technique for Autologous Chondrocyte Implantation with a 
periosteal cover
The procedure was divided into 2 stages as described by Brittberg et al ^  and is 
summarized here. An arthroscopy was carried out initially. If the defect was 
suitable for chondrocyte implantation, a full thickness cartilage biopsy of 
approximately 300-500 mg was harvested from the margin of the trochlea of the 
damaged knee using a gouge. The specimen was then removed from the knee via 
one of the arthroscopy portals. The cartilage biopsy was then put into a sterile 
container and transferred to the laboratory. In the laboratory the specimen was 
enzymatically digested releasing the chondrocytes, which were then grown in a 
monolayer culture. The patient was readmitted 3 to 5 weeks following the harvest 
of cartilage and the second stage of the procedure was performed.
To ensure a bloodless field a tourniquet was applied and a medial or lateral 
parapatellar arthrotomy was performed depending on the location of the defect. 
Intravenous antibiotics (1g of flucloxacillin and 1g of amoxycillin) were 
administered over the peri-operative period as prophylaxis against infection. Once 
the defect was identified it was debrided back to a stable rim of normal cartilage. 
The base of the defect was also debrided down to the subchondral bone, taking 
care not to make it bleed. If bleeding did occur a swab soaked in 1:200,000 
adrenaline solution was applied directly to the base of the defect to control it.
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To retain the cultured chondrocytes within the defect, a periosteal flap was 
harvested from the patients' proximal tibia or distal femur. The periosteum was 
secured to the rim of the defect using multiple 6  O' vicryl sutures placed 3-4 mm 
apart. A purple suture material was used so that it could be seen against the white 
cartilage. The sutures were applied leaving a small 2-3 mm gap between the final 
two sutures, through which a cannula could be inserted. Attached to this cannula 
was a syringe containing the cultured chondrocytes in a suspension. A water-tight' 
test was not performed because of concerns that the Hartmann's solution maybe 
toxic to the cultured chondrocytes. Fibrin glue was applied to the suture line as a 
seal. The chondrocytes were then injected underneath the periosteal flap into the 
defect. Enough of the chondrocyte suspension was infiltrated to cause tenting of 
the flap. Approximately 6  million cells were injected with a range of 5 to 10 million 
cells depending on the size of the lesion. The small opening through which the 
chondrocytes had been injected was closed and the entire suture line was re­
inforced where necessary with more fibrin glue. After three minutes once the glue 
had set, the knee was manipulated to ensure that the graft was stable. The knee 
was closed in layers using non-absorbable sutures.
One patient required reconstruction of the anterior cruciate ligament (ACL), which 
was performed 6  months prior to the chondrocyte implantation. A hamstring repair 
was used which was routed through standard tibial and femoral tunnels. Femoral 
fixation was achieved through a separate lateral incision with the anchoring sutures 
attached over a biodegradable post. The tibial fixation was secured using a 
biodegradable screw. Six months later the chondrocyte implantation was 
performed as described.
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There were 2 patients who were considered suitable for a combined ACI and 
mosaicplasty. Both procedures were performed under the same general 
anaesthetic. For the mosaicplasty technique, large mosaic plugs 4.5mm in 
diameter were used when possible to fill the defect. The plugs were placed slightly 
prominent in order to allow contact with the opposite articular surface during 
normal movement. This was thought to help with nutrition of the cartilage. The 
plugs of cartilage were harvested from the margins of the trochlea. Attempts were 
made to match the slope of the donor articular surface to the contour of the defect. 
Once the mosaicplasty had been performed the chondrocyte implantation was then 
undertaken as previously described. At the end of the procedure the joint was 
moved through a full range of movement to check that both the mosaics and the 
chondrocyte implantation were stable and did not catch.
Rehabilitation
Following closure of the wound the leg was placed in a compressive Robert Jones 
bandage that was reinforced with a plaster of Paris backslab. Patients were 
encouraged to rest overnight with the leg elevated and perform regular foot and 
ankle exercises. Full weight bearing was encouraged at 24 hours following surgery 
to stimulate cartilage metabolism. Once the post-operative swelling had 
diminished, which was usually at 2  to 3 days after surgery the backslab was 
removed and a light weight fibre glass cylinder cast with the knee in full extension 
was applied. Once the patients were safe mobilizing with crutches and fully weight 
bearing, they were discharged. After 10 days the cast was removed and the 
patients were allowed to continue fully weight bearing with crutches. Patients 
attended regular physiotherapy sessions at least twice a week for the first two 
weeks doing graduated active exercises in order to achieve a full range of
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movement. At the two week stage if the wound was completely healed, patients 
were encouraged to perform other activities such as swimming, cycling on an 
exercise bike without any resistance and rowing exercises. At 6  weeks it was 
anticipated that the patients would be able to straight leg raise and flex their 
operated knee to 90°. If patients were making satisfactory progress at the 6  week 
clinical review they discarded their crutches and continued their exercise 
programme under the supervision of a Physiotherapist. By 6  months if the patients 
were making good progress, light jogging was allowed but patients were advised to 
avoid sporting activities until after the 1 2  month review and check arthroscopy.
The patients who had an ACL repair as well as a chondrocyte implantation were 
rehabilitated in the immediate post operative period on a continuous passive 
motion machine and were discharged once they achieved 90° of flexion. Further 
rehabilitation focused on improving the patients’ range of movement and muscle 
strengthening exercises.
Evaluation of Results
Patients were reviewed in the Orthopaedic Clinic at regular intervals in the first 
year and 6  monthly thereafter. One Observer, who did not perform any of the 
implantations, independently reviewed the patients. A clinical and functional 
assessment was made using the modified Cincinnati rating system (table IV) 
and the Bentley functional rating system As reported by Bentley et al there 
was no difference in the results when using either system. The results were graded 
as excellent (> 80), good (55 to 79), fair 30 to 54) and poor (<30) based on the
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modified Cincinnati rating system. Those with an excellent or good result were 
considered a success whereas those with a fair result were considered unchanged 
and those with poor results were worse than they were before implantation.
Where possible arthroscopy and biopsy of the grafted area was performed at 1 
year from the procedure. In some instances this was not possible because of the 
inaccessibility of the graft especially in the patellofemoral joint and also patients 
who declined a further arthroscopy. The repair was assessed using the 
International Cartilage Repair Society (ICRS) grading system. A 2.5mm biopsy was 
taken from the centre of the graft using a Jamshidi biopsy needle (see figure XIX) 
which was angled so that it was perpendicular to the surface. In the case of the 
patellofemoral joint it was often quite difficult to angle the needle correctly. Care 
was taken to ensure that some of the subchondral bone was included in the biopsy 
specimen so that the degree of bonding of the graft to the underlying bone could 
be assessed. The specimens were all examined by a Pathologist with a special 
interest in the musculoskeletal system.
Statistical analysis. Statistical comparison of the clinical assessment scores at 
1,2,3 and 4 years was by the paired Students T test. Comparisons between the 
good and excellent group and fair and poor group were made using the unpaired 
Student T test. A p value of less than 0.05 was considered statistically significant.
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PARAMETER MAXIMUM SCORE
Pain 2 0
Giving way 2 0
Swelling 1 0
Walking ability 1 0
Stair walking 1 0
Running 5
Jumping/twisting 5
Overall activity 2 0
Total 1 0 0
Table IV. The Modified Cincinnati Rating System (for the sake of clarity 
this is the abbreviated version, the full version can be found on pages 306- 
309 in the appendices).
I l l
Figure XIX Photograph of a Jamshidi biopsy needle, used to take biopsies from 
the grafted defects.
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Results
Clinical Review
The pre-operative modified Cincinnati rating system scores are shown in table V, 
13 (39.4%) had a good score, 12 (36.4%) had a fair score and 8  (24.2%) had a 
poor score. Those patients with a good score were considered for an ACI, since 
they complained of considerable pain that was attributed to an articular cartilage 
defect. All these patients were athletic and functioned at a high level so that they 
were able to compensate on the remaining parameters of the modified Cincinnati 
score, which in this situation tends to give a misleading good impression of their 
symptomatology.
There was a significant improvement in the modified Cincinnati score at 1 year 
(p<0.005) at 2 years (p<0.005) and at 3 years (p<0.005) (table Va, Vb, Vc). The 
numbers of patients reviewed at 4 years were too small for statistical analysis 
(table Vd). Overall, of the 33 patients who were reviewed at 1 year 26 (78.8%) 
patients had a good or excellent result, of the 30 patients reviewed at 2 years 20 
(66.67%) had a good or excellent result, of the 17 patients reviewed at 3 years 11 
(64.7%) had a good or excellent result and of the 7 patients reviewed at 4 years 6  
(85.7%) patients had a good or excellent result.
The mean modified Cincinnati knee score improved from 46 pre operatively to 6 8  
post operatively at 1 year (p<0.005), representing a difference of the means of 22 
(95% confidence interval between 13.7 and 29.97, n=33). The mean modified 
Cincinnati knee score improved from 44 pre operatively to 61 (p<0.005) at 2 years, 
representing a difference of the means of 17 (95% confidence interval between
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TOTAL EXCELLENT GOOD FAIR POOR
33 13 1 2 8
Table V. Modified Cincinnati scores before ACI-P
technique.
TOTAL EXCELLENT GOOD FAIR POOR
33 9 17 6 1
Table Va.
TOTAL EXCELLENT GOOD FAIR POOR
30 9 11 7 3
Table Vb.
TOTAL EXCELLENT GOOD FAIR POOR
17 2 9 4 2
Table Vc.
TOTAL EXCELLENT GOOD FAIR POOR
7 3 3 1
Table Vd.
Table Va,b,c,d Modified Cincinnati scores at 1 year 
(table Va), 2 years (table Vb), 3 years (table Vc) and 4 
years (table Vd) following ACI-P technique.
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9.77 and 24.03, n=30). The mean modified Cincinnati knee score improved from 
42 pre operatively to 60 (p<0.005) at 3 years, representing a difference of the 
means of 18 (95% confidence interval between 7.21 and 29.03, n=17). The 
numbers at 4 years were too small to be statistically significant (n=7).
Factors affecting outcome
It was apparent when reviewing the patients that there seemed to be a difference 
between those patients who had a good or excellent result and those that had a 
fair or poor result. Table VI shows the difference between these groups in terms of 
their age, defect size, duration of symptoms leading up to surgery and number of 
surgical procedures before implantation.
Although patients in the Good or Excellent group were younger and had smaller 
defects this did not reach statistical significance.
Making a similar comparison at 2 years between the good/excellent group and the 
fair/poor group again showed that the patients with a better result were younger 
and had smaller defects however this did not achieve statistical significance 
(p=0.78 and p=0.54 respectively). A similar comparison at 3 years again showed 
that patients in the good/excellent group were younger (mean age 28.36 years) 
compared with the fair/poor group mean age 34.3 years and had smaller defects 
3.34cm^ compared with 5.43 cm .^ This time the difference was statistical significant 
in terms of age (p=0.05) and defect size (p<0.005). The number of patients 
reviewed at 4 years was too small for statistical analysis.
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GOOD/
EXCELLENT
FAIR/ POOR P VALUE
MEAN AGE (YRS) 30.42 
(range 15-52)
31.14 
(range 17-46)
p=0.84
MEAN DEFECT SIZE 
(CM )^
4.59 
(range 1.5-9.89)
4.96 
(range 1-8.75)
p=0.72
MEAN DURATION OF 
SYMPTOMS (YRS)
7.8
(range 1-27)
5.42 
(range 2-13)
p=0.38
NUMBER OF PREVIOUS 
PROCEDURES
1.96 
(range 1-4)
1.71 
(range 1-3)
p=0.58
Table VI. Comparison between the Good/excellent group and the Fair/poor group at 
1 year and p values, following the ACI-P technique.
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Femoral Condylar Defects
Eleven patients with 8 medial and 3 lateral femoral condylar defects were reviewed 
at 1 year. The mean age of the patients was 28.1 years (range 15 to 38 years) with 
a mean defect size of 5.02 cm^ (range 1.5 to 9 cm )^. The mean duration of 
symptoms leading up to surgery was 7.5 years (range 1.6 to 15 years) and all 
patients had undergone a previous arthroscopy, the mean number of further 
operations was 1.9 (range 1 to 4). Nine patients with 6 medial and 3 lateral femoral 
condylar defects were reviewed at 2 years and 7 patients with 5 medial and 2 
lateral femoral condylar defects were reviewed at 3 years. At 4 years, 3 patients 
with 1 medial and 2 lateral condylar defects were reviewed. Using the modified 
Cincinnati Rating System, of those patients who had repairs to defects over the 
medial femoral condyle, 7 out of 8 reported good or excellent results at 1 year, 3 
out of 6 at 2 years, 2 out of 5 at 3 years and 1 patient at 4 years reported a poor 
result. Of the patients who had repairs to defects over the lateral femoral condyle 3 
out of 3 reported a good or excellent result at 1 year, 3 out of 3 at 2 years, 2 out of 
2 at 3 years and 2 out of 2 at 4 years.
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TIME OF 
REVIEW
CLINICAL
OUTCOME
MEDIAL FEMORAL 
CONDYLE
LATERAL FEMORAL 
CONDYLE
1 YEAR
Excellent 2 2
Good 5 1
Fair 1
Poor
Total 8 3
2 YEARS
Excellent 2
Good 3 1
Fair 2
Poor 1
Total 6 3
3 YEARS
Excellent 1
Good 2 1
Fair 2
Poor 1
Total 5 2
4 YEARS
Excellent 1
Good 1
Fair
Poor 1
Total 1 2
Table VII. Clinical results at 1,2,3 and 4 years for patients who had an
ACI-P for chondral and osteochondral defects over the medial and lateral 
femoral condyle of the knee.
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Patellar defects
Eighteen patients with 13 single facet and 5 with multi-facet defects were reviewed 
at 1 year. The mean age of the patients was 29.94 years (17 to 46 years) with a 
mean defect size of 4.53 cm  ^ (range 1 to 8.75 cm )^. The mean duration of 
symptoms leading up to surgery was 5.75 years (range 1 to 18 years) and all 
patients had undergone a previous arthroscopy, the mean number of further 
operations was 1.78 (range 1 to 4). Eightteen patients with 12 single facet and 6 
with multi-facet defects were reviewed at 2 years and 8 patients with 7 single facet 
and 1 with multi-facet defects were reviewed at 3 years. At 4 years, 4 patients with 
single facet defects were reviewed.
Using the modified Cincinnati Rating system, of those patients who had repairs to 
defects over a single facet of the patella, 8 out of a total of 13 patients (61.5%) 
reported good or excellent results at 1 year, 7 out of 12 (58.3%) at 2 years, 5 out of 
7 (71.4%) at 3 years and 4 out of 4 at 4 years. Of those patients who had repairs to 
defects over both facets of the patella, 6 out of 6 reported good or excellent results 
at 1 year, 5 out of 6 (71.4%) at 2 years and 1 out of 1 at 3 years.
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TIME OF 
REVIEW
CLINICAL
OUTCOME
SINGLE FACET
PATELLAR
DEFECT
MULTI-FACET
PATELLAR
DEFECT
1 YEAR
Excellent 3 2
Good 5 4
Fair 4
Poor 1
Total 13 6
2 YEARS
Excellent 3 3
Good 4 2
Fair 2 1
Poor 3
Total 12 6
3 YEARS
Excellent 1
Good 4 1
Fair 2
Poor
Total 7 1
4 YEARS
Excellent 2
Good 2
Fair
Poor
Total 4
Table VIII. Clinical results at 1,2,3 and 4 years for patients who
had an ACI-P for chondral and osteochondral defects over the patella
(single and multi-facet).
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Traumatic defects
Of the 33 patients reviewed at 1 year, 13 (39.4%) had defects of traumatic origin. 
The mean age of the patients was 34.5 years (range 26 to 52 years) with a mean 
defect size of 4.53 cm  ^(range 1.5 to 9.89 cm )^. The mean duration of symptoms 
leading up to surgery was 8.5 years (range 1.5 to 27 years) and all patients had 
undergone a previous arthroscopy, the mean number of further operations was 2 
(range 1 to 4). Eleven patients were reviewed at 2 years, 7 at 3 years and 4 at 4 
years. Using the modified Cincinnati rating system, of those patients who were 
reviewed at 1 year, 11 out of a total of 13 (84.6%) patients reported good or 
excellent results, 8 out of 11 (73%) at 2 years, 4 out of 7 (57.1%) at 3 years and 3 
out of 4 (75%) at 4 years (table IX).
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TIME OF REVIEW CLINICAL OUTCOME TRAUMATIC DEFECTS
1 YEAR
Excellent 4
Good 7
Fair 2
Poor
Total 13
2 YEARS
Excellent 4
Good 4
Fair 3
Poor
Total 11
3 YEARS
Excellent 1
Good 3
Fair 2
Poor 1
Total 7
4 YEARS
Excellent 1
Good 2
Fair
Poor 1
Total 4
Table IX. Clinical results at 1,2,3 and 4 years for patients who had
defects of traumatic origin, following ACI-P.
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Chondromalacia Patellae
Of the 33 patients reviewed at 1 year, 15 (45.5%) had defects attributed to 
chondromalacia patellae. The mean age of the patients was 29.3 years (range 17 
to 46 years) with a mean defect size of 4.25 cm  ^(range 1 to 8.75 cm )^. The mean 
duration of symptoms leading up to surgery was 6 years (range 1 to 18 years) 
and all patients had undergone a previous arthroscopy, the mean number of 
further operations was 1.73 (range 1 to 4). Fourteen patients were reviewed at 2 
years, 6 at 3 years and 3 at 4 years.
Using the modified Cincinnati rating system, of those patients who were reviewed 
at 1 year, 10 out of a total of 15 (66.7%) patents reported good or excellent 
results, 10 out of 15 (66.7%) at 2 years, 5 out of 6 (83.3%) at 3 years and 3 out of 
3 at 4 years (table X).
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TIME OF REVIEW CLINICAL
OUTCOME
CHONDROMALACIA
PATELLAE
1 YEAR
Excellent 3
Good 7
Fair 4
Poor 1
Total 15
2 YEARS
Excellent 5
Good 5
Fair 3
Poor 2
Total 15
3 YEARS
Excellent 1
Good 4
Fair 1
Poor
Total 6
4 YEARS
Excellent 2
Good 1
Fair
Poor
Total 3
Table X. Clinical results at 1,2,3 and 4 years for patients who
had defects attributed to chondromalacia patellae, following ACI-P.
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The numbers of patients with trochlea and multiple defects and whose defects 
were attributed to osteochondritis dissecans were too small for useful analysis.
Arthroscopic review
A repeat arthroscopy at 1 year following the implantation revealed ICRS grades of 
1 or 2 in 24 of 30 patients (80%). The arthroscopy of 1 patient did not show any 
evidence of the graft and scored an ICRS of 4 (table XI). Nine arthroscopies were 
carried out at the 2 year review, which revealed ICRS grades of 1 or 2 in 5 of 9 
patients (55.6%). In the case of 1 patient there was no evidence of the graft and 
scored 4 on the ICRS grading system. Further review arthroscopies were not 
carried out unless there was a clinical indication.
Of the 13 biopsies taken at the time of the 1 year check arthroscopy, 5 were from 
the medial femoral condyle, 1 from the lateral femoral condyle and 7 from the 
patella. Of the 3 biopsies taken at the 2 year check arthroscopy, 2 were from the 
medial femoral condyle and 1 from the lateral femoral condyle.
Hyaline cartilage of normal appearance was found in 2 of the biopsies taken at 1 
year, consisting of cells located within a lacuna enveloped within a matrix that 
stained strongly for type II collagen using Safranin O. Of the remaining biopsies 
taken at 1 year, 4 showed evidence of mixed hyaline and fibrocartilage and 7 
showed evidence of fibrocartilage.
Of those biopsied at 2 years, 1 showed evidence of hyaline cartilage and 2 mixed 
hyaline and fibrocartilage.
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ICRS GRADE NUMBER (%)
1 YEAR 2 YEARS
1, Excellent 3
2, Good 21 5
3, Fair 5 3
4, Poor 1 1
Total 30 9
Table XI. Arthroscopic results at 1 and 2 years, following 
ACI-P.
126
One of the grafts biopsied at 1 year showed a mixed picture of hyaline and 
fibrocartilage however the same graft revealed hyaline cartilage alone when 
biopsied at 2 years. This may suggest that the grafts can take up to 2 years to fully 
mature as suggested previously by Bentley and Peterson
Complications
Within the first year following implantation there was 1 major complication, 11 
intermediate and 9 minor complications. Within the 2^  year of implantation there 
was 1 major complication, 1 intermediate and 1 minor complication. Within the 3"^  
year there were no major complications and 2 intermediate complications and 
there were no complications within the 4^ year from surgery (table XII).
Complications encountered within the year included one patient whose graft 
failed. The intermediate complications encountered within the first year of the 
implantation were attributed to hypertrophy of the graft with 11 patients requiring 
shaving of the graft at the 1 year check arthroscopy and 2 further patients who 
required an arthroscopy before the 1 year review. Two patients required further 
shaving of the grafts 6 months after the first shave for graft hypertrophy. Four 
patients were slow to mobilise in the immediate post operative period and required 
a manipulation under anaesthetic. One patient required removal of a large fibrous 
plica at the 1 year check arthroscopy. Of the 4 patients who required an unplanned 
arthroscopy within the first year 2 were for graft hypertrophy, 1 for ongoing pain 
and 1 for division of adhesions. At 2 years, there was 1 episode of graft failure after 
the patient had a fall and 4 patients required shaving of their grafts, which had 
hypertrophied. One patient was referred to the pain team for ongoing pain.
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At 3 years there were 2 patients who required an arthroscopy for graft overgrowth 
which were shaved.
There were no complications at 4 years.
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COMPLICATION NUMBER
MAJOR
Graft failure 1 at 1 year 
1 at 2 years
INTERMEDIATE
Graft hypertrophy 11 at 1 year
1 at 2 years
2 at 3 years
MINOR
Superficial wound infection 1 at 1 year
Slow to mobilise requiring a manipulation 
under anaesthetic
4 at 1 year
Unplanned arthroscopy 4 at 1 year 
1 at 2 years
Table XII. Complications following AGI with a periosteal cover.
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Discussion
Autologous chondrocyte implantation with a periosteal cover was first advocated 
by Peterson et al since October 1987 they have used this technique in 
approximately 1200 patients Worldwide, Brittberg et al estimate that 
variants of autologous chondrocyte implantation have been performed in 
approximately 10,000 patients.
Brittberg et al have achieved considerable success in the treatment of chondral 
and osteochondral defects of the knee with this technique. In a clinical evaluation 
of 244 patients followed for 2 to 10 years the percentage of good to excellent 
results was high (84% to 90%) for single condylar lesions but was lower (mean 
74%) for patients with other types of lesions
The results of our study are encouraging with 78.8% of patients reporting good or 
excellent results at 1 year, 66.67% at 2 years, 64.7% at 3 years and 85.7% at 4 
years.
The findings at the 1 year check arthroscopy revealed that 80% of those who were 
arthroscoped had repairs that were good or excellent based on the ICRS grading 
system. At 1 year 1 graft had failed, which was located over the medial facet of the 
patellar. At 2 years a further graft failed which again was located over the 
retropatellar surface, however immediately preceding the arthroscopy the patient 
had a significant fall and the failure was put down to delamination of the graft 
secondary to trauma. Although both failures occurred in patients with defects over 
the patella this was not typical of the group as a whole, with 72% of patients at 1 
year reporting good or excellent results, 66.67% at 2 years, 75% at 3 years and 
100% at 4 years.
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A number of factors were Identified that appeared to influence the outcome of the 
repair. A comparison between the good/excellent group and fair/poor at 1,2 and 3 
years revealed that patients who were younger and had smaller defects did better. 
However, the differences between age and defect size only reached statistical 
significance at the 3 year review. Other factors that may influence the clinical 
outcome were also assessed, including duration of symptoms leading up to 
surgery and number of surgical procedures before the implantation but there were 
no significant differences when the good/excellent group and the fair/poor group 
were compared.
Defects repaired in this study were larger than those repaired in other studies. The 
mean defect size of the femoral condyle lesions in Peterson et al's recent long­
term durability study was 3.4 cm  ^compared with 5.02 cm  ^ in this study. In Minas’ 
study the simple defects that he repaired had a mean size of 4.3cm^. As suggested 
from the results discussed above defect size has an impact on the clinical outcome 
following autologous chondrocyte implantation. This may explain why our results 
(50% good/excellent at 2 years) are not as good as the Swedish experience 
(89% at 2 years). However, it is difficult to make a direct comparison since it is not 
clear which scoring system Peterson et al use to arrive at their final figure.
The patients who were part of the Swedish groups’ study had a shorter duration 
of symptoms (3.4 years) compared to our patients (7.3 years). This may explain 
why the defects in our study were larger since patients have had them for longer. 
The delay in patients receiving treatment may also have a deleterious 
psychological effect that may adversely affect the clinical outcome, however this 
has not been quantified.
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We found no evidence to support the argument that the placing of multiple sutures 
into the surrounding articular cartilage at the margin of the defect results in 
damage to the cartilage. At the check arthroscopies at 1 and 2 years the articular 
cartilage adjacent to the graft was intact and appeared healthy.
Repairs to defects that are notoriously difTicult to repair such as the lateral femoral 
condyle did very well. Although only 3 patients were reviewed at 1 and 2 years, all 
achieved good/excellent results. At 3 and 4 years, 2 patients were reviewed and 
both achieved good and excellent results at each review.
Patients with traumatic defects did better than those with chondromalacia patellae. 
At 1 year 84.6% of patients with traumatic defects had good or excellent results 
compared with 66.6% for those with chondromalacia patellae. However, the site of 
the defect may also explain the difference between these 2 groups as well as the 
pathophysiology of the defects.
A review of the histology at 1 and 2 years following the chondrocyte implantation 
confirmed Peterson et I s findings that this technique can result in a hyaline 
cartilage repair. Two out of 13 biopsies showed hyaline cartilage alone and 4 
showed a mixture of hyaline and fibrocartilage. At 2 years 1 biopsy showed 
evidence of hyaline cartilage and 2 showed mixed hyaline and fibrocartilage.
Of concern was the high incidence of graft hypertrophy requiring shaving at 
arthroscopy. At 1 year 11 (33.3%) patients required shaving of hypertrophied grafts 
but this did not include those patients who required arthroscopies prior to the 1 
year check. In total 2 patients required an unplanned arthroscopy within the 1^ * 
year for graft hypertrophy and another 2 required a further arthroscopy after the
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graft re-hypertrophied. The highest incidence of graft hypertrophy was in the 1®* 
year, with only 4 patients requiring surgical intervention at the 2 year stage.
Some have argued that the periosteum works with the chondrocytes to repair the 
defect However, this conclusion was drawn from animal studies and such a 
relationship has never been demonstrated in human subjects. A prospective 
randomised study undertaken at this institution comparing AC I using a type I/Ill 
collagen cover with AGI using a periosteal cover has shown no difference based 
on the clinical outcome at 2 years and on arthroscopic assessment (see Chapter 
5). Other concerns of this technique include the co-morbidity associated with the 
longer incision needed for the harvesting of the periosteal flap
In summary, this study has shown that the results in terms of clinical outcome 
following the repair of chondral and osteochondral defects with ACI using a 
periosteal cover are encouraging over a 4 year follow-up. However, from this study 
the rate of graft hypertrophy following this technique requiring an arthroscopy and 
shaving of the graft is unacceptably high. At the Royal National Orthopaedic 
Hospital the periosteal cover has been abandoned in favour of the manufactured 
type I/Ill collagen cover which can also give a satisfactory repair but with a much 
lower incidence of graft hypertrophy (see Chapter 4).
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CHAPTER 4:
RESULTS OF THE AGI TECHNIQUE FOR THE TREATMENT OF 
OSTEOCHONDRAL DEFECTS OF THE KNEE USING A PORCINE MEMBRANE
Introduction
In their original technique Brittberg et al ^  used a periosteal cover to contain the 
chondrocytes within the defect (previous chapter). The use of a periosteal cover 
has brought into question whether it acts simply as a watertight seal or whether it 
releases factors essential to the development of a hyaline cartilage repair. The 
extra surgical exposure required to remove a piece of tibial periosteum may cause 
morbidity and pain to the patient which is also a disadvantage. Following the 
encouraging clinical results by Bentley et al ^  and the histological results by Briggs 
et al ^  using a type I/Ill collagen membrane as apposed to a periosteal cover, a 
group of patients who had this technique were reviewed over a 4 year period.
Patients and Methods
The South East Multi-Centre Research Ethics Committee and The Joint Research 
and Ethical Committee of the Royal National Orthopaedic Hospital Trust gave its 
approval before commencing this study (G. Bentley 2002 -  personal 
communication).
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Patients reviewed at 1 year after operation
A total of 130 patients were reviewed at 1 year with a mean age of 32 years (range 
14 to 54 years) with symptomatic articular cartilage defects and underwent the ACI 
technique using a type I/Ill collagen membrane. There were 70 men and 60 
women. The mean defect size was 4.82 cm* (range 1-12.5cm*) with 68 having 
defects in the right knee and 62 in the left. Of the 130 patients, 52 (40%) were on 
the medial femoral condyle, the patella in 39 (30%) (27, single facet and 12 
multiple facets), the lateral femoral condyle in 19 (15%), the trochlea in 7 (5%) and 
13 (10%) patients had multiple defects repaired (table XIII). The aetiology of the 
lesions included 52 (40%) patients who had post traumatic defects, 23 (17.7%) 
patients who had chondromalacia patellae, 18 (13.8%) had osteochondritis 
dissecans, 17 (13.1%) who had previous cartilage resurfacing techniques which 
had failed, 1 (0.8%) patient had evidence of early osteoarthritis and 19 (14.6%) 
patients who had defects of unknown aetiology, although they were most probably 
post traumatic (table XIV). Not all patients had a straightforward ACI technique, 2 
had a combined ACI and anterior cruciate ligament reconstruction, 2 had a 
combined ACI and mosaicplasty to a defect over the trochlea groove, 7 had a 
combined ACI and drilling to defects not suitable for chondrocyte implantation, 3 
had combined ACI and lateral release, 1 patient had combined ACI, mosaicplasty, 
patella realignment and drilling to the harvest site and 1 patient had a large 
osteophyte removed at the time of the chondrocyte implantation. The mean 
duration of symptoms was 7.67 years (range 1 to 25 years) and all patients had 
undergone a previous arthroscopy, the mean number of further operations was 
2.19 (range 1 to 6).
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Patients reviewed at 2 years after operation
A total of 82 patients were reviewed at 2 years with a mean age of 30.7 years 
(range 14 to 54 years). There were 43 men and 39 women. The mean defect size 
was 4.71 cm  ^(range 1 to 12.25cm^) with 46 having defects in the right knee and 36 
in the left. Of the 82 patients, 32 (16%) were on the medial femoral condyle, the 
patella in 24 (29%) (18, single facet and 6 multiple facets), the lateral femoral 
condyle in 13 (16%), the trochlea in 6 (7%) and 7 (9%) patients who had multiple 
defects repaired (table XIII). The aetiology of the lesions included 37 (45%) 
patients who had post traumatic defects, 12 (15%) patients who had 
chondromalacia patellae, 11 (13%) had osteochondritis dissecans, 9 (11%) who 
had previous cartilage resurfacing techniques which had failed, 1 (1%) patient had 
evidence of early osteoarthritis and 12 (15%) patients who had defects of unknown 
aetiology (table XIV). A number of patients reviewed at 2 years had combined 
procedures including, 2 who had a combined ACI and mosaicplasty to a defect 
over the trochlea groove, 4 who had a combined ACI and drilling to defects not 
suitable for chondrocyte implantation, 1 who had a combined ACI and lateral 
release and 1 patient had a combined ACI, mosaicplasty, patella realignment and 
drilling to the harvest site. The mean duration of symptoms was 7.08 years (range 
1 to 23 years) and all patients had undergone a previous arthroscopy, the mean 
number of further operations was 2.21 (range 1 to 5).
Patients reviewed at 3 years after operation
A total of 41 patients were reviewed at 3 years with a mean age of 30.76 years 
(range 17 to 49 years). There were 21 men and 20 women. The mean defect size 
was 4.03 cm  ^(range 1 to 12cm*) with 46 having defects in the right knee and 36 in
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the left. Of the 41 patients, 14 (34%) were on the medial femoral condyle, the 
patella in 13 (31%) (12, single facet and 1 multiple facets), the lateral femoral 
condyle in 8 (20%), the trochlea in 4 (10%) and 2 (5%) patients who had multiple 
defects repaired (table XIII). The aetiology of the lesions included 19 (46%) 
patients who had post traumatic defects, 7 (17%) patients who had 
chondromalacia patellae, 6 (15%) had osteochondritis dissecans, 3 (7%) who had 
previous cartilage resurfacing techniques which had failed and 6 (15%) patients 
who had defects of unknown aetiology (table XIV). A number of patients reviewed 
at 3 years had combined procedures including, 1 which had a combined ACI and 
mosaicplasty, 2 who had a combined ACI and drilling of defects not suitable for 
chondrocyte implantation and 1 patient had a combined ACI, mosaicplasty, patellar 
realignment and drilling of the harvest site. The mean duration of symptoms was 
6.72 years (range 1 to 23 years) and all patients had undergone a previous 
arthroscopy, the mean number of further operations was 2.18 (range 1 to 5).
Patients reviewed at 4 years after operation
A total of 16 patients were reviewed at 4 years with a mean age of 32.44 years 
(range 19 to 49 years). There were 7 men and 9 women. The mean defect size 
was 3.59 cm  ^(range 1.5 to 6 cm )^ with 8 having defects in the right knee and 8 in 
the left. Of the 16 patients, 5 (31.25%) were on the medial femoral condyle, the 
patella in 5 (31.25%) (4, single facet and 1 multiple facets), the lateral femoral 
condyle in 5 (31.25%) and 1 (6.25%) patient who had multiple defects repaired 
(table XIII). The aetiology of the lesions included 8 (50%) patients who had post 
traumatic defects, 2 (12.5%) patients who had chondromalacia patellae, 3 
(18.75%) had osteochondritis dissecans and 3 (18.75%) patients who had defects
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of unknown aetiology (table XIV). One patient had a combined ACI, mosaicplasty, 
patellar realignment and drilling to the harvest site. The mean duration of 
symptoms was 5.85 years (range 1 to 18 years) and all patients had undergone a 
previous arthroscopy, the mean number of further operations was 2.13 (range 1 to 
4).
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NUMBER NUMBER NUMBER NUMBER
ANATOMICAL OF OF OF OF
DISTRIBUTION PATIENTS PATIENTS PATIENTS PATIENTS
AT 1 YEAR AT 2 YEARS AT 3 YEARS AT 4 YEARS
Medial Femoral 52 32 14 5
Condyle (40%) (39%) (34%) (31.25%)
Lateral Femoral 19 13 8 5
Condyle (15%) (16%) (20%) (31.25%)
Patella-single 27 18 12 4
facet (21%) (22%) (29%) (25%)
Patella-multi 12 6 1 1
facet (9%) (7%) (6.25%)
Trochlea 1 6 4 0
(10%)
Multiple defects 13 7 2 1
(10%) (6.25%)
Total 130 82 41 16
(100%) (100%) (100%) (100%)
Table XIII. Anatomical site of the defects found in 130 patients at 1 year, 82 at 
2 years, 41 at 3 years and 16 at 4 years, by number and percentage.
NUMBER NUMBER NUMBER NUMBER
AETIOLOGY OF OF OF OF OF
DEFECTS PATIENTS PATIENTS PATIENTS PATIENTS
AT 1 YEAR AT 2 YEARS AT 3 YEARS AT 4 YEARS
Trauma 52 37 19 8
(40%) (45%) (46%) (50%)
Osteochondritis 18 11 6 3
dissecans (13.8%) (15%) (18.75%)
Chondromalacia 23 12 7 2
patellae (17.7%) (15%) (12.5%)
Previously failed 
cartilage 
resurfacing 
technique
17
(13.1%)
9
(11%)
3
Early
osteoarthritis
1
(0.8%)
1
(1%)
Other 19 12 6 3
(14.6%) (15%) (18.75%)
Total 130 82 41 16
(100%) (100%) (100%) (100%)
Table XIV. Aetiology of the defects found in 130 patients at 1 year, 82 at 2 
years, 41 at 3 years and 16 at 4 years, by number and percentage
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The indication for surgery in ail cases was pain associated with a chondral or 
osteochondral defect, other symptoms included swelling, giving way, catching and 
locking.
Surgical Technique
The procedure was divided into 2 stages as previously described for the ACI-P 
technique (pages 106-108). The ACI-C technique differed in that instead of 
harvesting periosteum from the distal femur or from the proximal tibia a type I/Ill 
collagen membrane was cut to size and used to retain the chondrocytes within the 
defect. The membrane was secured to the rim of the defect using multiple 6 O' 
vicryl sutures placed 3-4 mm apart and the edges of the defect were sealed with 
fibrin glue as before (figure XX).
Two patients required reconstruction of the anterior cruciate ligament (ACL), which 
was performed before implantation during the same operative procedure. In all 
cases a hamstring repair was used which was routed through standard tibial and 
femoral tunnels. Femoral fixation was achieved through a separate lateral incision 
with the anchoring sutures attached over a biodegradable post. The tibial fixation 
was secured using a biodegradable screw. Under the same general anaesthetic 
the ACI procedure was performed as described.
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Figure XX. Photograph showing 2 defects repaired with the ACI 
(collagen covered) technique. One defect is located over the patella 
and the other over the medial femoral condyle.
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Rehabilitation
Rehabilitation for patients following the ACI-C technique was the same as 
previously described for the ACI-P technique (pages 108-109).
The patients who had an ACL repair as well as a chondrocyte implantation were 
rehabilitated in the immediate post-operative period on a continuous passive 
motion machine and were discharged once they achieved 90° of flexion. Further 
rehabilitation focused on improving the patients’ range of movement and muscle 
strengthening exercises.
Evaluation
Patients were evaluated clinically and arthroscopically as described on pages 109- 
111 .
Statistical analysis. Statistical comparison of the clinical assessment scores at 
1,2,3 and 4 years was by the paired Students I  test. Comparisons between the 
good and excellent group and fair and poor group were made using the unpaired 
Student I  test. A p value of less than 0.05 was considered statistically significant.
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Results
Clinical Review
The pre-operative modified Cincinnati rating system scores are shown in table XV, 
32 (24.6%) had a good score, 57 (43.8%) had a fair score and 41 (31.5%) had a 
poor score. Those patients with a good score were considered for an ACI, since 
they complained of considerable pain that was attributed to an articular cartilage 
defect. All these patients were athletic and functioned at a high level so that they 
were able to compensate on the remaining parameters of the modified Cincinnati 
score, which in this situation tends to give a misleading good impression of their 
symptomatology.
There was a significant improvement in the modified Cincinnati score at 1 year 
(p<0.005) at 2 years (p< 0.005), at 3 years (p<0.005) and 4 years (p<0.005) 
following surgery. Overall, of the 130 patients who were reviewed at 1 year 81 
(62%) patients had a good or excellent result (table XVa), of the 82 patients 
reviewed at 2 years 48 (59%) had a good or excellent result (table XVb), of the 41 
patients reviewed at 3 years (59%) had a good or excellent result (table XVc) and 
of the 16 patients reviewed at 4 years 9 (56%) patients had a good or excellent 
result (table XVd).
It became evident during the course of the study that the results for years 1,2 and 
3 were adversely affected by a group of patients who had an ACI following a 
previous cartilage resurfacing technique, such as mosaicplasty or the matrix 
support prosthesis. Excluding this group the results were as follows; at 1 year, 77 
(68%) out of 113 patients reported good or excellent results, at 2 years 47 (64%) 
out of 73 patients and at 3 years 23 (61%) out of 38 patients.
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TOTAL EXCELLENT GOOD FAIR POOR
130
(100%)
32
(24.6%)
57
(43.8%)
41
(31.5%)
Table XV. Modified Cincinnati scores before ACI-C, 
numbers and percentages.
TOTAL EXCELLENT GOOD FAIR POOR
130 34 47 27 22
(100%) (26%) (36%) (21%)
Table XVa.
TOTAL EXCELLENT GOOD FAIR POOR
82 27 21 20 14
(100%) (33%) (26%) (24%) ff7%;
Table XVb.
TOTAL EXCELLENT GOOD FAIR POOR
41
(100%)
11
(26.8%)
13
(31.7%)
13
(31.7%)
4
(9.8%)
Table XVc.
TOTAL EXCELLENT GOOD FAIR POOR
16 4 5 5 2
(100%) (25%) (31.3%) (31.3%) (12.5%)
Table XVd.
Table XVa,b,c,d Modified Cincinnati scores at 1 year 
following ACI-C (table XVa), 2 years (table XVb), 3 years 
(table XVc) and 4 years (table XVd) by numbers and 
percentages.
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The mean modified Cincinnati knee score improved from 42 pre operatively to 60 
post operatively at 1 year (p<0.05), representing a difference of the means of 18 
(95% confidence interval between 14.09 and 22.12, n=130). The mean modified 
Cincinnati knee score improved from 41 pre operatively to 62 (p<0.05) at 2 years, 
representing a difference of the means of 21 (95% confidence interval between 
15.80 and 26.0, n=82). The mean modified Cincinnati knee score improved from 
40 pre operatively to 61 (p<0.05) at 3 years, representing a difference of the 
means of 21 (95% confidence interval between 14.17 and 28.90, n=41). The mean 
modified Cincinnati knee score improved from 44 pre operatively to 61 (p<0.05) at 
4 years, representing a difference of the means of 17 (95% confidence interval 
between 9.0 and 24.25, n=16).
Factors affecting outcome
It was apparent when reviewing the patients that there seemed to be a difference 
between those patients who had a good or excellent result and those that had a 
fair or poor result. As mentioned earlier, those with previous cartilage resurfacing 
techniques had a poorer outcome. However, other factors appeared to play a part. 
Table XVI shows the difference between these groups in terms of their age, defect 
size, duration of symptoms leading up to surgery and number of surgical 
procedures before implantation. The 81 patients with a good/excellent result at 1 
year were younger (p< 0.05) and had fewer surgical procedures (p< 0.05) before 
implantation compared to those who had a fair/poor result.
However, although 49 patients who had a fair or poor result had a longer duration 
of symptoms pre-operatively, the difference is not significant (p=0.19). Making a
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GOOD/
EXCELLENT
FAIR/ POOR P VALUE
MEAN AGE (YRS) 30.6
(range 15-54)
34.16
(range 16-49)
p<0.05
MEAN DEFECT SIZE 
(CM')
4.82
(range 1-12.25)
4.82
(range 1-12.5)
No difference
MEAN DURATION OF 
SYMPTOMS (YRS)
7.12
(range 1-23)
8.58
(range 1 -25)
p=0.19
NUMBER OF
PREVIOUS
PROCEDURES
1 .8 6
(range 1-5)
2.71
(range 1 -6 )
p<0.05
Table XVI. Comparison between the Good/excellent group and the Fair/poor 
group at 1 year and p values following ACI-C.
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similar comparison between the good/excellent group and the fair/poor group at 2  
years revealed a statistically significant difference in terms of the number of 
surgical procedures before implantation (p<0.05). A similar comparison at 3 years 
again showed a statistically significant difference in terms of the number of surgical 
procedures before implantation. At 4 years there was a statistically significant 
difference between these 2 groups in terms of the defect size (p<0.05). The mean 
defect size of the Fair/Poor group was 4.96 cm^ (range 2.7 to 6  cm*) and 2.64 cm* 
(range 1.5 to 5.25cm*) in the good/excellent group, however only 16 patients were 
reviewed at the 4-year mark.
Femoral Condylar Defects
Seventy-one patients with 52 medial and 19 lateral femoral condylar defects were 
reviewed at 1 year. The mean age of the patients was 31.15 years (range 15 to 49 
years) with a mean defect size of 4.74 cm* (range 1 to 12.5cm*). The mean 
duration of symptoms leading up to surgery was 8  years (range 1 to 25 years) and 
all patients had undergone a previous arthroscopy, the mean number of further 
operations was 2.24 (range 1 to 6 ). Fifty-eight patients with 32 medial and 13 
lateral femoral condylar defects were reviewed at 2 years and 22 patients with 14 
medial and 8  lateral femoral condylar defects were reviewed at 3 years. At 4 years, 
10 patients with 5 medial and 5 lateral condylar defects were reviewed. Using the 
modified Cincinnati Rating system, of those patients who had repairs to defects 
over the medial femoral condyle, 27 out of a total of 52 patients (52%) reported 
good or excellent results at 1 year, 18 out of 32 (56%) at 2 years, 7 out of 14 (50%) 
at 3 years and 2 out of 5 (40%) at 4 years (table XVII). However these results were 
adversely affected by a group of patients who had an ACI following a previous
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TIME OF CLINICAL MEDIAL FEMORAL LATERAL FEMORAL
REVIEW OUTCOME CONDYLE CONDYLE
Excellent 11 (21%) 8  (42%)
1 YEAR
Good 16 (31%) 7 (37%)
Fair 14 (27%) 3 (16%)
Poor 11 (21%) 1 (5%)
Total 52 (100%) 19(100%)
Excellent 8  (25%) 6  (46.2%)
2 YEARS
Good 10(31%) 3 (23%)
Fair 7 (22%) 2 (15.4%)
Poor 7 (22%) 2 (15.4%)
Total 32 (100%) 13(100%)
Excellent 4 (29%) 2 (25%)
3 YEARS
Good 3 (21%) 4 (50%)
Fair 5 (36%) 1 (12.5%)
Poor 2 (14%) 1 (12.5%)
Total 14(100%) 8  (100%)
Excellent 1 (20%) 1 (20%)
4 YEARS
Good 1 (20%) 2 (40%)
Fair 2 (40%) 1 (20%)
Poor 1 (20%) 1 (20%)
Total 5 (100%) 5(100%)
Table XVII. Clinical results at 1,2,3 and 4 years for patients who had an ACI- 
C for chondral and osteochondral defects over the medial and lateral femoral 
condyle of the knee by number and percentage.
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cartilage resurfacing technique such as mosaicplasty or the matrix support 
prosthesis. The results not including these patients were as follows, 24 out of a 
total of 39 patients (61.5%) at 1 year reported good/excellent results, 18 out of 26 
(69%) at 2 years and 7 out of 12 (58%) at 3 years. Of the patients who had repairs 
to defects over the lateral femoral condyle 15 out of a total of 19 (79%) reported 
good or excellent results at 1 year, 9 out of 13 (69.2%) at 2 years, 6  out of 8  (75%) 
at 3 years and 3 out of 5 (60%) at 4 years.
Patellar defects
Thirty-nine patients with 27 single facet and 12 with multi-facet defects were 
reviewed at 1 year. The mean age of the patients was 31.28 years (range 15 to 49 
years) with a mean defect size of 5.02 cm^ (range 1.26 to 12 cm^). The mean 
duration of symptoms leading up to surgery was 7.74 years (range 1 to 23 years) 
and all patients had undergone a previous arthroscopy, the mean number of 
further operations was 2.07 (range 1 to 6 ). Twenty-four patients with 18 single 
facet and 6  with multi-facet defects were reviewed at 2  years and 13 patients with 
12 single facet and 1 multi-facet defects were reviewed at 3 years. At 4 years, 5 
patients with 4 single and 1 multi-facet defects were reviewed.
Using the modified Cincinnati Rating system, of those patients who had repairs to 
defects over a single facet of the patella, 20 out of a total of 27 patients (74%) 
reported good or excellent results at 1 year, 11 out of 18 (61%) at 2 years, 7 out of 
12 (58%) at 3 years and 2 out of 4 (50%) at 4 years (table XVIII). Of the patients 
who had repairs to defects over both facets of the patella, 5 out of a total of 12 
(41.6%) reported good or excellent results at 1 year, 1 out of 6  (17%) at 2 years, 
none at 3 years and 1 out of 1 (100%) at 4 years.
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TIME OF 
REVIEW
CLINICAL
OUTCOME
SINGLE FACET 
PATELLAR DEFECT
MULTI-FACET 
PATELLAR DEFECT
1 YEAR
Excellent 7 (26%) 1 (8.3%)
Good 13 (48%) 4 (33.3%)
Fair 3(11%) 4 (33.3%)
Poor 4 (15%) 3 (25%)
Total 27 (100%) 1 2  (100%)
2 YEARS
Excellent 6  (33%) 1 (17%)
Good 5 (28%)
Fair 5 (28%) 5 (87%)
Poor 2(11%)
Total 18 (100%) 8(100%)
3 YEARS
Excellent 4 (33%)
Good 3 (25%)
Fair 5 (42%) 1 (100%)
Poor
Total 12(100%) 1 (100%)
4 YEARS
Excellent 1 (25%) 1 (100%)
Good 1 (25%)
Fair 2 (50%)
Poor
Total 4 (100%) 1 (100%)
Table XVIII. Clinical results at 1,2,3 and 4 years for patients who had an 
ACI-C for chondral and osteochondral defects over the patella (single and 
multi-facet) by number and percentage.
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Trochlea defects
Seven patients with defects over the trochlea were reviewed at 1 year. The mean 
age of the patients was 33.3 years (range 18 to 54 years) with a mean defect size 
of 4.83 cm  ^ (range 2 to 10.5 cm^). The mean duration of symptoms leading up to 
surgery was 5.14 years (range 1 to 15 years) and all patients had undergone a 
previous arthroscopy, the mean number of further operations was 2.29 (range 1 to 
5). Six patients were reviewed at 2 years and 4 patients were reviewed at 3 years. 
There were no patients reviewed at 4 years with defects over the trochlea.
Using the modified Cincinnati Rating system, of those patients who were reviewed 
at 1 year, 7 out of a total of 7 (100%) patients reported good or excellent results at 
1 year, 5 out of 6  (87%) at 2 years and 3 out of 4 (75%) at 3 years (table XIX).
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TIME OF REVIEW CLINICAL DEFECT OVER THE
OUTCOME TROCHLEAR
Excellent 4
1 YEAR
Good 3
Fair
Poor
Total 7
Excellent 5
2 YEARS
Good
Fair 1
Poor
Total 6
Excellent 1
3 YEARS
Good 2
Fair 1
Poor
Total 4
Table XIX. Clinical results at 1,2 and 3 years for patients who had an 
ACI-C for chondral and osteochondral defects over the trochlea.
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Multiple defects
Thirteen patients with 2 defects repaired at the time of surgery were reviewed at 
1 year. The mean age of the patients was 37.69 years (range 14 to 48 years) 
with a mean defect size of 4.73 cm  ^ (range 0.75 to 12.5 cm^) per defect. The 
mean duration of symptoms leading up to surgery was 6.92 years (range 1 to 24 
years) and all patients had undergone a previous arthroscopy, the mean number 
of further operations was 2.15 (range 1 to 5). Seven patients were reviewed at 2 
years, 2 were reviewed at 3 years and 1 was reviewed at 4 years.
Using the modified Cincinnati Rating system, of those patients who were 
reviewed at 1 year, 7 out of a total of 13 (54%) patients reported good or 
excellent results, 4 out of 7(54%) at 2 years, 1 out of 2 (50%) at 3 years and 1 
out of 1 (100%) at 4 years (table XX).
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TIME OF REVIEW CLINICAL
OUTCOME
MULTIPLE DEFECTS
1 YEAR
Excellent 3
Good 4
Fair 3
Poor 3
Total 13
2 YEARS
Excellent 1
Good 3
Fair 2
Poor 1
Total 7
3 YEARS
Excellent
Good 1
Fair
Poor 1
Total 2
4 YEARS
Excellent 1
Good
Fair
Poor
Total 1
Table XX. Clinical results at 1,2,3 and 4 years for patients who had an 
ACI-C for multiple chondral and osteochondral defects of the knee.
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Traumatic Defects
Of the 130 patients reviewed at 1 year, 52 (40%) had defects of traumatic origin. 
The mean age of the patients was 32.7 years (range 15 to 49 years) with a mean 
defect size of 4.58 cm  ^ (range 1 to 12.5 cm*). The mean duration of symptoms 
leading up to surgery was 5.9 years (range 1 to 25 years) and all patients had 
undergone a previous arthroscopy, the mean number of further operations was 
2.23 (range 1 to 6 ). Thirty-seven patients were reviewed at 2 years, 19 at 3 years 
and 8  at 4 years. Using the modified Cincinnati Rating system, of those patients 
who were reviewed at 1 year, 36 out of a total of 52 (69.2%) patients reported good 
or excellent results, 22 out of 37 (59%) at 2 years, 14 out of 19 (73.7%) at 3 years 
and 7 out of 8  (87.5%) at 4 years (table XXI).
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TIME OF REVIEW CLINICAL
OUTCOME
TRAUMATIC DEFECTS
1 YEAR
Excellent 15 (28.8%)
Good 21 (40.4%)
Fair 9(17.3%)
Poor 7 (13.5%)
Total 52 (100%)
2 YEARS
Excellent 13 (35%)
Good 9 (24%)
Fair 8  (22%)
Poor 7 (19%)
Total 37 (100%)
3 YEARS
Excellent 6  (31.6%)
Good 8(42.1%)
Fair 3 (15.8%)
Poor 2 {10.5%)
Total 19 (100%)
4 YEARS
Excellent 4 (50%)
Good 3 (37.5%)
Fair
Poor 1 (12.5%)
Total 7 (100%)
Table XXI. Clinical results at 1,2,3 and 4 years for patients who had 
defects of traumatic origin, by number and percentage following ACI-C.
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Osteochondritis dissecans
Of the 130 patients reviewed at 1 year, 18 (13.8%) had defects attributed to 
osteochondritis dissecans. The mean age of the patients was 26.4 years (range 15 
to 44 years) with a mean defect size of 4.42 cm^ (range 1 to 11.25 cm^). The mean 
duration of symptoms leading up to surgery was 8.2 years (range 1 to 23 years) 
and all patients had undergone a previous arthroscopy, the mean number of 
further operations was 1.5 (range 1 to 3). Eleven patients were reviewed at 2 
years, 6  at 3 years and 3 at 4 years. Using the Modified Cincinnati Rating system, 
of those patients who were reviewed at 1 year, 14 out of a total of 18 (77.7%) 
patients reported good or excellent results, 9 out of 11 (82%) at 2 years, 3 out of 6  
(50%) at 3 years and 1 out of 3 (33%) at 4 years (table XXII).
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TIME OF REVIEW CLINICAL
OUTCOME
OSTEOCHONDRITIS
DISSECANS
1 YEAR
Excellent 11
Good 3
Fair 3
Poor 1
Total 18
2 YEARS
Excellent 6
Good 3
Fair 1
Poor 1
Total 11
3 YEARS
Excellent 2
Good 1
Fair 2
Poor 1
Total 6
4 YEARS
Excellent
Good 1
Fair 2
Poor
Total 3
Table XXII. Clinical results at 1,2,3 and 4 years for patients who had 
defects attributed to osteochondritis dissecans, following ACI-C.
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Chondromalacia Patellae
Of the 130 patients reviewed at 1 year, 23 (17.7%) had defects attributed to 
chondromalacia patellae. The mean age of the patients was 29.7 years (range 17 
to 45 years) with a mean defect size of 4.56 cm^ (range 1.26 to 10.35 cm*). The 
mean duration of symptoms leading up to surgery was 8.9 years (range 1 to 18 
years) and all patients had undergone a previous arthroscopy, the mean number of 
further operations was 2.26 (range 1 to 6 ). Twelve patients were reviewed at 2 
years, 7 at 3 years and 2 at 4 years.
Using the modified Cincinnati Rating system, of those patients who were reviewed 
at 1 year, 14 out of a total of 23 (61%) patients reported good or excellent results, 
4 out of 12 (33%) at 2 years, 3 out of 7 (43%) at 3 years and both patients 
reviewed at 4 years reported a fair result (table XXIII).
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TIME OF REVIEW CLINICAL CHONDROMALACIA
OUTCOME PATELLAE
Excellent 2
1 YEAR
Good 1 2
Fair 4
Poor 5
Total 23
Excellent 1
2 YEARS Good 3
Fair 6
Poor 2
Total 12
Excellent 1
3 YEARS
Good 2
Fair 4
Poor
Total 7
Excellent
4 YEARS
Good
Fair 2
Poor
Total 2
Table XXIII. Clinical results at 1,2,3 and 4 years for patients who 
had defects attributed to chondromalacia patellae following ACI-C.
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ACI foUowing failed cartilage repair techniques
Of the 130 patients reviewed at 1 year, 17 (13.1%) had an ACI following a failed 
cartilage resurfacing technique such as mosaicplasty or a matrix support 
prosthesis of carbon fibre. The mean age of the patients was 35.2 years (range 28 
to 48 years) with a mean defect size of 6.64 cm^ (range 2 to 12.25 cm^). The mean 
duration of symptoms leading up to surgery was 12.5 years (range 5 to 25 years) 
and all patients had undergone a previous arthroscopy, the mean number of 
further operations was 3.29 (range 2 to 6 ). Nine patients were reviewed at 2 years, 
3 at 3 years and none at 4 years. Using the modified Cincinnati Rating system, of 
those patients who were reviewed at 1 year, 4 out of a total of 17 (24%) patients 
reported good or excellent results, 1 out of 9 (11%) at 2 years and 1 out of 3 
(33%) at 3 years (table XXIV).
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TIME OF 
REVIEW
CLINICAL
OUTCOME
ACI FOLLOWING FAILED 
CARTILAGE REPAIR
1 YEAR
Excellent 1
Good 3
Fair 5
Poor 8
Total 17
2 YEARS
Excellent 1
Good
Fair 5
Poor 3
Total 9
3 YEARS
Excellent
Good 1
Fair 2
Poor
Total 3
Table XXIV. Clinical results at 1.2 and 3 years for patients who 
had an ACI-C repair following a failed cartilage resurfacing 
technique.
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Arthroscopic review
A repeat arthroscopy at 1 year following the Implantation revealed ICRS grades of 
1 or 2 in 84 of 100 patients (84%). The arthroscopy of 4 patients did not show any 
evidence of the graft and scored an ICRS of 4 (table XXV). Thirty-two 
arthroscopies were carried out at the 2 -year review, which revealed ICRS grades 
of 1 or 2 in 27 of 32 patients (84%). In the case of 1 patient there was no evidence 
of the graft and scored 4 on the ICRS grading system. Further review 
arthroscopies were not carried out unless there was a clinical indication. Of the 34 
biopsies taken at the time of the 1 -year check arthroscopy, 2 1  were from the 
medial femoral condyle, 7 from the lateral femoral condyle, 4 from the patella and 2 
from the trochlea. Of the 13 biopsies taken at the time of the 2 -year check 
arthroscopy, 5 were taken from the medial femoral condyle, 3 from the lateral 
femoral condyle, 4 from the patella and 1 from the trochlea.
Hyaline cartilage of normal appearance was found in 7 of the biopsies taken at 1 
year, consisting of cells in lacunae enveloped within a matrix that stained positively 
for type II collagen using Safranin O. Of the remaining biopsies taken at 1 year, 10 
showed characteristics of both hyaline and fibrocartilage and 17 showed evidence 
of fibrocartilage (table XXVI).
Of those repairs biopsied at 2 years, 3 showed evidence of hyaline cartilage, 5 
mixed hyaline and fibrocartilage and 5 fibrocartilage.
One of the grafts which showed mixed hyaline and fibrocartilage at 1 year, when 
biopsied again at 2 years revealed hyaline cartilage alone. This suggests that 
grafts can take up to 2 years to fully mature as suggested previously by Bentley 
and Peterson
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ICRS GRADE NUMBER (%)
1 YEAR 2 YEARS
1, Excellent 1 2  (12%) 1 (3%)
2, Good 72 (72%) 26 (81%)
3, Fair 1 2  (12%) 4(13%)
4, Poor 4(4%) 1 (3%)
Total 1 0 0  (100%) 32 (100%)
Table XXV. Arthroscopic results at 1 and 2 years, by 
number and percentage following ACI-C.
BIOPSY RESULT AT 1 YEAR
CLINICAL
RESULT
HYALINE OR MIXED 
HYALINE AND 
FIBROCARTILAGE
FIBROCARTILAGE
Excellent 6 6
Good 7 6
Fair 4 2
Poor 3
Table XXVI. Clinical results of patients based on their 
biopsy result at 1 year, following ACI-C.
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Patients biopsied at 1 year who had a hyaline or mixed repair had a better clinical 
result than those biopsied at 1 year who had a fibrocartilage repair. Of the 17 
patients who had a hyaline or mixed repair, 76.5% reported good or excellent 
results at 1 year compared with the 17 patients that had a fibrocartilage repair who 
reported 70.5% good or excellent results. However, this difference did not reach 
statistical significance (p=0.40). At 1 year of the 34 patients who were biopsied, 3 
patients had a poor clinical result based on the modified Cincinnati rating system, 
all of whom had a fibrocartilage repair when biopsied (table XXVI).
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COMPLICATION NUMBER
MAJOR
Deep vein thrombosis 2  at 1 year
Graft failure 1 at 1 year
2  at 2  years 
1 at 3 years
INTERMEDIATE
Graft hypertrophy 11 at 1 year 
4 at 2 years 
2 at 4 years
MINOR
Stitch abscess 1 at 1 year
Slow to mobilize requiring a manipulation 
under anaesthetic
11 at 1 year
Unplanned arthroscopy 9 at 1 year 
2 at 4 years
Table XXVII. Complications following the ACI-C.
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Complications
Within the first year following chondrocyte implantation there were 3 (2.3%) major 
complications and 32 (24.6%) intermediate and minor complications. Within the 2** 
year of transplantation there were 2 (2.4%) major complications and 4 (4.9%) 
intermediate and minor complications. Within the 3^ year there was 1 (2.4%) major 
complication and no intermediate or minor complications and within the 4‘^  year 
there were no major complications and 4 intermediate and minor complications 
(table XXVII).
Complications encountered within the 1®* year included, two patients who 
developed a deep vein thrombosis and required anticoagulation with warfarin and 
one patient whose graft failed at the 1 year mark. Eleven patients were slow to 
mobilize and required a manipulation under anaesthetic. Eleven patients had 
hypertrophy of the graft at the time of the check arthroscopy at 1 year. Nine 
patients had an unplanned arthroscopy within the first year, 1 for graft hypertrophy, 
2  who required division of adhesions, 1 for a torn meniscus, 2  for ongoing pain, 1 
for excision of a plica and 2  patients required an arthroscopy since an infective 
process was suspected but nothing was grown in culture. One patient had a stitch 
abscess that resolved with a course of oral antibiotics.
At 2 years, there were 2 episodes of graft failure and 4 patients required shaving of 
their grafts, which had hypertrophied.
At 3 years there was 1 patient who required an arthroscopy for ongoing pain and it 
was found that the graft had failed.
At 4 years there were 2 patients who required an arthroscopy for shaving of 
hypertrophied grafts.
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Discussion
Autologous chondrocyte implantation using a type l/l II collagen membrane offers 
an altemative to a periosteum cover in containing cultured chondrocytes within a 
chondral or osteochondral defect. Peterson et al has suggested that the 
periosteum not only provides a membrane preventing the leakage of implanted 
cells but also contributes growth factors and cells to the graft repair. This view has 
been supported by observations made using an animal model but has not been 
demonstrated in the human subject as previously discussed. An alternative to a 
periosteal covering was sought due to concerns of the possible co-morbidity 
associated with harvesting the periosteum and also problems with its hypertrophy 
requiring an arthroscopy and shaving (see Chapter 3, pages 127-129).
The results of this study are encouraging with 6 8 % of patients reporting good or 
excellent results at 1 year, 64% at 2 years, 61% at 3 years and 56% at 4 years (not 
including the group who previously had cartilage resurfacing techniques such as 
mosaicplasty or a matrix support prosthesis). Although this would suggest a clinical 
deterioration following transplantation the decrease in good or excellent scores 
over the 4 year period was not statistically significant. (p=0.70).
The findings at the 1 and 2 year check arthroscopies revealed that 84% of those
who were arthroscoped had repairs that were good or excellent based on the ICRS
grading system. At 1 year 4 grafts had failed, 2 occurred with defects over the
retropatellar surface, 1 over the lateral femoral condyle and 1 over the medial
femoral condyle. At 2 years 1 graft failed which was located over the retropatellar
surface. Although the majority of graft failures occurred in patients with defects
located over the retropatellar surface this was not typical of the group as a whole,
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with 64% of patients at 1 year reporting good or excellent results. However, 
patients with repairs to single facet defects (74%) did better than those with repairs 
to both facets (41.6%).
As for the periosteal covered ACI, it became apparent that there were a number of 
factors that influenced the outcome of the repair. A comparison between the 
good/excellent group and fair/poor group at 1,2 and 3 years revealed that patients 
who had fewer surgical procedures leading up to the implantation did better and 
those that had previous cartilage resurfacing techniques such as mosaicplasty did 
worse. Other factors that seemed to affect the outcome of the implantation 
included the age of the patient, with patients older than 34 years having a worse 
outcome and the size of the defect that was repaired. At 1 -year, patients who were 
younger and at 4 years those that had smaller defects did better.
Defects repaired in this study were larger than those repaired in other studies. The 
mean defect size of the femoral condyle lesions in Peterson et al’s recent long­
term durability study was 3.4cm^ compared with 4.74cm^ in this study. Similarly, 
simple defects that were repaired in Minas’ study had a mean size of 4.3 cm .^ 
The difference in the size of the defects repaired over the medial femoral condyle 
may explain why our results (69% good or excellent at 2 years) are not as good as 
the Swedish experience (89% good or excellent at 2 years). Although Peterson 
et al use 5 scoring systems in their study to evaluate the patients’ clinical outcome, 
it is not clear which system they use to arrive at this figure, so it is difficult to make 
a direct comparison.
Patients referred for chondrocyte implantation to the Swedish group had a shorter 
duration of symptoms (3.4 years) compared to our patients ( 8  years). This may 
account for the defects in our group being bigger since patients have had them for
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longer. The majority of our patients are referred via other institutions and 
regrettably results in a delay in them receiving surgical intervention. Possibly this 
delay results in the defect getting bigger and may have a deleterious psychological 
effect although this has not been quantified.
Patients’ age, size of the defect, number of operations before implantation and 
duration of symptoms leading up to surgery may all play a role in the clinical 
outcome following chondrocyte implantation and may have implications for patient 
selection for this technique. This requires further analysis.
Concerns have been raised about the insertion of multiple sutures into the 
surrounding cartilage at the margin of the defect resulting in damage to the 
articular surface. Similar to the periosteal covered ACI there was no evidence in 
this study to suggest that this was the case. At the check arthroscopies at 1 and 2 
years the articular cartilage adjacent to the graft was intact and appeared healthy. 
Of more concern with this technique was the length of time it took to attach the 
membrane to the rim of the defect resulting in relatively long tourniquet and 
anaesthetic times of up to 2  hours.
Repairs to areas of the knee that have been considered difficult in the past have 
also had good results. Defects over the lateral femoral condyle can be difficult to 
access using this technique. However, at 1 year 79% of patients reported good or 
excellent results and 75% at 3 years. Although the patients with defects over the 
lateral femoral condyle were a small group the results are encouraging. Similarly, 
patients who had repairs to the trochlea did well with 1 0 0 % of patients reporting 
good or excellent results at 1 year, 87% at 2 years and 75% at 3 years, although 
these are encouraging results the group was small with only 7 patients reviewed at 
1 year.
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Patients with traumatic defects and those with osteochondritis dissecans did better 
than those with chondromalacia patellae or had defects repaired previously by 
other resurfacing techniques. The results for the last group were disappointing with 
24% reporting good or excellent results at 1 year, 11 % at 2 years and 33% at 3 
years. The defects repaired in this group were considerably bigger (mean 6.64 
cm^) and were often quite deep. These patients also had a longer duration of 
symptoms compared with other groups (12.5 years) and had multiply operated 
knees (3.29 operations before implantation). As previously mentioned, all these 
factors probably play an important role in the final outcome of chondrocyte 
implantation.
A review of the histology at 1 and 2 years following the chondrocyte implantation 
revealed that this technique can result in a hyaline repair with 7 out of 34 biopsies 
showing hyaline cartilage alone and 1 0  showed a mixture of hyaline and 
fibrocartilage. At 2 years, 3 biopsies showed evidence of hyaline cartilage alone 
and 5 showed mixed hyaline and fibrocartilage. These encouraging results support 
the findings published by Briggs et al ^  for this technique. In this review patients 
that had a hyaline or mixed repair, reported a better clinical result than those that 
had a fibrocartilage repair at 1 year, although this did not achieve statistical 
significance.
There is considerable speculation about the maturing process which might occur in 
the graft, so that a graft that appears fibrous or fibrocartilaginous or a mixture of 
hyaline and fibrocartilage at 1 year, may mature to hyaline cartilage at 2  years 
In this study there was a case of 1 patient when biopsied at 1 year having a 
mixture of hyaline and fibrocartilage but at 2  years the same patient had hyaline 
cartilage alone. Although both biopsies were taken from the graft, there maybe
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considerable variability in the histological appearance of the graft from one area to 
the next, which may account for this apparent change. Further long-term studies 
are required to clarify this point.
In summary, our study has shown that the ACI technique using a type I/Ill 
biodegradable porcine membrane rather than a periosteal cover can result in a 
hyaline repair of chondral and osteochondral defects. There was a significant 
improvement in the Modified Cincinnati scores at each of the clinical reviews from 
years 1 to 4 especially for the post-traumatic, trochlea and patella defects, with 
84% having good or excellent repairs as judged on the ICRS grading system at the 
follow up arthroscopies.
However, not all patients may be suitable for this technique and factors such as the 
patients’ age, defect size, duration of symptoms leading up to surgery and number 
of surgical procedures before implantation appear to be important in patient 
selection.
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CHAPTER 5:
A PROSPECTIVE, RANDOMISED STUDY COMPARING TWO TECHNIQUES 
OF AUTOLOGOUS CHONDROCYTE IMPLANTATION FOR OSTEOCHONDRAL 
DEFECTS IN THE KNEE: Periosteum covered versus type I/Ill collagen 
covered
Introduction
The previous 2 chapters have described 2 techniques to retain the cultured 
chondrocyte suspension within an osteochondral defect. As already mentioned 
Brittberg et al ^  used a periosteal cover sutured to the rim of the defect (ACI- 
periosteum) whereas other authors have used a type I/Ill collagen cover which was 
similarly attached to the rim of the defect (ACI-collagen) There is considerable 
speculation as to whether the periosteal cover acts simply as a watertight seal or 
whether it secretes factors essential for the development of a hyaline cartilage 
repair The results have been encouraging for both techniques (see previous 
chapters), but there are no prospective, randomised controlled trials, which 
compare the two techniques. This study compares ACI-periosteum and ACI- 
collagen for the repair of chondral and osteochondral defects over the femoral 
condyles, patella and trochlea at 2 years. This comparison was made at 2 years 
since both Bentley et al and Peterson et al have suggested that grafts can 
take this long to mature to a hyaline-like repair.
Patients and Methods
The South East Multi-Centre Research Ethics Committee and The Joint Research 
and Ethical Committee of the Royal National Orthopaedic Hospital Trust gave its
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approval before commencing this study (G. Bentley 2002 -  personal 
communication).
Between March 1999 and February 2002, a total of 6 8  patients with a mean age of 
30.52 years (range 15 to 52 years) with symptomatic articular cartilage defects 
were randomised to have either ACI with a periosteum cover (33 patients) or ACI 
with a type I/Ill synthetic cover (35 patients). There were 33 men and 35 women 
with a mean age of 30.52 years (range 15 to 52 years) for those that underwent 
the ACI with periosteum technique and 30.54 years (range 16 to 49 years) for 
those that underwent the ACI technique with a type I/Ill collagen cover. The mean 
defect size was 4.54 cm^ (range 1 to 12 cm^) with 38 having defects in the right 
knee and 30 in the left. Of the 6 8  patients, 26 (38%) defects were on the medial 
femoral condyle, 27 (40%) on the patella, 11 (16%) on the lateral femoral condyle, 
and 4 (6 %) on the trochlea (table XXVIII). The aetiology of the lesions included 34 
(43%) patients who had post traumatic defects, 20 (29%) patients had 
chondromalacia patellae, 12 (18%) had osteochondritis dissecans and 7 (10%) 
had defects of unknown aetiology, although they were most probably post 
traumatic (table XXIX).
The mean duration of symptoms was 7.09 years (range 1 to 27 years) and all 
patients had undergone a previous arthroscopy, the mean number of further 
operations was 2.09 (range 1 to 8 ). All patients were followed up at 24 months.
The indication for surgery in all cases was disabling pain associated with a 
chondral or osteochondral defect. Other symptoms included swelling, giving way, 
catching and locking.
174
ANATOMICAL
DISTRIBUTION
TOTAL PERIOSTEUM 
COVERED ACI
COLLAGEN 
COVERED ACI
Medial femoral condyle 26 (38%) 8  (24%) 18(51%)
Patella 27 (40%) 2 0  (61%) 7 (20%)
Lateral femoral condyle 11 (16%) 3(9%) 8  (23%)
Trochlea 4(6%) 2(6%) 2(6%)
Total 6 8  (100%) 33 (100%) 35 (100%)
Table XXVIII. Anatomical site of the defects found in 68 patients, 
by number and percentage for the ACI-C vs ACI-P study.
AETIOLOGY OF 
DEFECTS
TOTAL PERIOSTEUM 
COVERED ACI
COLLAGEN 
COVERED ACI
Trauma 29 (43%) 12 (36%) 17 (49%)
Osteochondritis
dissecans
12  (18%) 5 (15%) 7(20%)
Chondromalacia patellae 20 (29%) 15 (46%) 8(17%)
Other 7 (10%) 1 (3%) 5 (14%)
Total 6 8  (100%) 33 (100%) 35 (100%)
Table XXIX. Aetiology of the defects found in 68 patients, by number 
and percentage for the ACI-C vs ACI-P study.
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Surgical Technique
The surgical technique for the periosteal covered ACI and the collagen covered 
technique (figure XXI) have already been described on pages 106-108 and pages 
140-141 respectively.
Patients were randomised using random sample numbers in sealed envelopes. 
Rehabilitation
The rehabilitation programme was identical for both techniques and has been 
previously described on page 108-109.
Evaluation
Patients were evaluated clinically and arthroscopically as described on pages 109- 
111 .
Statistical analysis. The sample size and power calculation were based on 30 
patients in each group with an expected 2 year Cincinnati score of 43 to 91 in the 
collagen covered ACI group and between 38 and 8 6  in the periosteum covered 
ACI group. Thus, an expected difference of 20 between the 2 groups was 
considered clinically significant and a power of 90% was assumed.
Statistical comparison of the pre-operative and postoperative clinical assessment 
scores at 2 years for each of the techniques was by the paired Students T test. 
Comparison of outcome scores between the groups was made using the unpaired 
Student T test. A p value of less than 0.05 was considered statistically significant.
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Figure XXI. Photograph of a type I/Ill collagen membrane secured
to the rim of an osteochondral defect located over the medial femoral condyle. 
A cannula has been introduced through a small opening underneath the 
membrane so that a suspension of cultured chondrocytes can be injected into 
the defect.
(Courtesy of G. Bentley)
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Results 
Clinical Review
The pre-operative modified Cincinnati rating system scores are shown in table XXX 
for both techniques. Out of a total of 33 patients who had the AGI technique with 
periosteum cover, 13 (39.4%) had a good score, 11 (33.3%) had a fair score and 9 
(27.3%) had a poor score pre-operatively. Out of a total of 35 patients who had the 
ACI technique with a type I/Ill collagen cover 12 (34%) had a good score, 15 (43%) 
had a fair score and 8  (23%) had a poor score pre-operatively. Those patients that 
had a good score were nevertheless considered suitable for chondrocyte 
implantation because they complained of considerable pain on exertion that was 
attributable to their articular cartilage defects. All these patients were athletic and 
functioned at a high level so that despite scoring badly for pain they were able to 
compensate on the remaining parameters of the Modified Cincinnati score.
There was a significant improvement in the modified Cincinnati score at 2 years 
following the ACI technique with a periosteum cover (p<0.005) and the ACI 
technique with a type I/Ill collagen membrane (p<0.005). After 2 years the mean 
modified Cincinnati knee score was 62 compared with 45 pre-operatively for the 
periosteum covered ACI group, this represented a 38% increase. For the collagen 
covered ACI group the mean modified Cincinnati score was 67 at 2 years 
compared with 45 pre-operatively, this represented a 49% increase. Hence the 
difference of the means at 2 years for the 2 groups was 5 with a 95% confidence 
interval that the true mean Cincinnati score for the ACI-collagen group at 2 years 
lies between 55 and 79. There was no statistically significant difference between 
the 2 groups (p value = 0.367).
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ACI
(PERIOSTEAL
COVER)
TOTAL EXCELLENT GOOD FAIR POOR
33 13
(39.4%)
11
(33.3%)
9
(27.3%)
ACI
(COLLAGEN
COVER)
TOTAL EXCELLENT GOOD FAIR POOR
35 1 2
(34%)
17
(43%)
11
(23%)
Table XXX. Modified Cincinnati scores before surgery, 
for the ACI-C vs ACI-P study.
ACI
(PERIOSTEAL
COVER)
TOTAL EXCELLENT GOOD FAIR POOR
33 1 0
(30.3%)
1 2
(36.4%)
7
(21.2%)
4
(12.1%)
ACI
(COLLAGEN
COVER)
TOTAL EXCELLENT GOOD FAIR POOR
35 1 2
(34.3%)
14
(40%)
5
(14.3%)
4
(11.4%)
Table XXXI. Modified Cincinnati scores at 2 years following 
the ACI technique with either a periosteum covering or type I/Ill 
collagen covering.
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Based on the Cincinnati score, of the 35 patients with defects treated by the 
collagen covered ACI technique, 26 (74%) had a good or excellent result (table 
XXXI) compared with 22 of 33 (67%) patients treated by ACI with a periosteum 
cover.
Table XXXII shov/s the results at 2 years based on the site of the defect. Of the 18 
defects of the medial femoral condyle treated by ACI-collagen, 13 (72%) had a 
good or excellent result compared with 5 (62.5%) out of 8  treated by ACI- 
periosteum (p>0.05). However, this difference was not significant. In the case of 
defects of the lateral femoral condyle, 6  (75%) out of 8  had a good or excellent 
result following the ACI-collagen technique compared with 3 out of 3 after ACI- 
periosteum (p>0.05). For defects over the patellar 6  out of 7 (8 6 %) had a good or 
excellent result following ACI-collagen compared with 12 out of 20 (60%) following 
ACI-periosteum (p>0.05). The numbers of defects of the trochlea were too small 
for statistical analysis.
All patients were randomized as previously deschbed, however it is clear from the 
data analysis that more patients who underwent the periosteum covered ACI had 
defects over the patella, a group which are notorious for being difficult to treat (^ "^ ). 
This anomaly occurred purely by chance and could represent a confounding factor 
of the study. This point will be referred to again in the discussion.
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ANATOMICAL
DISTRIBUTION
TOTAL EXCELLENT GOOD FAIR POOR P
VALUE
MFC
ACI (periosteum) 8 1 4 2 1
ACI (collagen 18 5 8 2 3 p>0.05
membrane)
LFC
ACI (periosteum) 3 2 1
ACI (collagen 8 4 2 1 1 p>0.05
membrane)
Patella
ACI (periosteum) 2 0 6 6 5 3
ACI (collagen 7 2 4 1 p>0.05
membrane)
Trochlea
ACI (periosteum) 2 1 1
ACI (collagen 2 1 1
membrane)
Table XXXII. Clinical results at 2 years for 68 patients who had either an AGI with a 
periosteum cover or an ACI with a collagen membrane cover for osteochondral defects of 
the knee. (MFC = Medial femoral condyle and LFC = Lateral femoral condyle).
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Arthroscopic Review
A repeat arthroscopy was made at the 1 and 2 year mark following the 
chondrocyte implantation. Of the 35 patients who had an ACI-collagen technique 
29 had a repeat arthroscopy at 1 year (table XXXIII), 23 (79%) had an ICRS grade 
of 1 or 2 compared with 25 (81%) patients out of 31 who had the ACI-periosteum 
technique. At 2 years 11 patients who had the ACI-collagen technique had a 
repeat arthroscopy of whom 9 (82%) had an ICRS grade of 1 or 2. After the ACI- 
periosteum technique 9 patients had a repeat arthroscopy at 2 years, which 
revealed that 5 (55.6%) had an ICRS grade of 1 or 2. This difference was not 
significant (p>0.05). At 1 year the majority of grafts following either the ACI- 
collagen technique or the ACI-periosteum technique completely filled the defects 
with evidence of good incorporation into the surrounding articular surface resulting 
in a high ICRS score. However, at 1 year the grafts were relatively soft on probing 
compared with the surrounding cartilage but at 2  years the grafts did appear firmer.
Of the 13 biopsies taken from the ACI-collagen patients at the time of the 1 year 
check arthroscopy, 8  were from the medial femoral condyle, 3 were from the lateral 
femoral condyle, 1 was from the patella and 1 from the trochlea. Hyaline cartilage 
was found in 3 of the biopsies taken at this time (figure XXIII), consisting of 
chondrocytes in lacunae enveloped within a matrix that stained positively for 
Safranin O (figure XXII, XXIV). Of the remaining biopsies taken at 1 year, 6  
showed both hyaline cartilage and fibrocartilage and 4 showed fibrocartilage alone. 
At 2 years 7 biopsies were taken from grafts following the ACI-collagen technique, 
1 showed hyaline cartilage, 4 showed a mixture of hyaline and fibrocartilage and 2 
showed fibrocartilage. At 1 year following the ACI-periosteum technique 14 
biopsies were taken at the time of the repeat arthroscopy, 5 were taken from the
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medial femoral condyle, 8  from the patella, and 1 from the lateral femoral condyle. 
Two showed hyaline cartilage, 4 showed a mixture of hyaline and fibrocartilage, 
and 8  showed fibrocartilage. At 2 years 3 biopsies were taken following the ACI- 
periosteum technique 1 showed hyaline cartilage and 2  showed a mixture of 
hyaline and fibrocartilage (table XXXIV).
One of the grafts following the ACI-periosteum technique showed mixed hyaline 
and fibrocartilage at 1 year, when biopsied again at 2  years revealed hyaline 
cartilage alone. This observation would support previous suggestions that 
grafts may take up to 2  years to fully mature.
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ICRS GRADE ACI-COLLA GEN ACI- PERIOSTEUM
1 YEAR 2 YEARS 1 YEAR 2 YEARS
1, Excellent 3 (10.3%) 1 (9%) 3 (9.7%)
2, Good 20 (69%) 8  (73%) 22 (71%) 5 (55.5%)
3, Fair 5(17.2%) 2 (18%) 5 (16%) 3 (33.3%)
4, Poor 1 (3.4%) 1 (3.2%) 1 (11.1%)
Total 29 (100%) 11 (100%) 31 (100%) 9 (100%)
Table XXXIII. Arthroscopic results at 1 and 2 years for patients who 
had either and ACI with a periosteum cover or ACI with a type I/Ill 
collagen cover, by number and percentage.
BIOPSY
RESULT
ACI-COLLAGEN ACI- PERIOSTEUM
1 YEAR 2 YEARS 1 YEAR 2 YEARS
Hyaline 3 (23%) 1 (14%) 2  rM .2 %; 1 (33.3%)
Mixed hyaline 
and
fibrocartilage
6  (46%) 4 {57%) 4 (26.6%; 2 (66.6%)
Fibrocartilage 4 (31%) 2 (29%) 8(57.1%)
Total 13(100%) 7 (100%) 14 3 (100%)
Table XXXIV. Biopsy results at 1 and 2 years for patients who had 
either and ACI with a periosteum cover or ACI with a type I/Ill collagen 
cover, by number and percentage.
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Figure XXII. Photomicrograph taken at the surface of a full thickness core 
biopsy of repair tissue following an ACI-C procedure at 2 years showing a 
normal hyaline appearance with orderly columns of chondrocytes (Polarized 
light .Safranin O x 34). Patient number 129 (see Appendix III: Table of Results).
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Figure XXIII . Photomicrograph of a full thickness core biopsy of repair 
tissue following an ACI-C procedure at 1 year (Haemophyllin and Eosin stain 
X 10). Surface of biopsy to the left of the photomicrograph and subchondral 
bone to the right. Patient number 74 (see Appendix III: Table of Results).
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Figure XXIV. Photomicrograph taken of the middle third of a full 
thickness core biopsy of repair tissue following an ACI-C procedure at 
2  years showing chondrocytes in lacunae embedded in a matrix which 
stains strongly for matrix proteoglycan (Safranin O x 34). Patient 
number 80 (see Appendix III: Table of Results).
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Complications
Within the first year following chondrocyte implantation there were 3 (4%) major 
complications and 43 (63%) intermediate and minor complications (table XXXV). 
Following the ACI-collagen technique 1 patient was diagnosed with a DVT. Other 
relatively minor complications included 3 patients who were found to have a tear of 
the medial meniscus at the 1 year repeat arthroscopy and required trimming, 1 
patient developed a lateral popliteal nerve neuropraxia following a cylinder cast 
which resolved after the plaster was split. Three patients were slow to mobilize and 
had a manipulation under anaesthetic. Three patients had an unplanned 
arthroscopy within the first year, 1 for graft hypertrophy and 1 for removal of a plica 
and 1 for ongoing pain. At 2 years, 1 patient had a hypertrophied graft that required 
shaving and 1 patient developed reflex sympathetic dystrophy and was under the 
care of the Pain Management Team. There were no incidences of graft failure in 
the ACI-collagen group at the 1 or 2 year follow-up.
Following the ACI-periosteum technique 2 grafts failed within the first year. Other 
relatively minor complications included 12 patients (36.4%) whose grafts had 
hypertrophied at the 1 year check arthroscopy (figure XXV), 4 patients (12.1%) 
who required a manipulation under an anaesthetic since they were unable to flex 
their operated knee to 90*, 1 patient who developed a superficial wound infection 
in the immediate post operative period that responded to oral antibiotics and 1 
patient who had a large plica removed at the time of the 1 year arthroscopy. Eight 
patients (24.2%) required an unplanned arthroscopy within the first year following 
the ACI-periosteum technique, 4 for graft hypertrophy that required shaving, 2 for 
ongoing pain, 1 for division of adhesions and 1 for a suspected septic arthritis
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however this was ruled out following negative cultures. At 2 years, there was 1 
case of graft hypertrophy at the repeat arthroscopy, 1 patient developed reflex 
sympathetic dystrophy and 3 patients who required an unplanned arthroscopy 
during the second year, 1 for graft hypertrophy that required shaving and 2  for 
division of adhesions.
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COMPLICATION NUMBER
ACI-COLLAGEN ACI-PERIOSTEUM
MAJOR 1 (3Vo) at 1 year 
Oat 2 years
2 (6 Vo) at 1 year 
Oat 2 years
Deep vein thrombosis 1 at 1 year
Graft failure 2 at 1 year
INTERMEDIATE AND MINOR 10 (29%) at 1 year 
2 (6%) at 2 years
26 (79%) at 1 year 
5 (15%) at 2 years
Graft hypertrophy at 1 or 2 year check 
arthroscopy (intermediate compiicaton) 1 at 2  years
12 at 1 year 
1 at 2 years
Superficial wound infection 1 at 1 year
Medial meniscal tear requiring 
shaving
3 at 1 year
Large plica removed at repeat 
arthroscopy
1 at year
Lateral popliteal nerve neuropraxia 
following cylinder cast -  resolved
1 at 1 year
Reflex sympathetic dystrophy 1 at 2 years 1 at 2  years
Slow to mobilise requiring a manipulation 
under anaesthetic
3 within 1 year 4 within 1 year
Unplanned arthroscopy
- graft hypertrophy 1 within 1 year 4 within 1 year 
1 within 2  years
- division of adhesions 2 within 2  years
- removal of plica 1 within 1 year
- ongoing pain 1 within 1 year 2  within 1 year
- division of adhesions and 1 within 1 year
graft hypertrophy
-? septic arthritis (nil grown) 1 within 1 year
Table XXXV. Complications within the first 2 years following autologous chondrocyte 
implantation with either a periosteum or type I/Ill collagen cover.
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Figure XXV. Photomicrograph taken at the surface of a full thickness core 
biopsy of repair tissue following an ACI-P procedure at 1 year. This slide shows 
histological detail at the surface of the repair tissue showing chondrocytes in 
lacunae embedded within a matrix which stains strongly for matrix proteoglycan, 
labeled B. At the surface of the graft is seen the remnant of the periosteum cover 
labeled A (Safranin O x 10). Patient number 15 (see Appendix III: Table of 
Results).
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Discussion
When the ACI technique was first described in the treatment of chondral and 
osteochondral defects in patients’ knees by Brittberg et al ^  a periosteum cover 
was used to contain the chondrocytes within the defect. This led to some 
speculation as to how autologous chondrocyte implantation resulted in a cartilage 
repair. Minas and Nehrer suggested 3 possible mechanisms. The first was that 
the implanted chondrocytes re-populate the area of the defect and synthesize a 
new cartilage matrix. The periosteum patch acts simply as a watertight seal 
ensuring the cells stay within the defect. The second proposed mechanism is that 
cytokines secreted by the periosteum stimulate the cultured chondrocytes to 
divide. Finally, the third possible explanation is that the implanted cells and 
periosteum stimulate chondrocytes in the adjacent cartilage, in the subchondral 
bone or in the periosteum itself to enter the defect and repair it. However the last 
suggestion can probably be discounted since relatively poor results have been 
seen in periosteum patch repairs of defects in animal models and in the human 
subject To help address the issue of whether the periosteum plays more of a 
role in cartilage repair than just a watertight cover, Lindahl et al performed an 
animal study using rabbits with artificially-created knee osteochondral defects. 
Dead periosteum (periosteum which had been snap frozen in liquid nitrogen) was 
sutured to the rim of the defect and a chondrocyte suspension was injected into the 
defect underneath the periosteum. Only 1 out of 8  rabbits developed good repair 
tissue. Lindahl concluded that the periosteum and chondrocytes work together to 
repair the defect. It has also been suggested that in using both periosteum and 
chondrocytes there appeared to be a chondroprotective effect on the surrounding 
cartilage since the number of apoptotic cells was reduced by 60% compared with
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an untreated defect However this has not been seen in human subjects but the 
results seen in rabbits has led to the Swedish Bone and Cartilage Research Group 
to favour periosteum over collagen membranes.
This reciprocal arrangement between the periosteum and chondrocytes suggested 
by Lindahl has not been supported by studies using alternatives to the periosteal 
flap. Bentley et al reported comparable results using a biodegradable type I/Ill 
collagen membrane rather than periosteum to contain the chondrocytes within the 
defect. In this study 46 patients had autologous chondrocyte implantation with a 
type I/Ill collagen membrane and the remaining 12 patients had a periosteum 
cover as part of a prospectively randomized study comparing ACI with 
mosaicplasty. The mean age of the patients was 31.6 years and the mean defect 
size was 4.66 cm .^ Of the 58 patients treated with ACI, 51 (8 8 %) had a good or 
excellent result. The mean follow up was 19 months. This confirmed that 
comparable results could be obtained using a type I/Ill biodegradable membrane 
rather than periosteum and favoured the hypothesis that the 
membrane/periosteum acts purely as a watertight seal.
There have been also some concerns about certain aspects of autologous 
chondrocyte implantation with a periosteum cover They included the co­
morbidity associated with the longer incision required for the harvesting of the 
patch of periosteum and hypertrophy attributed to the periosteum which required 
shaving
In this study there was a significant improvement in the modified Cincinnati score 
at 2 years following the ACI technique with a periosteum cover (p<0.005) and the 
ACI technique with a type I/Ill collagen membrane (p<0.005). There was a 49% 
improvement in the modified Cincinnati score at 2 years for the collagen covered
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ACI group compared with a 38% Improvement for the periosteum covered ACI. Of 
the 35 patients with defects treated by the ACI-collagen technique, 26 (74%) had a 
good or excellent result compared with 22 of 33 (67%) patients treated by ACI with 
a periosteum cover. There was no statistically significant difference between the 2 
groups at 2 years based on the modified Cincinnati score (p value = 0.367) 
although there was trend for the ACI-collagen group to perform better based on the 
95% confidence Interval of the difference of the means.
The results from this prospective, randomized controlled trial would support the 
conclusions reached by Bentley et al that a periosteum cover Is not essential for 
the development and maturation of a hyaline repair following ACI. There was a 
tendency for the collagen covered ACI technique to result In a better outcome 
however this was not a significant finding with the numbers available, also this may 
have been due to a possible confounding factor In our study. As mentioned In the 
results more patients who had the periosteum covered technique had defects 
located over the patella than the collagen covered technique. Overall, 61% of the 
periosteum covered ACI group had patellar defects compared with 20% for the 
collagen covered group. However, of the patellar defects treated with the collagen 
covered ACI 8 6 % reported a good or excellent result at 2 years although there 
were only 7 patients In this group. Out of the 20 patients with defects over the 
patella treated with the periosteum covered technique, 60% reported a good or 
excellent result. Comparing the patients who had defects over the medial femoral 
condyle, of the 8  patients treated with the periosteum covered ACI, 62.5% reported 
a good or excellent result which compared with 72% for the collagen covered ACI 
patients (18 patients In total). Clearly the Ideal prospective, randomized study Is a
194
study in which all the possible confounding factors have been standardized and the 
only variable is the one that you are assessing. However, in practical terms this is 
difficult to achieve since to standardize for age, sex, number of operations 
preceding chondrocyte implantation, duration of symptoms, aetiology of defect as 
well as location of the defect to name but a few is a near-impossible task. Possibly 
a larger study would have reduced the impact of this confounding factor, however 
in the light of the number of cases of graft hypertrophy following the periosteum 
covered technique it was felt inappropriate to continue randomizing patients to this 
technique and so the study was stopped. However, the results presented here do 
suggest that the techniques are at least comparable in terms of clinical outcome.
Peterson et al reported on 61 patients who underwent an autologous 
chondrocyte implantation with a periosteum cover for isolated cartilage defects on 
the femoral condyle or the patella with a mean follow up of 7.4 years. At 2 years 51 
(81.96%) of the 61 patients had a good or excellent result. This compares with our 
results of 74% good or excellent at 2 years for the ACI-collagen technique and 
67% for the ACI-periosteum technique. This difference in outcome following ACI 
may be explained by the fact that the defects we operated on were bigger (mean 
defect size 4.54cm^) and patients had a longer duration of symptoms (mean 
duration of symptoms 7.09 years compared with 3.4 years for patients with femoral 
condylar defects in Peterson’s report) and had undergone more operations on their 
knees before the chondrocyte implantation (a mean of 2.09 operations compared 
with 1.5). In view of these differences it is difficult to make a direct comparison 
between our results and those of Peterson et al
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Arthroscopic examination at 1 year revealed remarkably similar results for both 
techniques, with the ACI-periosteum technique having 81% good or excellent 
results and ACI-collagen showing 79% good or excellent results based on the 
ICRS grading system.
At 1 year 13 patients in the ACI-collagen group and 14 patients in the ACI- 
periosteum group had biopsies of their grafts taken at arthroscopy. This showed 
that 9 (69.2%) out of 13 had a hyaline or mixed hyaline and fibrocartilage repair 
following the ACI-collagen technique compared with 6  (42.8%) out of 14 following 
the ACI-periosteum technique. This is encouraging for the ACI-collagen technique 
but the numbers are too small to be statistically significant.
Although there were considerable similarities in terms of the clinical result and 
arthroscopic assessment of the cartilage repair following these 2  techniques there 
were marked differences in terms of complications in the first 2  years following 
surgery. Within the first year 4 (12.1%) out of the 33 patients who had the ACI- 
periosteum technique required an unplanned arthroscopy for graft hypertrophy and 
shaving of the graft, this compared with 1 (2.9%) for the ACI-collagen group. At the 
1 year check arthroscopy 12 (36.4%) patients who had the ACI-periosteum 
technique required shaving of hypertrophied grafts whereas no patients in the ACI- 
collagen group had this problem. At 18 months, 1 patient who had previously had 
their graft shaved and who had an ACI-periosteum repair required an unplanned 
arthroscopy for graft hypertrophy. One patient who had the ACI-collagen technique 
required an unplanned arthroscopy for graft hypertrophy within the second year 
following surgery and 1 patient had some graft hypertrophy at the 2  year repeat 
arthroscopy. Patients who developed this problem presented to the review clinic 
complaining of ‘crunching’ and grinding’ from within the knee associated with pain
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and catching as the knee flexed. In all cases their symptoms were relieved 
following an arthroscopy and shaving of the hypertrophied graft.
The high number of grafts that hypertrophied following the ACI-periosteum 
technique may be due to the fact that of the 33 patients who had this technique 20 
(61%) had repairs to defects over the patella. However, this is an area of the knee 
where the articular cartilage is at its thickest and so problems of incomplete filling 
of the defect would be expected rather than ‘overfilling’.
This is the first study to compare these 2 techniques of autologous chondrocyte 
implantation. From this study it can be concluded that the ACI-collagen technique 
compares favorably with the ACI-periosteum technique at 2 years. The only long­
term follow-up in the published literature at present is for the ACI-periosteum 
technique Longer follow-up is needed to see if the ACI-collagen technique can 
also stand the test of time.
In summary, this study suggests that the results or the collagen covered ACI and 
the periosteum covered ACI are comparable based on clinical outcome and 
arthroscopic assessment at 2 years. However, the most striking feature seen in our 
review was the high incidence of graft hypertrophy in the periosteum-covered 
group which caused considerable morbidity, resulting in additional surgery in 6  
patients (18%).
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CHAPTER 6:
THE PRELIMINARY RESULTS OF THE MAGI TECHNIQUE FOR THE 
TREATMENT OF OSTEOCHONDAL DEFECTS OF THE KNEE
Introduction
The results following the treatment of osteochondral defects in the knee with the
autologous chondrocyte implantation technique have been encouraging as can be
seen form the previous chapters and from the literature 36 ^ 2;89;91;153;156 However,
there have been some concerns about certain aspects of autologous chondrocyte
implantation with a periosteum or collagen cover reservations include
the potential for further surgical injury caused by the excision of a periosteal flap
and the morbidity associated with a longer surgical incision needed to excise the
periosteal flap and secure it to the rim of the osteochondral defect, possible
damage to the recipient articular cartilage associated with the sutures used to fix
the flap or membrane and the unequal distribution of chondrocytes after injection
with the possibility of leakage of the chondrocyte suspension from beneath the flap
or cover. With these reservations in mind a new technique of implanting the
chondrocytes into a defect has been evolved. The Matrix carried Autologous
Chondrocyte implantation (MACI; Verigen, Leverkusen, Germany) technique uses
a porcine derived type I/Ill collagen membrane. One surface is smooth and
represents the articular surface. On the reverse the surface is coarse which is due
to large gaps between the collagen fibres which can be seen at a microscopic
level. The chondrocytes are able to anchor themselves to the collagen fibres and
form multiple layers on the coarse surface of the membrane. The method of
implanting the membrane is more straightforward than that described for the ACI
technique (involving no sutures and Tisseel’ glue for fixation of the membrane)
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and is quicker as a result, allowing for a shorter general anaesthetic time as well as 
tourniquet time. Also, the distribution of implanted cells in the defect is uniform 
although the number of cells implanted may be 2 or 3 times less than with injected 
cells.
Initial reports of the technique have been encouraging. Cherubino et al, showed 
that 6  patients with a minimum follow up of 6  months had an improvement in 
clinical and functional status after surgery
The aim of this study was to review the 1 year results of the MACI technique in the 
first 107 patients at a single specialist centre. This represents the largest review at 
1 year of this technique.
Patients and Methods
The South East Multi-Centre Research Ethics Committee and The Joint Research 
and Ethical Committee of the Royal National Orthopaedic Hospital Trust gave its 
approval before commencing this study (G. Bentley 2002 -  personal 
communication).
A total of 107 patients with a mean age of 35 years (range 17 to 73.3 years) with
symptomatic articular cartilage defects of the knee undenvent the MACI technique.
There were 64 men and 43 women. The mean defect size was 4.4 cm^ (range 1 to
15.75 cm )^ with 54 having defects in the right knee and 53 in the left. Of the 107
patients, 54 defects were on the medial femoral condyle, 29 on the patella (21,
single facet and 8  multiple facets), 1 2  on the lateral femoral condyle and 2  on the
trochlea, 10 patients had multiple defects (table XXXVI). The aetiology of the
lesions included 61 (57%) patients who had post traumatic defects, 16 (15%)
patients had chondromalacia patellae, 6  (5.6%) had osteochondritis dissecans, 4
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(3 .7 %) patients who had previous cartilage resurfacing techniques which had 
failed, 1 (0.9%) patient who had evidence of early osteoarthritis and 19 (17.8%) 
patients who had defects of unknown aetiology, although they were most probably 
post-traumatic (table XXXVII).
The mean duration of symptoms was 6.1 years (range 9 months to 38 years) and 
all patients except 1 had undergone a previous arthroscopy, the mean number of 
further operations was 2.15 (range 0 to 9). All patients were followed up at 12 
months.
Not all patients had a straightforward MAC I technique, 5 had a combined MAGI 
and anterior cruciate ligament reconstruction (ACL) reconstruction (4 using a 
hamstring graft and 1 using a bone-patellar tendon-bone graft), 3 had a MAC I 
sandwich technique since they had defects that had a depth of more than 1 cm, 1 
had microfracturing of an additional defect on the tibial plateau, 1 had a lateral 
release, 1 had a combined high tibial osteotomy, 1 had drilling of a trochlea defect 
and 1 patient required a bone graft to the base of the defect before the 
implantation was performed.
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ANATOMICAL DISTRIBUTION NUMBERS OF 
PATIENTS
Medial femoral condyle (MFC) 54 (50%)
Lateral Femoral Condyle (LFC) 12(11%)
Patella-single facet 21  (20%)
Patella-multi facet 8(7%;
Trochlea (Troch) 2(2%)
MFCx2 2(2%)
MFC + LFC 1 (1%)
Patella + LFC 1 (1%)
Troch + MFC 1 (1%)
Patella + Trochlea 3(3%)
Patella-multi facet + Troch 1 (1%)
Patella (med + lat) + Troch x 3 1 (1%)
Total 107(100%)
Table XXXVI. Anatomical site of the defects found in 107 
patients before undergoing the MAC! technique, by number 
and percentage.
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AETIOLOGY OF DEFECTS NUMBERS OF 
PATIENTS
Trauma 62 (57.9%)
Osteochondritis dissecans 6 (5.6%)
Chondromalacia patellae 16(15%)
Previously failed cartilage 
resurfacing technique
4(3.7%)
Other 19(17.8%)
Total 107 (100%)
Table XXXVII. Aetiology of the defects found in 107 
patients undergoing the MAC! technique, by number and 
percentage.
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The indication for surgery in all cases was pain associated with a chondral or 
osteochondral defect. Other symptoms included swelling, giving way, catching and 
locking.
Surgical Technique
The procedure was divided into 2 stages. An arthroscopy was carried out initially 
together with an examination under anaesthesia to assess the stability of the knee. 
If the defect was suitable for chondrocyte implantation, a full thickness cartilage 
biopsy of approximately 300-500 mg was harvested from the margin of the trochlea 
of the damaged knee using a gouge. The specimen was then removed from the 
knee via one of the arthroscopy portals. The cartilage biopsy was then put into a 
sterile container and transferred to the laboratory. The specimen was 
enzymatically digested releasing the chondrocytes, which were then grown in a 
monolayer culture.
The patient was readmitted 3 to 5 weeks later and the second stage of the 
procedure was performed. To ensure a bloodless field a tourniquet was applied 
and a medial or lateral parapatellar arthrotomy was performed depending on the 
location of the defect. Intravenous antibiotics (1g of flucloxacillin and 1g of 
amoxycillin) were administered over the peri-operative period as prophylaxis 
against infection. Once the defect was identified it was debrided back to a stable 
rim of normal cartilage with a scalpel to minimize cartilage trauma. The base of the 
defect was also debrided of old cartilage down to the subchondral bone, taking 
care to avoid bleeding. If bleeding did occur this was controlled by pressure on the 
bone with a gauze swab soaked in 1 in 200,000 Adrenaline.
203
■■■
I
Figure XXVI. Photograph showing a MAC I repair of an 
osteochondral defect over the medial femoral condyle 
employing tissue glue rather than sutures to secure the 
membrane to the defect.
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Once the defect had been prepared the membrane carrying the cells (0.5-1 
million/cm^) was cut to size and secured using fibrin glue to the base of the defect 
with the cells facing down. Firm pressure was applied to the graft for approximately 
3 minutes whilst the glue set, any excess glue was carefully removed (figure
XXVI). The knee was then manipulated to ensure that the graft was stable. If there 
were concerns about graft stability, 4 6’G tacking sutures were used at the 12,3,6 
and 9 ’0’ clock positions. The knee was closed in layers using non-absorbable 
sutures.
Four patients had defects that were greater than 1 cm deep and it was felt 
necessary to use cancellous bone graft to restore the congruity to the bony 
articular surface immediately prior to chondrocyte implantation. One patient 
underwent simple cancellous bone grafting to the base of the defect and three 
required a so-called' MACI sandwich technique based on Peterson’s description 
and recently reported by Bartlett et al In this technique after the defect had 
been debrided, bone graft was taken from the distal femur immediately superior to 
the medial femoral condyle and impacted into the base of the defect. Sufficient 
bone graft was used to restore the bony contour. Then two MACI membranes were 
cut to the size of the defect. The first membrane was implanted into the base of the 
defect with the cells facing up and was secured to the base of the defect with fibrin 
glue. The second MACI membrane was implanted on top of the first membrane 
with the cells facing down and again secured with fibrin glue. Light digital pressure 
was applied to the graft for 3 minutes whilst the glue set. The knee was then 
closed using non-absorbable sutures.
Five patients with a confirmed ruptured anterior cruciate ligament at arthroscopy, 
as well as an osteochondral defect and who complained of pain and instability had
an anterior cruciate ligament reconstruction as well as a MACI repair. This was
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performed before implantation during the same operative procedure. In 4 cases a 
hamstring reconstruction and in 1 case a bone-patellar tendon-bone graft was 
used which was routed through standard tibial and femoral tunnels. Femoral 
fixation was achieved through a separate lateral incision with the anchoring sutures 
attached over a biodegradable post. The tibial fixation was secured using a 
biodegradable screw. Under the same general anaesthetic the MACI procedure 
was performed as described. One patient had a varus malalignment, which was 
corrected with a lateral closing wedge high tibial osteotomy, which was performed 
before implantation under the same general anaesthetic.
Rehabilitation
The patients who had the MACI technique only, followed the same course of 
rehabilitation as previously described for the ACI-P and ACI-C techniques (page 
108-109).
The 5 patients who had an ACL repair as well as a chondrocyte implantation were 
rehabilitated in the immediate post-operative period on a continuous passive 
motion machine and were discharged once they achieved 90° of flexion. In the 
case of the patient who had a combined osteotomy and MACI, he was rehabilitated 
in a knee brace, which was locked in extension and was allowed to partially 
weight-bear for the first two weeks. At this stage the brace was unlocked and the 
patient was allowed to continue partially weight bearing for a further 4 weeks. At 6 
weeks after surgery the brace was removed and the patient was allowed to 
gradually increase the weight put through the leg as comfort allowed. Further 
rehabilitation focused on improving the patients’ range of movement and muscle 
strengthening exercises.
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Evaluation
Patients were evaluated clinically and arthroscopically as described on pages 109- 
111 .
Statistical analysis. Statistical comparison of the clinical assessment scores at 1 
year was by the paired Students T test. Comparisons between the good and 
excellent group and fair and poor group were made using the unpaired Student T 
test. A p value of less than 0.05 was considered statistically significant.
Results 
Clinical review
The pre-operative modified Cincinnati rating system scores are shown in table 
XXXVIII, 34 (32%) had a good score, 54 (50%) had a fair score and 19 (18%) had 
a poor score. Those 34 patients with a good score were nevertheless considered 
suitable for a MACI because they complained of considerable pain on exertion that 
was attributed to an articular cartilage defect. All these patients functioned at a 
high level so that despite scoring badly for pain they were able to compensate on 
the remaining parameters of the modified Cincinnati score, which in this situation 
tends to give a misleading impression of their symptomatology.
The mean modified Cincinnati knee score improved from 45 pre operatively to 64 
post operatively at 1 year (difference of the means 18, with a 95% confidence 
interval that the difference of the means lies between 17.20 and 19.38, p<0.005), 
representing a 42% increase. Of the 107 patients, 74 (69%) had a good or 
excellent result (table XXXIX).
207
TOTAL EXCELLENT GOOD FAIR POOR
107 34
(32%)
54
(50%)
19
(18%)
Table XXXVIII. Modified Cincinnati scores before 
undergoing the MACI technique.
TOTAL EXCELLENT GOOD FAIR POOR
107 30 44 26 7
(28%) (41%) (24%)
Table XXXIX. Modified Cincinnati scores following 
the MACI technique at 1 year.
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ANATOMICAL
DISTRIBUTION
TOTAL EXCELLENT GOOD FAIR POOR
Medial femoral 
condyle
54 14
f26%)
19
(35%)
17
(32%)
4
Lateral femoral 
condyle
12 6
(50%)
5
(42%)
1
Patella-single
facet
21 6
(23.8%)
10
(47.6%)
4
(19%)
2
(9.5%)
Patella-multiple
facet
8 2
(25%)
3
(37.5%)
2
(25%)
1
(12.5%)
Trochlea 2 1
(50%)
1
(50%)
Multiple defects 10 2
(20%)
6
(60%)
2
(20%)
Table XL. Clinical results at 1 year for 107 patients who had a MACI for 
chondral or osteochondral defects of the knee by number and percentage.
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Table XL shows that at 1 year of the 54 patients with defects over the medial 
femoral condyle treated by MACI, 33 (61%) had a good or excellent result. For the 
lesions of the lateral femoral condyle 11 (92%) out of 12 patients reported good or 
excellent results. For patellar lesions, 20 (69%) out of 29 patients reported good or 
excellent results. Of the 10 patients who had multiple defects 8 (80%) reported a 
good or excellent results, the numbers of patients with trochlea defects were too 
small for any useful analysis.
Factors which affect outcome
A comparison was made between those patients in the good/excellent group and 
those in the fair/poor group. Table XLI shows the differences between these 
groups in terms of their age, defect size, duration of symptoms leading up to 
surgery and number of surgical procedures before chondrocyte implantation.
The 74 patients with a good/excellent result at 1 year had an average age of 33.9 
years compared with the 33 patients who had a fair or poor result who had an 
average age of 37.2 years, however this difference was not significant (p=0.096).
There was no significant difference between the good/excellent group and the 
fair/poor group in terms of defect size (4.76cm^ vs 4.07cm^, p=0.2), duration of 
symptoms (6.06 years vs 5.97 years, p=0.95) or surgical procedures prior to 
implantation (2.2 vs 2.09, p=0.78).
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GOOD/
EXCELLENT
FAIR/ POOR P VALUE
MEAN AGE (YRS) 33.9
(range 17-73.3)
37.2
(range 21-50.6)
0.096
MEAN DEFECT 
SIZE (CM")
4.76
(range 1-15.75)
4.07
(range 1-8.75)
0.2
MEAN DURATION 
OF SYMPTOMS 
(YRS)
6.06
(range 0.75-38)
5.97
(range 1.3-28)
0.95
PRE OPERATIVE 
SURGERY
2.2
(range 0-9)
2.09
(range 1-7)
0.78
Table XLI. Comparison between the Good/excellent group and the Fair/poor 
group following MACI technique.
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Arthroscopic review
A total of 40 patients had a repeat arthroscopy and biopsy at 1 year following the 
chondrocyte implantation. The International Cartilage Repair Society Score (ICRS) 
was 1 (excellent) or 2 (good) in 32 of 40 patients (80%). The arthroscopy of 4 
patients did not show any evidence of the graft and scored an ICRS of 4 and were 
recorded as graft failures (10%) (table XLII).
Of the biopsies taken at the time of the check arthroscopy, 2 were from the 
trochlea, 5 from the patella, 4 from the lateral femoral condyle and 29 from the 
medial femoral condyle. Hyaline cartilage (figure XXVII) was found in 6 patients 
(15%), which consisted of sparse, oval shaped cells, evenly distributed in lacunae 
enveloped within a matrix that stained positively for Safran in O. The biopsies of 9 
patients (22.5%) showed a mixture of hyaline and fibrocartilage, that is the biopsy 
specimen contained more than 40% but less than 60% hyaline cartilage. Of the 40 
biopsies, 25 (62.5%) had the appearance of fibrocartilage, which had a rather 
disorganised appearance and under polarised light, a meshwork of collagen fibrils 
could be seen throughout the specimen.
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ICRS GRADE NUMBER (%)
1, Excellent 18 (45%)
2, Good 14 (35%)
3, Fair 4 (10%)
4, Poor 4 (10%)
Total 40 (100%)
Table XLII. Arthroscopic results at 1 year 
for 40 patients following the MACI technique, by 
number and percentage.
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Figure XXVII. Photomicrograph of a full thickness biopsy of a MACI 
repair showing the interface of the cartilage repair and underlying bone. 
Hyaline like cartilage material, C is seen bonded to the underlying bone, B. 
The intact bone/cartilage interface is indicated, D. The underlying bone 
marrow is also indicated A. (Haematoxylin and eosin x 34). Patient number 
264 (see Appendix III: Table of Results).
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BFigure XXVIII. Photomicrograph of a full thickness biopsy of a MACI repair 
showing the surface of the cartilage repair (same biopsy specimen as figure
XXVII). Hyaline like cartilage material, A is seen with overlying fibrocartilage 
nearer the surface B (Haematoxylin and eosin x 3.4). Patient number 264 (see 
Appendix III: Table of Results).
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Figure XXIX. Photomicrograph taken at high power of a full thickness biopsy 
of a MACI repair showing chondrocytes within lacunae embedded within a matrix 
which stains strongly for proteoglycan (Safranin O x 34). Patient number 249 
(see Appendix III: Table of Results).
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Complications
There were 5 non graft related and 18 graft related complications in this review 
(table XLIII). One patient developed an above knee deep vein thrombosis and was 
anticoagulated for 6 months with warfarin. One patient developed septic arthritis 
following harvesting which resolved following a washout and a course of 
antibiotics, this delayed the time of implantation for 2 weeks but there were no long 
term adverse sequelae as the graft successfully filled the defect and clinically the 
patient made an excellent recovery. Two patients developed a superficial wound 
infection which resolved with a course of antibiotics. One patient went into urinary 
retention post operatively and required a urinary catheter.
Three patients required an arthroscopy before the 1 year check. One patient 
required an arthroscopy and division of adhesions at 1 month following grafting to 
5 defects. One patient developed a lateral meniscal tear that was debrided and the 
last patient complained of ‘clunking’ and so a diagnostic arthroscopy was carried 
out but no cause was found. Eight patients were slow to mobilise and required a 
manipulation under anaesthetic. Three patients complained of painful catching and 
a subsequent check arthroscopy at 1 year revealed that the grafts had 
hypertrophied. Their symptoms resolved following arthroscopic shaving of the 
grafts. Of the 40 patients who had a repeat arthroscopy at 1 year there were 4 
cases of graft failure, although this represents 4% of the total patient population (4 
out of 107 patients). The grafts in these cases were over the retropatellar surface.
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COMPLICATION NUMBER
MAJOR
Septic arthritis following harvesting 1
Deep Vein Thrombosis 1
Graft failure 4
INTERMEDIATE
Graft hypertrophy at 1 year 3
MINOR
Urinary retention post operatively required 
urinary catheter
1
Superficial wound infection 2
Slow to mobilise requiring a manipulation 
under anaesthetic
8
Unplanned arthroscopy 3
Table XLIII. Complications in the first year following MACI in 107 
patients.
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Discussion
This is the largest current review of a relatively new technique for the treatment of 
symptomatic osteochondral defects of the knee. Our results have shown that the 
MACI technique can result in a significant improvement in the functional score at 1 
year and of the 107 patients reviewed, 69% reported a good or excellent score. 
Out of a total of 40 repeat arthroscopies at 1 year, 36 showed good filling of the 
defect with bonding at the edges of the repair to the surrounding articular cartilage. 
Hyaline cartilage or mixed hyaline and fibrocartilage were present in 15 of 40 
(37.5%) biopsies. A higher frequency of hyaline and mixed hyaline and 
fibrocartilage repairs have been reported in other studies 36:72;90;165 has 
previously been noted there is some evidence to suggest that cartilage repairs 
continue to mature after 1 year Therefore, more hyaline repairs could be 
expected if the biopsies were to be repeated at years 3 or 4.
Bentley et al reported 88% good or excellent results following the AC I technique 
with either a collagen or periosteum cover at a mean follow up of 19 months 
Possibly MACI grafts take longer to mature in comparison to the ACI-C and ACI-P 
techniques. They may take longer to mature since unlike the ACI-C or ACI-P 
techniques the base of the defect in the MACI technique is covered in a layer of 
fibrin glue to secure the membrane. As a result the chondrocytes have to diffuse 
through this fibrin layer to attach themselves to the subchondral bone. In the past 
there has been some controversy whether the chondrocytes are able to migrate 
through the fibrin glue at all More recently Zheng et al have shown in their 
studies with the MACI membrane that chondrocytes are able to migrate from 
the membrane into the glue within 2 weeks. Willers et al went on to conclude 
that the fibrin glue forms an integral component of the MACI membrane scaffold
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and at the Combined Orthopaedic meeting in Sydney 2004, Zheng concluded that 
human chondrocytyes are able to express thrombin receptors on their surface and 
that fibrin-sealant is capable of inducing chondrocyte proliferation and migration 
However, unlike the collagen or periosteum covered techniques which ensure 
direct contact between the chondrocytes and the base of the defect, the layer of 
fibrin glue which secures the MACI membrane could act as a delaying factor for 
the successful development of a graft.
There were 4 cases where the graft had failed, 3 of these occurred in patients with 
defects over the retropatellar surface and 1 over the medial femoral condyle. In the 
case of the patella failures, this could well be due to a combination of factors 
including the thickness of native cartilage in this area of the joint and also due to 
the high loading forces that occur in the patellofemoral joint. In the recent report by 
Bartlett et al there were no failures for the collagen covered technique( ACI-C) 
and Peterson reported 2 failures (total of 58 patients) following the periosteum 
covered technique (ACI-P) in his 2003 paper In our study, out of a total of 40 
patients who had repeat arthroscopies there were 4 (10%) graft failures, although 
including patients who did not have a repeat arthroscopy, this represented 4% of 
the total (4 out of 107 patients).
The repairs to defects over the lateral femoral condyle were encouraging with 92% 
of patients reporting good or excellent results. Although only 12 patients were 
reviewed, these results are extremely encouraging for an area of the joint, which 
can be difficult to repair using the collagen or periosteum covered techniques. The 
results for repairs to the medial femoral condyle were not as good as those results 
reported by Bentley and Peterson with only 61% reporting good or excellent 
results. This could be due to delayed graft maturation as discussed above.
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In this study there was no significant difference between the good/excellent and 
fair /poor group in terms of age, defect size, duration of symptoms leading up to 
surgery and number of surgical procedures before chondrocyte implantation. 
Perhaps these factors become more prevalent with longer follow up.
In summary, we have shown that the MACI technique can result in an 
improvement in patients’ functional scores and can result in a hyaline repair. 
However, there are concerns about the relatively high rate of graft failure (10% of 
those arthroscoped at lyear) compared with other chondrocyte implantation 
techniques and the low frequency of hyaline repairs. Longer follow up may show 
more hyaline repairs as the grafts mature. For this technique to gain widespread 
recognition these issues need to be resolved.
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CHAPTER 7:
PROGRESS OF A PROSPECTIVE, RANDOMISED STUDY COMPARING TWO 
TECHNIQUES OF AUTOLOGOUS CHONDROCYTE IMPLANTATION FOR 
OSTEOCHONDRAL DEFECTS IN THE KNEE: MACI vs ACI
Introduction
The Matrix associated autologous chondrocyte implantation technique or MACI 
attempts to address the concerns about certain aspects of autologous chondrocyte 
implantation with either a periosteum or collagen cover. The co-morbidity 
associated with harvesting of the periosteal flap, the unequal distribution of 
chondrocytes after injection and the placing of multiple sutures in the rim of healthy 
cartilage to anchor the cover, are but a few of these concerns. Following the 
encouraging results reported in the last chapter for the MACI technique, a 
prospectively, randomised study was established to compare the results following 
the MACI and collagen covered ACI techniques at 1 year.
Patients and Methods
The South East Multi-Centre Research Ethics Committee and The Joint Research 
and Ethical Committee of the Royal National Orthopaedic Hospital Trust gave its 
approval before commencing this study (G. Bentley 2002 -  personal 
communication).
Between March and November 2002, a total of 52 patients with symptomatic 
articular cartilage defects were randomised to have either ACI with a type I/Ill 
porcine collagen cover (26 patients) or MACI (26 patients) technique. There were 
29 men and 23 women with a mean age of 37.5 years (range 25 to 52 years) for
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the ACI group and 31.72 years (range 20 to 46 years) for the MACI group. The 
mean defect size was 5.09 cm  ^ (range 1.5 to 10.35 cm^) for the ACI group and 
4.66 cm^ (range 1 to 16 cm^) for the MACI group. This apparent difference in 
defect size was not statistically significant with a p value >0.05.
Of the 52 patients 31 had defects over the left knee and 21 over the right. Of the 
26 patients in the ACI group 13 (50%) had defects over the medial femoral 
condyle, 2 (8%) over the lateral femoral condyle, 10 (38%) over the patella (5 
single facet and 5 multi-facet) and 1 over the trochlea (4%). Of the 26 patients in 
the MACI group 10 (38%) had defects over the medial femoral condyle, 2 (8%) 
over the lateral femoral condyle, 10 (38%) over the patella (6 single facet and 4 
multi-facet), 1 (4%) over the trochlea, 1 (4%) patient with a defect over the patella 
and a further defect over the trochlea, 1 (4%) patient with 2 defects over the medial 
femoral condyle and 1(4%) patient with 5 defects, 2 over the patella and 3 over the 
trochlea (table XLIV).
The aetiology of the lesions for the ACI group included 8 (30.8%) who had post- 
traumatic defects, 2 (7.7%) who had osteochondritis dissecans, 6 (23.1%) who had 
chondromalacia patellae, 7 (26.9%) who had a previous failed Matrix support 
prosthesis (MSP) or Mosaicplasty or ACI and 3 (11.5%) who had defects of 
unknown aetiology, although were most probably post-traumatic. Thirteen (50%) 
of the MACI group had post-traumatic defects, 1 (4%) had osteochondritis 
dissecans, 6 (23%) had chondromalacia patellae, 1 (4%) had early osteoarthritis, 
1(4%) had a previously failed MSP and 4 (15%) had defects of unknown aetiology 
(table XLV).
The mean duration of symptoms was 9.6 years (range 1 to 38 years) and all 
patients had undergone a previous arthroscopy, the mean number of further 
operations was 2.3 (range 1 to 7). All patients were followed up at 12 months.
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The indication for surgery in all cases was disabling pain associated with a 
chondral or osteochondral defect. Other symptoms included swelling, giving way, 
catching and locking.
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ANATOMICAL DISTIBUTION
TOTAL ACI MACI
Medial femoral condyle 23 13 (50%) 10 (38%)
Lateral femoral condyle 4 2(8%) 2 (8%)
Patella (single facet) 11 5 (19%) 6 (23%)
Patella multi-facet) 9 5 (19%) 4 (15%)
Trochlea 2 1 (4%) 1 (4%)
Patella + Trochlea 1 1 (4%)
Patella (medial and lateral facet) + 
trochlea x 3
1 1 (4%)
Medial femoral condyle x 2 1 1
Total 52 (100%) 26 (100%) 26 (100%)
Table XLIV. Anatomical site of the defects found in 52 patients, by number and 
percentage, for the MAC! vs ACI-C study.
AETIOLOGY OF DEFECTS
TOTAL ACI MACI
Trauma 21 8 (30.8%) 13(50%;
Osteochondritis dissecans 3 2 (7.7%) 1 (4%)
Chondromalacia patellae 12 6(23.1%) 6 (23%)
Early osteoarthritis 1 1 (4%)
Previous failed MSP/Mosaicplasty/AC 1 8 7 (26.9%) 1 (4%)
Other 7 3(11.5%) 4 (15%)
Total 52 (100%) 26 (100%) 26 (100%)
Table XLV. Aetiology of the defects found in 52 patients, by number and 
percentage, for the MAC I vs ACI-C study.
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Surgical Technique
The surgical technique for the ACI-C and the MACI procedure has already been 
described (ACI-C pages 140-141 and MACI pages 203-206).
Patients were randomised using random sample numbers in sealed envelopes.
Rehabilitation
The rehabilitation programme was identical after both techniques and followed the 
same course as previously described page 108-109.
Evaluation
Patients were reviewed in the Orthopaedic Clinic at regular intervals up to 1 year. 
One Observer, who did not perform any of the implantations, independently 
reviewed the patients. Patients were evaluated clinically and arthroscopically as 
described on pages 109-111.
Statistical analysis. Statistical comparison of the pre-operative and postoperative 
clinical assessment scores at 1 year for each of the techniques and a comparison 
of the outcome scores between the groups, was by the paired Students T test. A p 
value of less than 0.05 was considered statistically significant.
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Results
Clinical Review
The pre-operative modified Cincinnati rating system scores are shown in table 
XLV! for both techniques. Out of a total of 26 patients who had the ACI technique, 
4 (15%) had a good score, 15 (58%) had a fair score and 7 (27%) had a poor 
score pre-operatively. Out of a total of 26 patients who had the MACI technique 5 
(19%) had a good score, 18 (69%) had a fair score and 3 (12%) had a poor score 
pre-operatively. Those patients that had a good score were nevertheless 
considered suitable for chondrocyte implantation because they complained of 
considerable pain particularly on exertion that was attributed to their cartilage 
defects. All these patients were athletic and were able to function at a high level 
and so were able to compensate for the poor pain score with the other parameters 
on the modified Cincinnati rating system. The mean modified Cincinnati score at 1 
year for the patients who undenvent the MACI technique was 59 (n=26) and for the 
ACI technique was 49 (n=26), to give a difference of the means of 10 (with a 95% 
confidence interval that the true difference of the means lies between 5.37 and 
24.37, p=0.2)
There was a significant improvement in the modified Cincinnati score at 1 year 
following the MACI technique (p<0.05). However the group of patients who had 
previous extensive cartilage repairs such as MSP or mosaicplasty adversely 
affected the ACI results. Not including this subgroup, there was also a significant 
improvement in clinical outcome at 1 year (p<0.05).
Overall, of the 26 patients with defects treated by the ACI technique, 12 (46%) had 
a good or excellent result (table XLVII) compared with 16 of 26 (62%) patients 
treated by the MACI technique.
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ACI TOTAL EXCELLENT GOOD FAIR POOR
26 0 4 15 7
MACI TOTAL EXCELLENT GOOD FAIR POOR
26 0 5 18 3
Table XLVI. Modified Cincinnati scores before surgery, for the 
MACI vs ACI-C study.
ACI TOTAL EXCELLENT GOOD FAIR POOR
26 3 9 7 7
MACI TOTAL EXCELLENT GOOD FAIR POOR
26 7 9 5 5
Table XLVII. Modified Cincinnati scores at 1 year following the 
ACI-C and MACI technique.
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Table XLVII! shows the results at 1 year based on the site of the defect. Of the 13 
defects over the medial femoral condyle treated with the ACI technique, 4 (31%) 
had a good or excellent result compared with 6 (60%) out of 10 treated by the 
MACI technique (p>0.05). Of the 13 patients with MFC defects treated with the ACI 
technique 6 had previous extensive cartilage repairs (either with MSP or 
Mosaicplasty), which adversely affected the results.
In the case of defects over the patella, 6 (60%) out of 10 had a good or excellent 
result following the ACI technique compared with 5 (60%) out of 10 for the MACI 
technique (p>0.05).
The numbers of defects of the lateral femoral condyle, trochlea and multiple 
defects were too small for statistical analysis.
These results show that there is no statistically significant difference between the 
ACI and MACI technique in terms of clinical outcome at 1 year.
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ANATOMICAL
DISTRIBUTION
TOTAL EXCELLENT GOOD FAIR POOR P VALUE
MFC
ACI 13 4 4 5 p>0.05
MACI 10 2 4 2 2
LFC
ACI 2 1 1 Sample
MACI 2 2 too small
Patella
ACI 10 2 4 3 1 p>0.05
MACI 10 2 3 2 3
Trochlea
ACI 1 1 Sample
MACI 1 1 too small
Multiple
ACI Sample
MACI 3 1 2 too small
Table XLVIII. Clinical results at 1 year for 52 patients who had either an ACI or a 
MACI for osteochondral defects of the knee.
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Arthroscopic Review
A repeat arthroscopy was made at the 1 year mark following the chondrocyte 
implantation. Of the 26 patients who had the ACI technique, 9 had a repeat 
arthroscopy at 1 year (table XLIX). All 9 patients had an ICRS grade of 1 or 2 
compared with 8 (80%) out of 10 who had the MACI technique. Unfortunately, at 
the time of this review 33 patients were awaiting a repeat arthroscopy at 1 year, 
resulting in the small numbers.
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ICRS GRADE
ACI MACI
1 YEAR 1 YEAR
1, Excellent 1 2
2, Good 8 6
3, Fair 1
4, Poor 1
Total 9 10
Table XLIX. Arthroscopic results at 1 year for 
patients who had either the ACI or MACI technique.
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Complications
Within the first year following chondrocyte implantation there was just one case of 
graft failure in the case of a MACI patient who had a defect over the patella, 
otherwise the rest of the complications were minor (table L). There were 4 patients 
in each group who had graft hypertrophy requiring shaving at 1 year. Three 
patients in the ACI group were slow to mobilise (unable to flex to 90® at 6 weeks) 
and required a manipulation under anaesthetic compared with 2 in the ACI group 
and there were 3 patients in each group who required unplanned arthroscopies for 
adhesions.
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COMPLICATION NUMBER
ACI MACI
MAJOR
Graft failure 1
INTERMEDIATE
Graft hypertrophy 4 4
MINOR
Urinary retention post-operatively requiring a 
catheter 1
Large plica removed at repeat arthroscopy 1
Reflex sympathetic dystrophy 1
Slow to mobilize requiring a manipulation under 
anaesthetic
3 2
Unplanned arthroscopy 
division of adhesions 
meniscal tear 
? infection
1
1
1
2
1
Table L. Complications within the first year following the ACI and MACI 
technique.
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Discussion
Brittberg’s original technique of autologous chondrocyte implantation uses a 
chondrocyte suspension, which is injected into a cartilage defect underneath a 
periosteum cover. Because of concerns of graft hypertrophy and also possible 
morbidity associated with harvesting of periosteum alternatives were sought to the 
periosteum cover. Considerable success has been achieved with a porcine type 
I/Ill collagen cover as an alternative to periosteum. However, even with this 
technique there have been some misgivings. These include possible damage to 
the cartilage at the rim of the defect to which the collagen membrane is sutured; 
there is also the possibility that the chondrocyte suspension may leak out from 
underneath the membrane. Other concerns include the uneven distribution of the 
chondrocyte suspension over the cartilage defect. To address these issues the 
MACI technique evolved. With this technique the chondrocytes are applied evenly 
over a collagen membrane and the membrane is glued to the base of the defect 
with fibrin glue. This technique avoids the use of sutures and any possible damage 
to the cartilage at the rim of the defect. However, at the time of writing there are no 
studies that have compared the ACI and MACI techniques.
The results of the ACI group in this study were heavily influenced by a group of 
patients who had ‘revision’ cartilage resurfacing techniques. The 7 patients who 
had a previous mosaicplasty or matrix support prosthesis which were subsequently 
revised using the ACI-collagen technique did not do well, resulting in just 46% 
good or excellent results in this group as a whole. This compared with 62% treated 
by the MACI technique. Excluding the 7 patients who had repeat cartilage
resurfacing, there was no statistically significant difference between the 2 groups in
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terms of clinical outcome. In terms of arthroscopic findings at 1 year following the 
chondrocyte implantation there was no difference in macroscopic appearance, 
however the numbers were small.
The number of complications encountered following both techniques was 
essentially the same with both techniques having similar numbers of graft 
hypertrophy, unplanned arthroscopies and patients who were slow to mobilize 
requiring an MUA.
It is interesting to compare these results with those of Peterson et al in their paper 
of 2002 Peterson reported on 19 patients who had repairs to defects over the 
femoral condyle using the ACI-periosteum technique. Eighty-nine percent of 
patients reported good or excellent results at 2 years with a mean defect size of 
3.4 cm  ^and a mean duration of symptoms of 3.4 years. In our study 15 patients 
had the ACI-collagen technique to the femoral condyles, 33% reported good or 
excellent results. Patients that had a previous mosaicplasty or MSP to the same 
defect adversely affected these results. The mean defect size for this group was 
4.84 cm  ^and the mean duration of symptoms was 12.5 years. Of the MACI group 
who had repairs to the femoral condyle, 67% reported good or excellent results at 
1 year. The mean defect size for this group was 4.22 cm  ^and the mean duration of 
symptoms was 11 years.
Peterson reported on 17 patents who had defects over the patella with 65% 
reporting good or excellent results with a mean defect size of 4.4 cm  ^and a mean 
duration of symptoms of 7.2 years. In our study 10 patients with patella defects had 
the ACI-collagen technique with 60% reporting good or excellent results with a 
mean defect size of 3.54 cm  ^and a mean duration of symptoms of 9.8 years. Ten 
patients in the MACI group had defects repaired over the patella with 50%
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reporting good or excellent results with a mean defect size of 5.31 cm  ^and a mean 
duration of symptoms of 5.4 years.
These results would suggest that the periosteum covered ACI technique is 
superior to both MACI and the ACI-collagen technique particularly for femoral 
condylar defects. However, Petersons’ patients have on average smaller defects 
and a shorter duration of symptoms and also all our patients were reviewed at 1 
year as apposed to 2 years as in Petersons’ study.
The preliminary results of this prospectively randomized study did not show a 
statistically significant difference between the 2 techniques in terms of clinical 
outcome at 1 year. There did not appear to be a difference between the grafts 
arthroscopically at 1 year, although only a small number of patients had a repeat 
arthroscopy by the time of this review.
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CHAPTER 8:
CHONDROCYTE IMPLANTATION IN THE KNEE COMBINED WITH OTHER 
SURGICAL PROCEDURES
Introduction
Minas and Nehrer reported in their review that any tibiofemoral malalignment or 
ligamentous instability or bone insufficiency must be managed prior to, or at the 
time of cartilage repair. Rupture or laxity of the anterior cruciate ligament can result 
in abnormal translation and rotation of the femur on the tibia resulting in shearing 
of the chondrocyte graft and failure of the repair.
If limb malalignment is not corrected prior to or at the time of the chondrocyte 
implantation excessive loading on the repair may result in early graft failure. 
Brittberg et al went on to suggest that patients with large defects who do not 
have major malalignment may benefit from either an unloader brace or even an 
unloading osteotomy. They suggested that repairs that are not protected may have 
a good appearance at 2 years but high loads on the repair area may cause 
progressive thinning of the matrix that ultimately leads to destruction of the graft. At 
present however, osteotomies are reserved for patients who have a significant 
valgus or varus malalignment.
Repairs to lesions up to 8mm in depth are stated to achieve a good clinical result 
after autologous chondrocyte implantation alone However, Brittberg et al have 
recommended that bone grafting is required for defects of more than 8 to 10 mm in 
depth to restore the bony contour of the articular surface.
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Following the encouraging results of these combined techniques this study 
reports on 12 patients who had a chondrocyte implantation combined with another 
reconstructive surgical procedure aimed restore the biomechanics of the joint to 
normal or near-normal.
Patients and Methods
The South East Multi-Centre Research Ethics Committee and The Joint Research 
and Ethical Committee of the Royal National Orthopaedic Hospital Trust gave its 
approval before commencing this study (G. Bentley 2002 -  personal 
communication).
A total of 12 patients were reviewed following a chondrocyte implantation 
combined with another surgical technique, 6 patients had a combined chondrocyte 
implantation and an anterior cruciate ligament (ACL) reconstruction (3 matrix 
induced chondrocyte implantation (MACI; Verigen, Leverkusen, Germany) and 3 
autotogous chondrocyte implantation (ACI)), 2 had a combined chondrocyte 
implantation and high tibial osteotomy (1 MACI and 1 ACI), 1 patient required bone 
grafting to the base of the defect followed by the chondrocyte implantation (MACI) 
and 3 patients had the MACI sandwich technique (Table LI).
Of the 12 patients, there were 7 men and 5 women. The mean age of the patients 
was 30.5 years (range 15 to 46 years) with a mean duration of symptoms of 10.46 
years (range 1 year to 28 years). The mean defect size was 4.9 cm  ^ (range 1.5 
cm* to 10 cm*) with 10 having defects in the left knee and 2 in the right. Nine 
patients had defects over the medial femoral condyle, 1 patient had a defect over 
the lateral femoral condyle, 1 over the trochlea and 1 over the medial facet of the 
patella (Table LI I). The aetiology of the lesions included 7 (58.3%) patients who
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COMBINED PROCEDURE NUMBERS OF 
PATIENTS
Chondrocyte Implantation and 
ACL reconstruction
6
Chondrocyte Implantation and 
High Tibial Osteotomy
2
Chondrocyte Implantation and 
Bone Grafting
1
MACI Sandwich 3
Total 12
Table LI. Combined Chondrocyte Implantation and other 
surgical procedures.
ANATOMICAL
DISTRIBUTION
NUMBERS OF 
PATIENTS
Medial femoral condyle 9
Lateral Femoral Condyle 1
Patella-single facet 1
Trochlea 1
Total 12
Table Lll. Anatomical site of the defects found in 12 
patients pre-combined ACI and other surgical procedure.
AETIOLOGY OF DEFECTS NUMBER OF PATIENTS
Trauma 7
Osteochondritis dissecans 1
Chondromalacia Patellae 2
Previously failed cartilage 
resurfacing technique
2
Total 12
Table Llll. Aetiology of the defects found in 12 patients 
pre-combined ACI and other surgical procedure.
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had post traumatic defects, 2 (16.6%) patients had chondromalacia patellae, 1 
(8.3%) had osteochondritis dissecans and 2 (16.6%) patients who had previous 
cartilage resurfacing techniques which had failed (Table Llll).
The indication for surgery in all cases was pain associated with a chondral or 
osteochondral defect. Other symptoms included swelling, giving way, catching and 
locking.
Surgical Technique
The surgical technique for the ACI-C and the MACI procedure has already been 
described (ACI-C page 140-141 and MACI pages 203-206).
Six patients required reconstruction of the anterior cruciate ligament (ACL) (figure 
XXX), which was performed before implantation during the same operative 
procedure. In all cases a hamstring repair was used which was routed through 
standard tibial and femoral tunnels. Femoral fixation was achieved through a 
separate lateral incision with the anchoring sutures attached over a biodegradable 
post. The tibial fixation was secured using a biodegradable screw.
Two patients had a varus malalignment, which was corrected with a lateral closing 
wedge high tibial osteotomy, which was also performed before implantation under 
the same general anaesthetic.
Four patients had defects that were greater than 1 cm deep and it was felt 
necessary to use cancellous bone graft to restore congruity to the bony articular 
surface. One patient underwent simple bone grafting to the base of the defect and 
three required a MACI sandwich technique based on Peterson’s description 
In this technique after the defect had been debrided, bone graft was taken from the 
distal femur immediately superior to the medial femoral condyle and
241
Figure XXX. Photograph of a repair of chondral defect over
the medial femoral condyle with the autologous chondrocyte 
transplantation technique (A) and also showing a repair of the anterior 
cruciate ligament (B) performed at the same operation. (Courtesy of J. 
Skinner).
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impacted into the base of the defect. Sufficient bone graft was used to restore the 
bony contour. Then two MACI membranes were cut to the size of the defect. The 
first membrane was implanted into the base of the defect with the cells facing up 
and was secured to the base of the defect with fibrin glue. The second MACI 
membrane was implanted on top of the first membrane with the cells facing down 
and again secured with Fibrin glue. Light digital pressure was applied to the graft 
for 3 minutes whilst the glue set. The knee was then closed using non absorbable 
sutures.
Rehabilitation
The rehabilitation followed the same course as previously described page 108-109.
The patients who had an ACL repair as well as a chondrocyte implantation were 
rehabilitated in the immediate post operative period on a continuous passive 
motion machine and were discharged once they achieved 90° of flexion. Further 
rehabilitation focused on improving the patients' range of movement and muscle 
strengthening exercises. The 2 patients who had a combined osteotomy and 
chondrocyte implantation were rehabilitated in a knee brace that was locked in 
extension and were allowed to partially weight bear for the first two weeks. At this 
stage the brace was unlocked and the patients were allowed to continue partially 
weight bearing for a further 4 weeks. At 6 weeks after surgery the brace was 
removed and the patients were allowed to gradually increase the weight put 
through the leg as comfort allowed. Further rehabilitation focused on improving the 
patients’ range of movement and muscle strengthening exercises.
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The four patients who had either bone grafting to the base of the defect or had a 
MACI sandwich were rehabilitated in exactly the same way as for the standard ACI 
or MACI technique.
Evaluation
Patients were reviewed in the Orthopaedic Clinic at regular intervals up to 1 year. 
One Observer, who did not perform any of the implantations, independently 
reviewed the patients. Patients were evaluated clinically and arthroscopically as 
described on pages 109-111.
Statistical analysis. Statistical comparison of the clinical assessment scores at 1 
year was by the paired Students I  test. Comparisons between the good and 
excellent group and fair and poor group were made using the unpaired Student I  
test. A p value of less than 0.05 was considered statistically significant.
Results
Clinical Review
The pre-operative modified Cincinnati rating system scores are shown in table LIV, 
4 (33.3%) had a good score, 7 (58.3) had a fair score and 1 (8.3%) had a poor 
score. As before, those 4 patients with a good score were nevertheless considered 
suitable for surgical intervention because they complained of considerable pain 
that was attributed to the articular cartilage defects. All these patients were athletic 
and functioned at a high level so that despite scoring badly for pain they were able 
to compensate on the remaining parameters of the modified Cincinnati score which 
in this situation tends to give a misleading impression of their symptomatology.
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TOTAL EXCELLENT GOOD FAIR POOR
12 4 7 1
Table LIV. Modified Cincinnati scores before
combined ACI and other surgical procedure.
TOTAL EXCELLENT GOOD FAIR POOR
12 3 7 2
Table LV. Modified Cincinnati scores at 1 year 
following combined ACI and other surgical technique.
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There was a significant improvement in the modified Cincinnati score at 1 year 
(p<0.005) following surgery. Of the 12 patients who were treated by combination 
surgery 10 (83.3%) patients had a good or excellent result (table LV).
Table LVI shows that at 1 year of the 6 patients who had combined chondrocyte 
implantation and ACL reconstruction 5 (83.3%) had a good or excellent result. Of 
the 4 patients who had defects that required bone grafting or a MACI sandwich 
technique, 3 (75%) reported good or excellent results. Two patients had combined 
chondrocyte implantation and high tibial osteotomy and both reported good results. 
There was a statistically significant improvement in the modified Cincinnati scores 
at 1 year in the group of patients who had a combined chondrocyte implantation 
and anterior cruciate ligament reconstruction (p<0.05), however, the results for the 
other patient groups were not analysed because of the small numbers involved.
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TOTAL EXCELLENT GOOD FAIR POOR
Chondrocyte implantation 
and ACL reconstruction 6 1 4 1
Chondrocyte implantation 
and high tibial osteotomy 2 2
Chondrocyte implantation 
and bone graft 1 1
MACI sandwich 3 1 2
Table LVI. Clinical results at 1 year for 12 patients who had a combination of 
chondrocyte implantation with another surgical technique for chondral or 
osteochondral defects of the knee.
ICRS GRADE NUMBER (%)
1, Excellent 2
2, Good 2
3, Fair 2
4, Poor
Total 6
Table LVII. Arthroscopic results at 1 year for 6 patients, following combined ACI 
and other surgical procedure.
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Arthroscopic review
Of the 6 patients who had a repeat arthroscopy at 1 year post implantation, 1 
patient had a combined MACI and ACL repair, 2 had a combined ACI and ACL 
repair, 1 had an ACI and high tibial osteotomy, 1 had a MACI sandwich and 1 had 
a MACI and bone graft to the base of the defect.
The results of the arthroscopies at 1 year following implantation revealed ICRS 
grades of 1 or 2 in 4 out of 6 patients (66.6%). None of the grafts had failed at 1 
year, with 2 grafts scoring 3 out of 4 on the ICRS grading system (table LVII).
The 3 biopsies taken at the time of the check arthroscopy were all from grafts 
located on the medial femoral condyle (1 combined MACI and ACL repair, 1 
combined ACI and ACL repair and 1 combined MACI and bone graft). Hyaline 
cartilage was found in 1 patient based on the findings of well spaced out 
chondrocytes in lacunae enveloped within a matrix that stained positively for type II 
collagen using Safranin O. The biopsies of the two other patients showed a mixture 
of hyaline and fibrocartilage.
Complications
The majority of patients completed the rehabilitation programme without any 
complications. One patient was slow to mobilize and required a manipulation under 
anaesthetic. One patient complained of catching and at the check arthroscopy and 
was found to have graft hypertrophy that required shaving. None of the grafts failed 
in this review.
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Discussion
Patients who have a tibiofemoral malalignment, ligamentous instability or a large 
bony defect require correction of these underlying abnormalities before or at the 
time of cartilage repair Peterson et al reported on 11 patients who had a 
repair of the anterior cruciate ligament and a chondrocyte implantation to 
osteochondral defects over the femoral condyles with a mean defect size of 4.0 
cm*. At 2 years after surgery, 91% of patients reported good or excellent results. 
There were 2 treatment failures due to the chondrocyte implantation and 1 patient 
required a further operation since the ligament repair re-ruptured. Minas 
reported on 9 patients who required a high tibial osteotomy together with an 
autologous chondrocyte implantation. The osteotomies were performed either 
before or at the same time as the cartilage repair surgery. In his study the 
indications for a high tibial osteotomy included defects on the weight bearing 
femoral condyle greater than 8-10 mm* or a mechanical axis deviation greater than 
25% of the width of the tibial plateau and kissing lesions of the tibial and femoral 
condyles were also considered for this procedure. Minas observed that patients 
who had an ACI alone did better than those who also required a high tibial 
osteotomy
The results of this study are encouraging with 83.3% of patients reporting a good 
or excellent result at 1 year although the numbers are small. Of the 6 patients who 
had a combination of chondrocyte implantation and anterior cruciate ligament 
reconstruction 83.3% reported good or excellent results and of the 2 patients who 
had a chondrocyte implantation and high tibial osteotomy both reported good 
results and are comparable with previous results published for combination 
techniques
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One patient had a simple cancellous bone graft to a defect that was greater than 
8mm deep. At 1 year the patient reported a fair result, although this was an 
improvement on their pre operative score. Three patients had the MACI sandwich 
technique. One patient reported an excellent result and the other 2 patients 
reported good results at 1 year. Two of these patients formed part of a slightly 
larger group of 5 patients that all had the MACI sandwich technique and were 
recently reported in the literature out of a total of 5 patients who were reviewed 
at 1 year, 3 had an excellent result, 1 a good and 1 a fair result.
The MACI technique is more suitable for repairing osteochondral defects of the 
knee in combination with other techniques since it is technically less demanding 
than the AC I procedure. The ACI technique is more time consuming and if 
performed in combination with an anterior cruciate ligament repair for example, can 
result in very long tourniquet and anaesthetic times. For this reason the MACI 
technique maybe more suitable in the repair of osteochondral defects in patients 
who require other surgical procedures to restore normal anatomy.
Although the importance of correcting instability and malalignment can be 
appreciated, it is difficult to assess whether a patients' improvement following a 
combined procedure is due to the chondrocyte implantation or adjunct procedure 
or a combination of both. A prospectively randomized study may clarify this point.
In summary, chondrocyte implantation is unlikely to succeed if normal anatomy of 
the knee joint is not restored prior to or at the time of chondrocyte implantation 
This preliminary study demonstrates that additional procedures can successfully 
be performed at the time of the chondrocyte implantation to restore ligament 
instability, malalignment and the surface bony contours of the knee joint.
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CHAPTER 9:
OVERALL DISCUSSION AND CRITIQUE
Articular cartilage has many unique properties attributed to the lack of blood supply 
and nerve supply and the interplay between chondrocytes and the extracellular 
matrix they produce. These unique characteristics and its poor capacity to repair 
have posed a significant clinical problem in management of damaged cartilage.
Articular cartilage is susceptible to various pathologies including trauma, 
osteochondritis dissecans and chondromalacia patellae. Following injury there is 
negligable inflammation since there are no blood vessels. Very few chondrocytes 
undergo necrosis since having no blood supply, chondrocytes are relatively 
insensitive to hypoxia. Since there are no blood vessels to conduct reparative cells 
to the site of injury, the only possibility for repair in superficial lesions is for 
chondrocytes near the edges of the defect to undergo proliferation and synthesis of 
extracellular matrix. By contrast, injuries to articular cartilage which involve the 
subchondral bone precipitate the formation of a haematoma which organizes into a 
fibrin clot. With the ingrowth of capillaries from the subchondral bone the clot 
becomes granulation tissue which gradually undergoes transition to fibrocartilage 
containing type I and type III collagen. Although short-term this repair is quite 
satisfactory it does not appear to have the durability of hyaline cartilage and 
eventually degenerates. This is considered to be due to the preponderance of type 
I and type III collagen and the relative absence of type II (seen in abundance in 
hyaline cartilage). To a certain degree this is conjecture since relatively little is 
known about the natural history of osteochondral defects. Messner and Maletius ^  
demonstrated both clinical and radiographic deterioration following cartilage injury
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over a 14 year period in young athletes and Curl et al concluded from a review of 
over 30,000 arthroscopies that significantly injured articular cartilage is never 
spontaneously restored to normal. The majority of studies describe the 
deterioration of early osteoarthritis to severe osteoarthritis rather than the 
progression of osteochondral defects to osteoarthritis.
Based on the current literature, cartilage repair techniques should be reserved for 
patients with symptomatic chondral or osteochondral defects rather than for 
preventing progression of osteoarthritis 89;91;142;167
The presence of an articular cartilage defect is made based on the history and 
examination findings and confirmed with either plain radiographs for large defects 
or an MRI scan. The exact size and character of the defect can sometimes only be 
identified at arthroscopy.
Much has been written on the treatment of osteochondral defects. In the case of 
juvenile osteochondritis dissecans the non-operative option is best employed 
Patients with superficial injuries are also best untreated since long-term follow-up 
studies have not demonstrated progression to degenerative disease 
However, patients with symptomatic full-thickness defects should be considered for 
a cartilage repair technique. There are a number of surgical options available to 
treat these defects with varying degrees of success. Simple techniques such as 
lavage and debridement of damaged cartilage, techniques that penetrate the 
subchondral bone to encourage a fibrocartilage repair 7^;20;25;3i;53;95:98;ioo;ioi
osteotomies periosteal perichondral grafting, autologous
osteochondral grafting (mosaicplasty) osteochondral allografts 35;137;138
and autologous chondrocyte implantation have been used. Scaffolds such as the 
matrix support prosthesis have been used to try and improve the durability of
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the fibrocartilage repair but although initial results were encouraging there remain 
concerns about the long-term viability of such a technique.
The most widely-used techniques at present are those that penetrate the 
subchondral bone resulting in a fibrocartilage repair and more recently those that 
result in a hyaline or hyaline-like repair such as autologous chondrocyte 
implantation.
There are a number of techniques involving subchondral bone penetration. 
Subchondral bone drilling was first described by Pridie and is still the first line of 
treatment in many orthopaedic centres. Microfracture has been popularized by 
Steadman et al who reported that 75% of patients derived pain relief at 3-5 years 
post procedure
Of the techniques that encourage a hyaline-like repair the perichondral and 
periosteal grafting appeared promising particularly in the animal model ^^ 3:124 
however this never lived up to expectations in patients
Osteochondral allografts may have a role in the management of young patients 
with large unipolar defects but there are considerable problems in accessing 
suitable donor tissue particularly in the U.K. because of concerns regarding the 
risks of transmission of infection and also the long-term viability of the donor 
chondrocytes.
Some success has been achieved with autogenous osteochondral grafting or 
mosaicplasty. Horas reported encouraging results at 2 years and Hangody at 3 
years In a more recent paper Hangody reported on a group of patients with a 
10 year follow up, 92% of patients reported good/excellent results for femoral 
condyle defects but the assessment parameters are not described. However, 
there remain concerns of donor site morbidity and patellar defects did not do as
well. Hangody mentioned that the ideal defect size should be between 1-4 cm ,^
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although did n’t mention the mean defect size for his patients. Also no other 
studies have replicated his results. This indicates that mosaicplasty does not have 
a role in the management of defects of 4cm^ or larger. Bentley et al concluded that 
Mosaicplasty may only have a role in the treatment of smaller defects of 1cm  ^or 
less
The origins of autologous chondrocyte implantation can be traced back to Bentley 
and Greer’s report in Nature’ of successful transplantation in rabbits and 
Smith’s work on isolating adult articular chondrocytes in a suspension (Nature 
1965). But it was Brittberg et al in 1994 ^  who first reported this technique in the 
treatment of osteochondral defects in human subjects. In this study they used 
periosteum to retain the suspension within the defect and achieved some excellent 
results with 14 out of 16 patients having good/excellent results.
AUTOLOGOUS CHONDROCYTE IMPLANTATION WITH A PERIOSTEAL 
COVER (ACI-P)
We performed a 4 year review of all patients treated with ACI-P technique. At 1 
year, of the 33 patients reviewed 26 (78.8%) had good or excellent results, at 2 
years 65.6% (21 out of 32 patients) and 64.7% (11 out of 17) at 3 years. At 4 years 
7 patients were reviewed, 6 of whom had good or excellent results. In terms of 
factors that appeared to affect outcome, age and defect size had an impact. 
Patients in the fair or poor group at 3 years were older, had larger defects, and 
were much less athletic. This also seemed to be the case at other yearly reviews 
but did not achieve statistical significance. Defects repaired in our study were 
larger than those reported in other studies. Peterson et al’s long term durability 
study reported a mean defect size of 3.4 cm  ^ compared with 5.02 cm^ in our
study. Also Peterson’s patients had shorter duration of symptoms (3.4 years
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compared with a mean of 7.3 years in our study) and fewer previous procedures. 
These differences may explain the disparity in terms of clinical outcome between 
Peterson’s and our results. In our study 65.6% achieved good or excellent results 
at 2 years compared with 89% for the Swedish group.
The aetiology of the defect also played a role with 84.6% of patients with traumatic 
defects achieving good or excellent results compared with 66.6% for those with 
chondromalacia. However, this may have more to do with the location of the defect 
since patients with chondromalacia have defects over the patella and the majority 
of patients with traumatic defects were located over the medial femoral condyle.
At the 1 year check arthroscopy 80% of the repairs achieved ICRS grades of 1 or 2 
and over 4 years just 2 grafts failed, both were located over the retropatellar 
surface. Encouragingly 6 out of the 13 biopsies at 1 year showed either hyaline or 
mixed hyaline and fibrocartilage as did all 3 biopsies at 2 years.
However, of the complications there was a high incidence of graft hypertrophy 
requiring arthroscopic debridement in 33% of patients at 1 year.
AUTOLOGOUS CHONDROCYTE IMPLANTATION WITH A TYPE I/Ill 
COLLAGEN COVER (ACI-C)
Using a porcine derived type I/Ill collagen membrane instead of a periosteum 
cover to retain the chondrocytes within the defect, obviates the need to extend the 
arthrotomy to harvest the periosteum with its associated morbidity. Of the 130 
patients reviewed at 1 year 62% achieved good or excellent results, with 59% at 2 
years, 59% at 3 years and 56% at 4 years. However it became clear during our 
study that the results in years 1, 2 and 3 were adversely affected by a group of 
patients who had a implantation following a previous cartilage resurfacing
technique such as mosaicplasty or the matrix support prosthesis. Excluding this
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group at 1 year, 68% of patients achieved good or excellent results, 64% at 2 
years and 61% at 3 years. Even excluding the patients who had previous extensive 
cartilage repairs , there appears to be a clinical deterioration following 
transplantation from years 1 to 4, but this was not statistically significant (p=0.70). 
As with the ACI-P group we also analysed possible factors that may affect the 
outcome following the ACI-C technique. Of the patients reviewed at 1 year, those 
that were in the good or excellent group were younger and had fewer surgical 
procedures. At years 2 and 3, patients in the fair and poor group had more surgical 
procedures before implantation than the good or excellent group. At 4 years, the 
patients in the fair or poor group had defects that were significantly bigger than 
those patients in the good or excellent group.
Of those patients arthroscoped, 84% had good/excellent repairs based on the 
ICRS grading system at year 1 and year 2. The majority of graft failures occurred 
in the first year and were to repairs over the retropatellar surface. However, this 
was not typical of the patellar group, with 64% of patients at 1 year reporting 
good/excellent results. As would be expected, patients with single defects over one 
facet (74% good/excellent) did better than those with repairs to both facets (42%). 
As with the ACI-P group, defects repaired in this study were bigger than those 
reported in other studies and also our patients had a longer duration of 
symptoms. As suggested previously these 2 parameters are probably related. At 
the Royal National Orthopaedic Hospital delays occurred in patients with 
symptomatic defects receiving surgical intervention due to the way patients are 
referred and also insufficient operating time resulting in long periods on the waiting 
list. This may explain the longer duration of symptoms and may also be 
responsible for the larger mean defect size seen at the time of implantation since 
the defects have had time to get bigger.
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Traumatic defects again did better than defects caused by chondromalacia. But 
those with previous extensive cartilage repairs did worse with 24% reporting 
good/excellent results at 1 year, 11% at 2 years and 33% at 3 years. These 
defects were bigger (mean of 6.64 cm*) and were often quite deep and the patients 
had a longer duration of symptoms and more operations preceding their 
transplantation (mean 3.29).
The histology was encouraging with 50% of biopsies showing hyaline-like or mixed 
hyaline and fibrocartilage repairs at 1 year and 62% at 2 years for the ACI-C group. 
Also in this review, patients with a hyaline-like or mixed repair reported a better 
clinical result although this was not statistically significant.
From this review of ACI-C it was apparent that this technique could result in a 
durable repair in the short to medium term.
ACI-C vs ACI-P
There has been considerable speculation as to whether the periosteum in the ACI- 
P technique acts simply as a watertight seal or whether it secretes growth factors 
necessary for the development of a hyaline-like repair. The results following our 4- 
year review of both techniques were similar with 68% of patients following the ACI- 
C technique having good or excellent results at 1 year, 64% at 2 years, 61% at 3 
years and 56% at 4 years. This compared favorably with the ACI-P group with 
78.8% of patients having good/excellent results at 1 year, 65.6% at 2 years, 64.7% 
at 3 years and 85% at 4 years (but only 7 patients were reviewed at 4 years). To 
be able to conclude that these 2 techniques are comparable, a prospective 
randomized study was carried out. There were 33 patients in the ACI-P arm and 35
patients in the ACI-C arm. At 2 years 74% of the ACI-C patients had
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good/excellent results compared to 67% of the ACI-P patients. This apparent 
difference was not statistically significant (p>0.05). Arthroscopic examination also 
showed very similar results for both groups. Following the ACI-P technique 81% 
had good/excellent results and 79% following the ACI-C technique at 1 year. The 
biopsies reviewed at 1 year were also encouraging with 69% of the ACI-C biopsies 
having hyaline-like or mixed hyaline and fibrocartilage repairs and 43% following 
the ACI-P group. Although this looks better for the ACI-C technique the numbers 
involved were small.
What was also interesting in this study was the marked difference in terms of graft 
hypertrophy following both techniques. Previously the problems of graft 
hypertrophy following the ACI-P technique had been alluded to but never 
compared directly with ACI-C in a randomized study. Within the first year following 
the ACI-P technique 36% of patients required shaving of a hypertrophied graft 
compared to one in the ACI-C group. This complication was important since 
patients would complain of pain and catching which was subsequently relieved by 
arthroscopic shaving. Graft hypertrophy following the ACI-P technique has been 
reported in other studies. Peterson et al reported that as many as 26 (40%) 
patients out of 65 had graft hypertrophy but only 7 (11%) were symptomatic In 
Minas’ study there was a 20% incidence of graft hypertrophy and in all these 
cases, the patients were symptomatic. More recently in Knutsen’s study there were 
25% of patients following the ACI-P technique who had graft hypertrophy and 
required arthroscopic debridement or shaving
However, the findings of this study conflicts with the animal work by Lindahl et al 
In his study, rabbits with artificially-created osteochondral defects had either a 
chondrocyte suspension injected under dead periosteum or under fresh ‘live’
periosteum. Of those rabbits that had the dead periosteum cover, only 1 developed
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a hyaline-like repair. From these results Lindahl concluded that ‘live’ periosteum 
was needed for a successful chondrocyte implantation. However, these findings 
have not been supported by work in human subjects and so perhaps are an 
idiosyncrasy of the rabbit model. Since the ACI-C technique is comparable to the 
ACI-P technique both clinically and arthroscopically but results in less hypertrophy, 
it could be concluded that this technique is the new gold standard’ which other 
techniques are compared.
There are very few randomized studies to date in the field of chondrocyte 
implantation. Bentley et al published a study which compared ACI with 
mosaicplasty This study reported that 88% of the ACI patients had good or 
excellent results at 1 year compared with 69% following mosaicplasty and went on 
to conclude that ACI was valuable for selected patients since it was able to result 
in a hyaline-like repair which could reduce symptoms of pain and disability.
Horas et al performed a prospective clinical study comparing ACI with 
osteochondral cylinder transplantation at 2 years in 40 patients with a single focal 
articular lesion of the femoral condyle In this study both techniques resulted in 
an improvement in symptoms but the ACI group seemed to lag behind the 
improvement provided by the osteochondral cylinder transplantation. The results 
were also disappointing histologically with the ACI technique since primarily the 
defects were filled with fibrocartilage, whereas the osteochondral cylinder 
transplants retained their hyaline character albeit with a persistent gap between the 
plugs and lack of integration with the surrounding articular cartilage. Possibly the 
ACI technique would be expected to lag the osteochondral cylinder transplantation 
technique since the ACI technique takes longer to generate repair tissue compared 
to the osteochondral cylinder transplantation technique which involves
transplantation of differentiated hyaline cartilage into the defect from day 1. The
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advantage of the ACI technique is that it can result in a hyaline-like repair which is 
integrated into the surrounding articular cartilage. With osteochondral cylinder 
transplantation there is a concern of donor site morbidity although this was not 
encountered in Horas’ study. Horas’ study only reported on 40 patients in total and 
their randomization involved a technique of altemating consecutive selection. 
Bentley et al reviewed a total of 100 patients and used random sample numbers 
in sealed envelopes and concluded that mosaicplasty may only be useful in the 
treatment of small defects.
More recently a prospectively randomized study by Knutsen et al compared 
microfracture and periosteum-covered ACI. A total of 80 patients were randomized, 
40 to the microfracture technique and 40 to the ACI technique. The defects 
operated on were restricted to single defects over the medial femoral condyle or 
lateral femoral condyle. There was no clinical difference in terms of the Lysholm 
score at 12 and 24 months but microfracture achieved significantly better scores 
for the physical component of the SF36 scores at 2 years. However, as the authors 
suggested, this may be due to the fact that the microfracture technique is less 
invasive and therefore the rehabilitation is easier to complete. Although the authors 
reported that there was no difference between the histological appearance 
between the 2 repairs, they went on to say that there was a tendency for the ACI 
procedure to result in more hyaline cartilage repairs but it was not a significant 
finding with the numbers available. This suggests that their sample size was too 
small and possibly a difference would have been more apparent with a larger 
sample size. Similar clinical results were observed for both groups by Knutsen et al 
when they presented an update to this study at 5 years. Of note, each group
sustained 9 failures (22%) at 5 years, compared with 2 failures in the ACI group
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and 1 failure in the microfracture group at 2 years This was nonetheless an 
important study and highlighted a number of valid points regarding patient 
selection and the need for a simple operative technique in the treatment of 
osteochondral defects. One of the arguments for chondrocyte implantation is that it 
is one of the few techniques that can result in a hyaline-like repair with the 
expectation that it will last in the long-term.
MATRIX CARRIED AUTOLOGOUS CHONDROCYTE IMPLANTATION (MACI)
Following the success of the ACI-C technique a third technique has evolved of
implanting cultured chondrocytes into osteochondral defects. Instead of injecting a
chondrocyte suspension underneath a type I/Ill membrane, the chondrocytes are
seeded onto one surface in the laboratory and then the membrane is cut to size
and secured to the base of the defect with the cells facing downwards.
This is a relatively new technique and there are no long-term results and very few
published short-term follow-up studies. Of the 107 patents reviewed at 1 year 69%
had good/excellent results, this compared with 78% of the ACI-P patients and 68%
for the ACI-C patients. The check arthroscopy at 1 year following the MACI
technique was also encouraging with 80% of those arthroscoped having
good/excellent repairs which compared favorably with the ACI-C and ACI-P
results. There were 4 cases of graft failure where the graft delaminated and in 3 of
those cases the defects were located over the retropatellar surface. However, like
the ACI-C group this was not typical of the patellar group with 69% of patients
reporting good/excellent results. This was particularly encouraging since the
retropatellar surface can be very difficult to repair with the ACI-C or ACI-P
technique due to the high pressures developed in the joint and the irregularity of
the surface. This is particularly so when the defects are not contained (i.e. no
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surrounding cartilage to suture the collagen or periosteum cover). What was 
interesting was that the defects over the medial femoral condyle did not seem to do 
as well at the 1 year mark as compared with the ACI-C or ACI-P technique. The 
histology was also less good, with 37.5% of biopsies having hyaline-like or mixed 
hyaline and fibrocartilage at 1 year. These results appear to corroborate the recent 
study by Behrens et al In this study 8 out of 11 patients (73%) subjectively 
reported that their knee was ‘much better* or better' at 5 years which the authors 
observed was less than that reported for other ACI techniques, with patient 
satisfaction of up to 95% after 2 years
Possibly these results are due to the fact that the MACI grafts take longer to 
mature in comparison to the ACI-C and ACI-P techniques. Zheng et al have shown 
in their studies with the MACI membrane that chondrocytes are able to migrate 
from the membrane into the glue within 2 weeks. Nonetheless this fibrin glue layer 
through which the chondrocytes have to migrate to bond to the subchondral bone 
could result in a delay in the maturation of the graft. An alternative explanation is 
that the number of cells in the implant is approximately double with ACI compared 
with MACI.
From a practical viewpoint the MACI technique has clear advantages over the ACI- 
C and ACI-P techniques. It avoids the need to suture the membrane to the rim of 
the defect, it ensures a more equal distribution of chondrocytes over the defect and 
avoids leakage of chondrocytes, and it is also technically easier and quicker to do 
resulting in a shorter tourniquet time. The lesser number of cells implanted could 
prove to be an important defect in this method.
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Therefore, despite these attractions, longer follow-up should be obtained together 
with prospectively randomized studies before widespread usage of this technique.
OTHER POTENTIAL SCAFFOLDS FOR AUTOLOGOUS CHONDROCYTE 
IMPLANTATION
As mentioned earlier there are some limitations associated with the periosteum- 
covered ACI, including the complexity and morbidity associated with the surgical 
procedure and the frequent occurrence of periosteal hypertrophy^^^. In the 
conquest to reduce the complexity of this technique and also to reduce the size of 
incision needed to carry out the transplantation, alternative methods of implanting 
the chondrocytes have been suggested. The MACI technique involves a type I/Ill 
collagen scaffold, to which the chondrocytes attach themselves and are able to 
redifferentiate and produce an extracellular matrix, however there are other 
scaffolds which have been suggested. The most popular altematives in the 
literature include an agarose or alginate gel and a hyaluronan matrix ®^2;183 
In the past agarose gels have been used due to their capacity to stabilize the 
chondrocyte phenotype and although calcium alginate gels represent a
carrier material with similar biological properties, they have other advantages 
180,185 Qg|g guch as agarose and alginate ^^ 9;186-188 to maintain the
spherical shape of chondrocytes and also enable them to divide and express 
proteins characteristic of articular cartilage. However, within alginate gels, the 
average half-life of proteoglycans synthesized by chondrocytes is twice as long 
than if they were cultured in agarose gels which is similar to the turnover in 
normal articular cartilage Also, observations made following
immunohistochemical analyses suggest that matrix formed in alginate gels was
compartmentalized corresponding to the pericellular and territorial matrix which
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does not occur with agarose gels Alginate gels also have the advantage that 
they are readily biodegradable The calcium ions bound to the alginate are 
slowly replaced with ions that are not gel-inducing such as sodium ions resulting in 
softening of the gel and its eventual breakdown. Also, substances such as 
phosphate or citrate having a strong affinity for calcium ions will rapidly break up 
the calcium alginate complex and dissolve the gel.
In this technique the chondrocytes are cultured in the monolayer technique as 
described for the MACI technique and then the chondrocytes are suspended in a 
low viscosity alginate solution This solution can be pipetted into silicone moulds 
which have been placed on a pad soaked in calcium chloride. As soon as the 
gel/chondrocyte suspension comes into contact with the calcium chloride, ‘gelation’ 
of the alginate occurs. Following the animal studies of Hedbom et al they 
demonstrated that cultured chondrocytes in an alginate construct had the same 
cellularity as normal cartilage, with 20-25% of the normal proteoglycan 
concentration and 40-50% of the normal collagen concentration and could be 
cultured in vitro for 120 days. They concluded that the capacity of alginates to 
preserve the chondrocyte phenotype and the relatively high anabolic rate of the 
cells that they observed from their animal studies could lead to the adoption of this 
technique in vivo.
However, subsequent studies have been more circumspect. Mierisch et al
reported on the fate of genetically-marked chondrocytes following their
implantation within a calcium alginate scaffold. They confirmed findings from other
studies that chondrocytes were able to maintain their spherical shape within an
alginate gel ^^ 9:186-188 also noted the upregulation of cartilage-specific genes for
aggrecan and type II collagen. However, they noted that in vivo cells were
detectable for only 4 weeks, and their number seemed to diminish with time. They
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suggested that although nutrients could diffuse through the alginate gel, 
chondrocytes were not able to migrate out of the gel. Also, with time the gel loses 
its structural integrity and as a result the implanted cells lose their structural 
support. They concluded from their observations that implanted chondrocytes are 
neither incorporated into the host tissue nor do they contribute to the repair of the 
osteochondral defect and any repair that does occur is due to the surrounding host 
cells. However, these results were obtained from an animal model and they used 
chondrocytes derived from rib cartilage rather than articular chondrocytes.
Grunder et al concluded from their study of 11 patients with an average age of 
39.8 years that articular chondrocytes cultured in alginate beads showed 
upregulation of type II collagen and downregulation of type I collagen. Also the 
addition of BMP-2 seemed to have a positive effect on this up-regulation, with 
increased expression of collagen type II and aggrecan expression. However, 
consistent with other authors the growth of cells in alginate alone may not be 
sufficient for cell expansion due to their low proliferation rates and are unlikely to 
be sufficient for cartilage implantation techniques.
Hyaluronic acid (Hyaluronan) is a glycosaminoglycan that is widely distributed in 
the body. HYAFF® 11 (Fidia Advanced Biopolymers, Abano, Terme, Italy) is an 
esterified derivative of hyaluronan, which can be used to produce a number of 
biodegradeable structures with different shapes. Hyalograft® C (Fidia Advanced 
Biopolymers, Abano, Terme, Italy) Is a tissue engineered graft composed of 
autologous chondrocytes grown on a HYAFF® 11 scaffold. The technique of 
implanting Hyalograft® C into full thickness osteochondral defects has been used 
in a number of European countries since 1999, with more than 3600 patients 
treated The advantage of this technique over the periosteum-covered ACI
technique is that it involves a much smaller surgical incision and often does not
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require any sutures or fibrin glue to secure it to the rim of the defect because of the 
intrinsic adhesive properties of the hyaluronan scaffold Marcacci et al 
reported on 141 patients with follow-up ranging form 2 to 5 years and a mean age 
of 37.6 years. After a mean follow-up of 38 months after implantation, 91.5% of 
patients were subjectively improved. There was a 5% failure rate, although the 
authors observed that these failures occurred in patients who would have 
othenvise had an arthroplasty but had the Hyalograft® C technique in an attempt to 
delay it.
Nehrer et al reviewed 36 patients with a mean age of 33 years. At 3 years they 
reported 87% good or excellent results and no failures.
These are encouraging preliminary results, however longer follow-up and 
randomised controlled trials comparing Hyalograft® C with ACI would be useful to 
demonstrate whether this technique is a valid alternative.
CHONDROCYTE IMPLANTATION AND COMBINED PROCEDURES 
It has been well documented that prior to cartilage repair any instability or 
malalignment of the joint should be corrected Any laxity of the anterior cruciate 
ligament after chondrocyte implantation could result in abnormal translation and 
rotation of the femur on the tibia resulting shearing of the graft and failure of the 
repair. Similarly, if limb malalignment is not corrected then excessive loading on 
the graft could lead to its failure. Previous authors have suggested that patients 
with large osteochondral defects who have normal alignment may benefit from an 
unloading osteotomy. In this study the practice was to perform osteotomies only in 
patients with a significant varus or valgus malalignment.
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Brittberg also suggested that he found that defects with depths greater than 8mm 
benefited from bone grafting to restore the bony contour this was also the 
practice in this study.
A total of 12 patients were reviewed following chondrocyte implantation combined 
with another surgical technique. The results were encouraging, with 83% of the 
combined chondrocyte transplantations and ACL reconstructions having good or 
excellent results at 1 year. Both patients who had a combined chondrocyte 
implantation and osteotomy had similar results as well as those patients that had 
the MACI sandwich technique. One patient had a simple bone graft to their lesion 
before a graft was then implanted and reported only a fair result at 1 year, albeit an 
improvement from their pre-operative score.
This study highlighted a number of important issues. Firstly it supports conclusions 
drawn from other studies that instability and malalignment must be corrected 
prior to or at the time of chondrocyte implantation to avoid excessive loading on the 
repair. It also showed that successful results could be achieved following combined 
techniques but the difficulty is in determining whether the success is due to one or 
either of the techniques or a combination of both. For this question to be 
addressed a randomized controlled trial would be needed to address this issue. 
What was evident from this study was that although it was possible to perform an 
ACL reconstruction and MACI technique as a one-stage procedure, there was 
considerable difficulty in performing an ACL reconstruction and ACI repair due to 
time constraints imposed by the tourniquet.
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Critique
With a study of this size there were a number of difficulties which had to be 
overcome. Some patients were unable to attend clinic and so that a proportion of 
the clinical and functional scores were made either by telephone or by way of a 
postal questionnaire. Since the Royal National Orthopaedic Hospital is a tertiary 
referral hospital with patients all over the country this was unavoidable. However, 
all the assessment was performed by independent research staff who had no part 
in the surgical procedure.
It was intended that all patients would have a ‘2*  ^ look' arthroscopy at 1 and 2 
years post-operatively, however as is apparent from this thesis this was not the 
case. This was due to a few patients not attending their follow up arthroscopy and 
the technical difficulty of accessing some grafts by arthroscopic means especially 
in the patello-femoral joint.
In this study we used the Modified Cincinnati Rating system to asses the patients 
both clinically and functionally. Some authors do not use this scoring system, 
making a direct comparison of results difficult. Knutsen in his recent study used the 
Lysholm, Tegner and Meyers scores and Peterson et al used the Lysholm, 
Cincinnati knee score. Modified Noyes Cincinnati rating, Wallgren-Tegner score 
and the Brittberg Clinical score and Minas used the Cincinnati rating scale. Knee 
society score. Western Ontario McMaster Universities Osteoarthritis Index and the 
SF36. All these scoring systems are similar, but if different centres adopted the 
same scoring systems then comparisons could be made more easily. During the 
course of this study the SF36 questionnaire was adopted, which has the 
advantage of assessing the patients psychological profile as well as their physical 
status before and after surgery. Possibly this scoring system in conjunction with
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one other functional scoring system such as the Modified Cincinnati Rating would 
be acceptable to other centres involved in Chondrocyte implantation.
There was some discussion as to whether the author should assess all the 
biopsies for this study however since the author knew which procedure each 
patient had there was the possibility of bias and as a result the Consultant 
Histopathologist agreed to assess the grafts and was blinded as to whether the 
patients had either a MACI, ACI-C or ACI-P.
Another question encountered in this study was how best to assess the biopsies of 
the grafts taken at 1 and 2 years. In discussion with the Histopathologist at The 
Royal National Orthopaedic Hospital we concluded that a graft with sparse, oval­
shaped chondrocytes, evenly distributed in lacunae through the majority of the 
biopsy enveloped in extracellular matrix with a homogenous glassy appearance 
which stained with Safranin O, without the evidence of collagen fibrils and absence 
of blood vessels and nerves which had bonded to the subchondral bone was 
hyaline or hyaline-like cartilage. In contrast, grafts that were considered to be 
fibrocartilage had a high proportion of disorganised coarse type I collagen fibres 
with more frequent and elongated cells. The real problem was in agreeing what 
was mixed hyaline and fibrocartilage. In the end we used the same criteria as 
Knutsen if more than 60% of the core biopsy was hyaline cartilage it was 
considered hyaline -like, if it was less than 40% than it was considered to be that 
of fibrocartilage. Core biopsies containing more than 40% hyaline cartilage but less 
than 60% were considered to be that of a mixed hyaline and fibrocartilage. This is 
however fairly arbitrary but at present there is not a suitable alternative that is 
reproducible. Similarly, Peterson et al described the histological appearance 
based on a number of criteria including cellularity, columnar structure of the
cartilage and its appearance in polarized light and they also used immunostaining
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for Type II collagen. However, in Peterson et al’s study the authors did not explain 
how they concluded that a graft had the appearance of ‘mixed tissue’. Again as 
with the clinical scoring system, a universally-agreed classification would make 
comparisons between different centres a lot easier. After 5 years consideration of 
this matter the ICRS has yet to publish a definitive histological scoring system 
which indicates the difficulty of precise assessment.
The majority of patients presented in this study had a follow up of 1 or 2 years with 
a few patients who had been reviewed at 3 and 4 years. Although this study 
comprehensively presents the short to medium term results there is no data for the 
long term results at this centre, although this forms part of an ongoing project.
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CHAPTER 10:
SUGGESTIONS FOR FURTHER RESEARCH
PROSPECTIVELY RANDOMISED STUDIES
There is a clear need for more prospectively randomised studies in this field. 
Knutsen’s study was particularly interesting in comparing periosteum covered 
ACI and microfracture. Knutsen proposed that in the short-tenn, microfracture had 
the slight edge on autologous chondrocyte implantation but this study may have 
inadequate statistical power. However, the real test is the durability of the repair in 
the mid to long-term. Therefore a longer study comparing collagen covered ACI 
with microfracture at 8 years to 10 years would help dispel any doubts about which 
of these techniques is the most successful.
During the course of this study it was apparent that collagen-covered ACI 
produced repairs with similar characteristics to periosteum-covered ACI as regards 
clinical outcome, arthroscopic appearance and histological assessment of the 
graft. However the periosteum-covered ACI resulted in considerably more 
morbidity in terms of graft hypertrophy which required arthroscopic shaving since it 
caused catching and pain. It is proposed from this study that collagen-covered ACI 
is the new ‘gold standard’ in autologous chondrocyte implantation. Therefore in any 
new prospectively randomised studies comparisons should be made with the 
collagen-covered ACI as apposed to the periosteum-covered ACI the previous 
gold standard’ in chondrocyte implantation. Currently there is a multi-centre study 
comparing MACI with collagen covered ACI based at the Royal National 
Orthopaedic Hospital, Stanmore.
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REHABILITATION
Almost all centres adopt a different rehabilitation program. For example patients in 
this study were encouraged to fully weight-bear from the start since it is thought 
that load-bearing is important for the maintenance of the function of the recipient 
cartilage and possibly for stimulating the differentiation of the implanted 
chondrocytes. Peterson’s patients were only allowed to partially weight-bear for 
the first 8 weeks and were then allowed to fully weight bear from 8 to 12 weeks 
which was the same rehabilitation program that Knutsen used whereas Minas 
prevented his patients from weight-bearing for 6 weeks and then used 
progressive weight-bearing to full weight-bearing at 4 months. In Australia Wood et 
al give their patients a course of pre-operative physiotherapy (verbal 
communication). All of these groups use continuous passive motion (CRM) in the 
early post-operative period because it is thought that this stimulates the isolated 
implanted cells to produce more type II collagen, based on Salter’s’ observations 
A prospectively randomised study comparing 3 or 4 of the most widely-adopted 
rehabilitation programs may show that one rehabilitation program is better than the 
others. This may encourage the universal adoption of 1 rehabilitation program, 
making direct comparisons between different centres easier.
FUTURE TECHNOLOGIES
A possible area for future research in this field is the adoption of stem-cell 
technology so that cells harvested from the peripheral blood could then be cultured 
to produce chondrocytes and then implanted into osteochondral defects. Roufosse 
et al confirmed that although there is evidence for circulating mesenchymal 
precursor cells which are able to differentiate into a number of mesenchymal
tissues including cartilage there are difficulties in obtaining conclusive and
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reproducible results. They concluded that the inconsistent results were due to 
variations in ‘methods of cell purification, culture and characterisation'. 
Nonetheless, this would suggest that it is a realistic aim to be able to take a blood 
sample and culture chondrocytes from it that are able to produce type II collagen. 
From my clinical review of patients who undenvent autologous chondrocyte 
implantation, it became apparent that in the short-term there was considerable 
morbidity associated with the arthrotomy which was made during the second stage 
of the procedure. Patients complained of pain and tightness over the scar in the 
immediate post-operative period. In the short-term this undoubtedly hampered the 
patients’ ability to follow the rehabilitation program and delayed their recovery. 
From this observation I considered other ways to deliver the chondrocytes to the 
osteochondral defect.
A fascinating field of medicine which has made some impact in the field of 
oncology and also diagnostics amongst others is monoclonal antibody technology. 
In Oncology it has been used to deliver chemotherapeutic agents to tumours and 
perhaps this same technology could be used to deliver chondrocytes to exposed 
subchondral bone. The Fc component of the monoclonal antibody could bind to a 
surface antigen on the chondrocyte and the Fab component to surface antigens on 
osteoblasts or to the matrix itself. This would still be a 2-stage technique, the first 
requiring an arthroscopy and chondrocyte harvesting and the second stage the 
administering of a chondrocyte/monoclonal antibody suspension in the form of an 
intra-articular injection. The second stage would probably still require an 
arthroscopy to debride the defect and expose the subchondral bone. This 
technique would also ensure direct contact between the chondrocytes and the 
underlying bone although there would be a small gap bridged by the monoclonal
antibody. Lance was the first to establish specific monoclonal antibodies for
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human articular chondrocytes HUMC 1-5. Buija et ai went on to discover that 
there was a cross reaction with human fibroblasts and osteoblasts for the 
antibodies HUMC 2 and 5. However, they concluded that HUMC 1, 3 and 4 were 
specific for chondrocytes and suggested that they could be used in 
immunohistological analysis. Possibly with this technology an Fc component could 
be designed that would bind to either HUMC 1, 3 or 4 and a Fab component that 
could bind to a specific surface marker on osteoblasts or the bone matrix. The 
author proposes a pilot study to first identify which specific surface antigens have 
been isolated for cellular structures of chondrocytes and osteoblasts and then 
perform an in vitro study to analyse the relationship between the antibodies, 
chondrocytes and osteoblasts and their matrix.
The need for a simple procedure to generate a durable repair that shares the 
characteristics of normal articular cartilage in the treatment of osteochondral 
defects will ensure that this remains an exciting field for many years to come.
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CHAPTER 12 APPENDIX I: DATA COLLECTION FORM
PATIENT DETAILS
PATIENT NAME
MALE FEMALE
HOSPITAL NUMBER
DATE OF BIRTH
AGE AT TIME OF SURGERY (2"* STAGE)
OCCUPATION
SMOKER NO YES
OPPOSITE KNEE NORMAL ALMOST NORMAL NOT
NORMAL
MEDICATION NSAIDS CORTICOSTEROIDS OTHER
INDICATION FOR OPERATION
DURATION OF SYMPTOMS
PREVIOUS KNEE SURGERY
ARTHROSCOPY
MENISECTOMY
ARTICULAR CARTILAGE IMPLANTATION
MOSAICPLASTY
DRILLING / MICROFRACTURE
ARTHROSCOPY + REMOVAL OF LOOSE 
BODIES
OTHER
SIDE
RIGHT
LEFT
AETIOLOGY OF DEFECTS
TRAUMA
OSTEOCHONDRITIS DISSECANS
CHONDROMALACIA PATELLAE
EARLY OA
OTHER (? TRAUMA)
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EXAMINATION FINDINGS & SCORING SYSTEM AT TIME OF CARTILAGE IMPLANTATION
WASTING NIL <2CM >2CM
ALIGNMENT NORMAL VALGUS VARUS
EFFUSION NIL MILD MOD SEV
RANGE OF MOVEMENT (DEGREES)
CREPITUS NIL MILD MOD SEV
EXTENSION
JOINT
TENDERNESS
NIL LATERAL MEDIAL PFJ
EXT. LAG
PATELLA
TRACKING
STABLE UNSTABLE JSIGN
ABILITY TO 
SQUAT
NORMAL DIFFICULT UNABLE
ANTERIOR
DRAW
0 1 2 3
MCL
INSTABILITY
0 1 2 3
LCL
INSTABILITY
0 1 2 3
LACHMAN
TEST
0 1 2 3
POSTERIOR
SAG
0 1 2 3
PIVOT SHIFT POSITIVE NEGATIVE
VISUAL ANALOGUE SCORE (0-10)
BENTLEY FUNCTIONAL RATING SYSTEM (0-4)
PAIN (OUT OF 20)
GIVING WAY (OUT OF 20)
SWELLING (OUT OF 10)
WALKING ABILITY (OUT OF 10)
STAIR WALKING (OUT OF 10)
RUNNING (OUT OF 5)
JUMPING/TWISTING (OUT OF 5)
OVERALL ACTIVITY (OUT OF 20)
TOTAL (OUT OF 100)
CINCINATTI RATING SYSTEM
INVESTIGATIONS BEFORE CARTILAGE IMPLANTATION
XRAY FINDINGS VALGUS ANGLE SULCUS ANGLE
PATELLA BAJA ALTA
DEFECT VISIBLE YES NO
DEPTH (mm)
MRI FINDINGS DEFECT VISIBLE YES NO
DEFECT SIZE (mm) WIDTH DEPTH
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ANATOMICAL DISTRIBUTION OF CARTILAGE DEFECTS
MEDIAL FEMORAL CONDYLE
PATELLA-SINGLE FACET
PATELLA MULTI-FACETS
LATERAL FEMORAL CONDYLE
TROCHLEAR
LATERAL TIBIAL CONDYLE
NUMBER OF LESIONS
SINGLE
MULTIPLE
SIZE OF DEFECTS (mm)
1
2
CONSULTANT: COMPLETED BY: DATE:
HOW ARE CHONDROCYTES APPLIED
MACI
ACI
OTHER (EG. COMBINED PROCEDURE)
TYPE OF GRAFT
PERIOSTEUM
TYPE I/Ill COLLAGEN MEMBRANE
NUMBER OF CELLS GRAFTED
COMBINED PROCEDURES
ACI + OSTEOTOMY
ACI + ANTERIOR CRUCIATE LIGAMENT 
RECONSTRUCTION
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EXAMINATION FINDINGS & SCORING SYSTEM POST CARTILAGE IMPLANTATION
WASTING NIL <2CM >2CM
ALIGNMENT NORMAL VALGUS VARUS
EFFUSION NIL 1 MILD MOD SEV
RANGE OF MOVEMENT (DEGREES)
CREPITUS NIL MILD MOD SEV
EXTENSION
JOINT
TENDERNESS
NIL LATERAL MEDIAL PFJ
EXT. LAG
PATELLA
TRACKING
STABLE UNSTABLE JSIGN
ABILITY TO 
SQUAT
NORMAL DIFFICULT UNABLE
ANTERIOR
DRAW
0 1 2 3
MCL
INSTABILITY
0 1 2 3
LCL
INSTABILITY
0 1 2 3
LACHMAN
TEST
0 1 2 3
POSTERIOR
SAG
0 1 2 3
PIVOT SHIFT POSITIVE NEGATIVE
VISUAL ANALOGUE SCORE (0-10)
BENTLEY FUNCTIONAL RATING SYSTEM (0-4)
CINCINATTI RATING SYSTEM PAIN (OUT OF 20)
GIVING WAY (OUT OF 20)
SWELLING (OUT OF 10)
WALKING ABILITY (OUT OF 10)
STAIR WALKING (OUT OF 10)
RUNNING (OUT OF 5)
JUMPING/TWISTING (OUT OF 5)
OVERALL ACTIVITY (OUT OF 20)
TOTAL (OUT OF 100)
INVESTIGATIONS POST CARTILAGE IMPLANTATION
XRAY FINDINGS VALGUS ANGLE SULCUS ANGLE
PATELLA BAJA ALTA
DEFECT VISIBLE YES NO
DEPTH (mm)
MRI FINDINGS DEFECT VISIBLE YES NO
DEFECT SIZE (mm) WIDTH DEPTH
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EMPLOYMENT STATUS
STOPPED WORK BEFORE CARTILAGE 
IMPLANTATION
YES NO
TIME OFF WORK
RETURNED TO WORK POST CARTILAGE 
IMPLANTATION
NO PART FULL
TIME TIME
TIME AFTER SURGERY WHEN RETURNED TO WORK
INTERNATIONAL CARTILAGE RESEARCH SOCIETY ARTHROSCOPIC GRADING OF GRAFT BIOSY
ICRS 1 - EXCELLENT
ICRS 2 - GOOD
ICRS 3 - FAIR
ICRS 4 - POOR
ADDITIONAL INFORMATION
TIME OF CHECK ARTHROSCOPY
FIRMNESS EXCELLENT GOOD FAIR POOR
BIOPSY RESUITS FIBROCARTILAGE HYALINE MIXED
FOLLOW-UP
REHABILITATION PROGRAM
STANDARD
OTHER (EG. WITH COMBINED PROCEDURES)
COMPLICATIONS
SLOW TO MOBILISE REQUIRING MUA
UNPLANNED ARTHROSCOPY
THROMBO EMBOLIC PHENOMENON
INFECTION
GRAFT FAILURE
GRAFT HYPERTROPHY
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APPENDIX 11: Modified Cincinnati Rating System Questionnaire
This questionnaire has been designed to give your therapist information as to how 
your knee pain has affected your ability to manage in everyday life. Please answer 
every question by placing a mark in the one box that best describes your condition 
today.
We realize you may feel that 2 of the statements may describe your condition, but 
please mark only the box that most closely describes your current condition.
Section 1 - Pain Intensity
20 No pain, normal knee, performs 100%.
16 Occasional pain with strenuous sports or heavy work, knee not entirely
normal, some limitations but minor and tolerable.
12 Occasional pain with light recreational sports or moderate work activities,
running or, heavy labour, strenuous sports.
8 Pain, usually brought on by sports, light recreational activities or moderate
work. Occasionally occurs with walking, standing or light work.
4 Pain is a significant problem with simple activity such as walking, relieved
by rest, unable to do sports.
0 Pain present all the time. Not relieved by rest.
Section 2 - Swelling
10 No swelling
8 Occasional swelling with strenuous sports or heavy work. Some limitations
but minor and tolerable.
6 Occasional swelling with light recreational sports or moderate work
activities. Frequently brought on by vigorous activities, running, heavy 
labour, and strenuous sport.
4 Swelling limits sports and moderate work. Occurs infrequently with simple
walking activities or light work (approx 3 times a year).
2 Swelling brought on by simple walking activities and light work. Relieved by
rest.
0 Severe problem all the time, with simple walking activities.
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Section 3 - Giving Way
20 No giving way.
16 Occasional giving way with strenuous sports or heavy work.Can participate
in all sports but some guarding or limitations present.
12 Occasional giving way with light sports or moderate work. Able to
compensate but limits vigorous activities, sports, or heavy work not able to 
cut or twist suddenly.
8 Giving way limits sports and moderate work, occurs infrequently with
walking or light work (approx 3 times per year).
4 Giving way with simple walking activities and light work. Occurs once per
month, requires guarding.
0 Severe problem with simple walking activities, cannot turn or twist while
walking without giving way.
Section 4 - Overall activity level
20 No limitation, normal knee, able to do everything including strenuous sports
or heavy labour.
16 Perform sports including vigorous activities but at lower performance level: 
involves guarding or some limits to heavy labour.
12 Light recreational activities possible with rare symptoms, more strenuous
activities cause problems.Active but in different sports; limited to
moderate work.
8 No sports or recreational activities possible. Walking with rare symptoms;
limited to light work.
4 Walking, ADL cause moderate symptoms, frequent limitations.
0 Walking, ADL cause severe problems, persistent symptoms.
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Section 5 - Walking.
10 Walking unlimited.
8 Slight/mild problem.
6 Moderate problem: smooth surface possible up to approx 800m.
4 Severe problem, only 2-3 blocks possible.
2 Severe problem; requires stick or crutches.
Section 6 - Stairs
10 Normal, unlimited.
8 Slight/mild problem.
6 Moderate problems only 10-15 steps possible.
4 Severe problem; requires bannister support.
2 Severe problem only 1-5 steps possible
Section 7 - Running activity
5 Normal, unlimited; fully competitive, strenuous.
4 Slight mild problem; run half speed.
3 Moderate problem 2-4 km.
2 Severe problem only 1-2 blocks possible.
1 Severe problem only a few steps.
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Section 8 - Jumping or Twisting
5 Normal, unlimited, fully competitive, strenuous.
4 Slight to mild problem; some guarding but sport possible..
3 Moderate problem; gave up strenuous sports, recreational sports possible.
2 Severe problem; affects all sports; must constantly guard.
1 Severe problem; only light activity possible (golf, swimming).
TOTAL OUT OF 100:
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SPECIAL NOTE
THIS ITEM IS BOUND IN SUCH A
MANNER AND WHILE EVERY
EFFORT HAS BEEN MADE TO
REPRODUCE THE CENTRES, FORCE
WOULD RESULT IN DAMAGE
APPENDIX ill: TABLE OF RESULTS
Pat
no.
Age
(yrs)
Sex Cause No. of 
ops
Dur. Of
symp
(mths)
Gin Pre 
Op
Site Size
(mm*)
Surg
Proc
Date of
2nd
Stage
Gin 
1 yr
Gin
2
yrs
Gin
3
yrs
Gin
4
yrs
Notes
1 34 F Chond-P 2 24 56 Lpat
med
875 ACI-P 28/9/01 44 65 PvsC
2 17 F Chond-P 1 30 46 R pat lat 96 ACI-P + 
lat rel
15/5/01 44 30 P vs C
3 31 r M Trauma 1 36 69 L troch 195 ACI-P 18/12/01 52
4 24 F Chond-P 1 60 60 RPat 500 ACI-P 22/02/01 51 89 100 PvsC
5 34 F Trauma 2 60 32 LMFC 600 ACI-P 28/3/00 38 42 52 PvsC
6 46 F Chond-P 3 90 10 Rpat
sing
875 ACI-P 9/10/01 36 26 PvsC
7 32 F Chond-P 2 156 32 L pat 
med
330 ACI-P 7/12/01 28 18 PvsC
8 36 F Chond-P 1 12 38 L pat 
multi
800 ACI-P 21/9/01 66 56 PvsC
9 37 F Trauma 2 18 18 L pat 
sing 
L troch
420
250
ACI-P + 
lat rel 
ACI-P
1/7/00 84 50 24 PvsC
10 37 M Trauma 1 19 64 RMFC 400 ACI-P 16/11/99 75 55 42 24 PvsC
11 39 F Chond-P 2 24 18 R pat 360 ACI-P 10/3/00 70 52 54 68 PvsC
12 28 M Trauma 2 24 67 RLFC 375 ACI-P 24/3/00 90 90 88 89 PvsC
13 26 F Chond-P 1 24 56 L pat 
multi
384 ACI-P 26/6/01 69 83 PvsC
14 39 M Chond-P 3 24 62 R troch 450 ACI-P + 
div of 
med plica
21/9/01 76 80 PvsC
15 33 M Trauma 1 36 34 R pat 875 ACI-P 14/5/99 71 36 50 60 PvsC
16 21 M Chond-P 1 48 55 L pat lat 300 ACI-P 16/3/01 84 94 PvsC
17 30 F Chond-P 1 48 73 L pat 
multi
300 ACI-P 2/2/01 69 52 64 PvsC
18 35 M Trauma 3 48 28 R pat 
multi
525 ACI-P + 
mosaic to 
troch
16/10/01 67 83
.
PvsC
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19 23 M Chond-P 4 60 21 L pat 187.5 ACI-P + 
mosaic to 
troch
12/3/99 60 68 76 86 PvsC
20 15 F OCD 1 60 73 RMFC 700 ACI-P 9/3/01 74 86 PvsC
21 38 M Trauma 2 72 88 LLFC 150 ACI-P + 
drilling
5/10/99 65 90 78 74 PvsC
22 20 F OCD 1 72 26 LMFC 525 ACI-P 15/9/00 89 53 59 PvsC
23 33 M Other 3 84 24 R pat 
sing
400 ACI-P 15/9/00 58 61 65 PvsC
24 26 F Trauma 1 108 48 RMFC 375 ACI-P 15/9/00 87 71 70 PvsC
25 27 M Trauma 1 120 33 RMFC 300 ACI-P 3/10/00 71
26 22 F Chond-P 1 120 62 L pat 
multi
360 ACI-P 27/4/01 86 55 PvsC
27 26 M OCD 4 120 44 RLFC 900 ACI-P 8/2/00 84 69 PvsC
28 26 F Chond-P 2 144 42 R pat 360 ACI-P 24/10/00 93 56 56 PvsC
29 26 M OCD 2 156 20 RMFC 600 ACI-P 18/2/00 66 10 10 PvsC
30 32 M Trauma 4 180 68 RMFC 600 ACI-P 25/5/99 77 76 PvsC
31 25 F Chond-P 1 216 43 L pat 200 ACI-P + 
drilling 
harvest 
site
28/3/00 70 86 70 82 PvsC
32 39 F Trauma 4 276 41 L troch 300 ACI-P + 
ACL 
recon
2/2/01 68 68 69 P vs
c,
comb
33 52 M Trauma 2 324 72 R pat 
multi
989 ACI-P 1/2/02 82 100 PvsC
34 23 M OCD 4 120 50 LMFC 660 ACI-P 27/04/01 71 PvsC
35 33 F Trauma 8 216 10 R pat 
multi
800 ACI-P 07/12/01 18 PvsC
34 27 F Chond-P 
+ trauma
2 198 57 LMFC 300 ACI-C 26/04/01 77 79
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35 17 M Chond-P 1 60 59 L pat 800 ACI-C 18/01/00 57 73 76 PvsC
36 32 F Chond-P 3 144 32 L pat 270 ACI-C 26/03/99 86 79 66 46 PvsC
37 27 F Chond-P 1 180 38 L pat 
med
225 ACI-C 19/02/02 90 MACI
vs
ACI
38 39 F Chond-P 2 120 20 L pat 
multi
559 ACI-C 08/03/02 20
39 27 F Chond-P 3 156 58 L pat 
multi
500 ACI-C 13/07/01 58 52 PvsC
40 42 M Chond-P 3 216 50 L pat 
multi
600 ACI-C 28/05/02 66 MACI
vs
ACI
41 17 F Chond-P 3 72 35 L pat 
sing
400 ACI-C 07/09/99 45 38 32
42 25 F Chond-P 1 144 50 L pat 
sing
595 ACI-C 22/01/02 64 MACI
vs
ACI
43 32 F Chond-P 1 60 44 L pat 
sing
150 ACI-C 02/11/01 64
44 19 F Chond-P 
+ trauma
2 78 23 RLFC 300 ACI-C 15/05/00 68 38 34 PvsC
45 34 F Chond-P 2 120 25 Rpat 300 ACI-C 24/11/00 26 36
46 24 M Chond-P 1 60 28 Rpat 300 ACI-C 07/09/99 62 67 86 PvsC
47 22 F Chond-P 2 144 18 R pat 500 ACI-C 19/01/99 62 40 32 36
48 33 F Chond-P 3 144 32 R pat 126 ACI-C 18/01/00 79 38 43
49 31 F Chond-P 1 120 40 R pat lat 200 ACI-C 08/02/02 18 MACI
vs
ACI
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50 20 F Chond-P 2 84 28 R pat lat 300 ACI-C 09/11/01 58
51 32 F Chond-P 1 60 48 R pat 
multi
600 ACI-C 28/05/02 46 MACI
vs
ACI
52 32 M Chond-P 4 24 66 R pat 
multi
1035 ACI-C 22/03/02 72 MACI
vs
ACI
53 45 F Chond-P 1 72 51 R pat 
sing
875 ACI-C 07/11/00 10
54 39 F Chond-P 2 84 32 R pat
sing
700 ACI-C 27/08/99 42 28
55 30 M Chond-P 
+ trauma
5 36 23 RLFC 225 ACI-C + 
drilling to 
pat defect
05/05/00 42 96
56 38 F Chond-P 6 96 30 R pat 
multi
621 ACI-C 04/10/02 20
57 54 F Early
OA
3 48 30 R troch 300 ACI-C 07/09/01 86 94
58 31 F OCD 2 156 22 LMFC 506.25 ACI-C 31/05/02 79 MACI
vs
ACI
59 18 M OCD 1 48 52 LMFC 600 ACI-C 19/10/01 86
60 43 F OCD 1 36 58 L Pat 
multi
720 ACI-C 27/09/02 33 MACI
vs
ACI
61 34 M OCD 2 240 23 LMFC 900 ACI-C 05/01/01 24
62 38 M OCD 2 144 42 LMFC 950 ACI-C 04/10/02 25 MACI
vs
ACI
63 44 F OCD 3 18 32 LMFC 90 ACI-C 30/03/01 38 49 PvsC
64 26 F OCD 1 180 40 LMFC 1125 ACI-C 16/03/01 70 71 PvsC
65 20 F OCD 3 24 56 LMFC 225 ACI-C 21/09/01 91 100 PvsC
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66 22 F OCD 1 156 40 LMFC 600 ACI-C 17/07/98 93 68 68
67 43 M OCD 1 120 47 L pat 
med
144 ACI-C 30/06/00 86 84 91 PvsC
68 25 M OCD 2 72 58 RLFC 345 ACI-C 10/07/01 73
69 15 M OCD 1 24 68 RLFC 500 ACI-C 08/09/01 80
70 22 M OCD 2 30 77 RLFC 500 ACI-C 12/11/99 88
71 18 " F OCD 1 72 62 RLFC 160 ACI-C 30/03/01 92 93 PvsC
72 36 F OCD 2 276 13 RMFC 180 ACI-C 14/07/00 10 8 8 PvsC
73 21 M OCD 2 36 26 RMFC 600 ACI-C 19/02/99 48 68 89 54
74 16 M OCD 1 60 56 RMFC 375 ACI-C 17/08/01 81 97 PvsC
75 26 M OCD 1 228 58 RMFC 165 ACI-C 03/10/00 87
76 25 F OCD 1 72 50 Rpat
multi
525 ACI-C 05/02/99 89 91 54 75
77 35 M OCD 2 228 50 LMFC 1225 ACI-C 09/08/01 56
78 39 M OCD 2 60 24 LMFC 800 ACI-C 07/06/02 38 MACI
vs
ACI
79 43 M OCD 3 96 43 RMFC 200 ACI-C 25/01/01 22
80 25 F OCD 1 156 73 RMFC 600 ACI-C 19/02/99 98 87 54 54
81 30 M OCD 4 156 32 RMFC 1200 ACI-C 31/08/01 38
82 40 M Other 4 96 30 LMFC 500 ACI-C 16/04/99 45 64 22 22 PvsC
83 30 F Other 1 36 43 LMFC 600 ACI-C 12/03/02 50 MACI
vs
ACI
84 20 M Other 1 24 43 LMFC 500 ACI-C 24/03/00 75 87 PvsC
85 18 M Other 2 60 38 LMFC 500 ACI-C 02/08/02 76
86 32 M Other 3 276 14 1 L pat 204 ACI-C 16/04/99 64 71 52
87 47 F Other 1 36 42 L pat 400 ACI-C 02/02/01 88 80
88 28 M Other 1 84 41 L supra 
troch
ACI-C 09/03/01 92 98
89 35 M Other 2 48 32 RLFC 400 ACI-C 19/03/99 75 75 76 50 PvsC
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90 31 F Other 216 38 RLFC 150 ACI-C 13/04/99 79 68 87 60
91 36 F Other 1 18 29 RMFC 300 ACI-C 02/03/00 40 30 30 PvsC
92 31 M Other 1 84 59 RMFC 375 ACI-C 10/05/02 43 MACI
vs
ACI
93 33 M Other 1 156 26 RMFC 300 ACI-C 02/11/01 50
94 46 F Other 1 36 44 RMFC 280 ACI-C 18/01/00 73 93 94 PvsC
95 35 M Other 2 96 60 RMFC 437.5 ACI-C 14/11/00 76 63 PvsC
96 37 M Other 1 24 30 R troch 450 ACI-C 16/04/02 82 MACI
vs
ACI
97 39 M Other + 
failed 
mosaic 
plasty
6 300 48 RMFC 625 ACI-C 25/06/02 26 MACI
vs
ACI
98 37 M Other + 
previous 
failed 
MSP 
and 
mosaic 
plasty
5 168 20 LMFC 396 ACI-C 05/03/02 20 MACI
vs
ACI
99 19 M Trauma 2 36 32 LLFC 600 ACI-C 18/12/98 38 42 24 30
100 34 M Trauma 2 18 70 LLFC 375 ACI-C 10/03/00 86 86 65 PvsC
101 36 F Trauma 2 24 32 LLFC 218.75 ACI-C 09/03/99 88 87 58 65
102 32 F Trauma 1 36 32 LMFC 120 ACI-C 27/04/01 24 24 PvsC
103 37 M Trauma 3 12 48 LMFC 225 ACI-C 09/07/98 25 42 46 66
104 31 M Trauma 1 36 69 LMFC 1250 ACI-C 18/12/01 52
105 27 M Trauma 2 18 43 LMFC 600 ACI-C 10/11/98 53
106 33 M Trauma 4 192 73 LMFC 660 ACI-C 05/01/01 57 57 PvsC
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107 46 M Trauma 3 72 22 LMFC 450 ACI-C 31/05/02 58 MACI
vs
ACI
108 39 M Trauma 1 36 66 LMFC 600 ACI-C 21/12/01 60 26
109 34 M Trauma 1 36 62 LMFC 156 ACI-C 22/02/02 62
110 45 F Trauma 2 180 44 LMFC 150 ACI-C + 
ACL 
recon
22/03/02 68 MACI
vs
ACI,
comb
111 17 F Trauma 1 48 29 LMFC 225 ACI-C 01/06/99 70 59 PvsC
112 43 F Trauma 6 288 18 LMFC  
+ troch
300 ACI-C + 
drilling 
troch
26/07/02 18 MACI
vs
ACI
113 33 F Trauma 1 48 44 L pat 150 ACI-C 16/04/99 76 88 89 70 PvsC
114 49 F Trauma 5 132 22 L pat 
med
450 ACI-C 15/06/01 46 38
115 32 F Trauma 1 108 36 L pat 
med
720 ACI-C 04/12/01 64
116 34 F Trauma 3 24 54 L pat 
med
195 ACI-C 01/06/99 89 75 54 PvsC
117 16 F Trauma 2 84 22 L pat 
multi
300 ACI + Lat 
rel + med 
parapatela 
reefing
27/07/01 38 42
118 34 F Trauma 1 120 30 L pat 
multi
1050 ACI-C 16/02/01 64 36
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119 27 F Trauma 4 24 62 L pat 
sing
500 ACI + 
mosaic 
plasty lat 
edge of 
trochlea + 
drilling to 
harvest 
site + pat 
re­
alignment
12/11/99 84 84 84 83
120 38 F Trauma 5 300 22 RLFC 195 ACI-C 10/05/02 20 MACI
vs
ACI
121 26 M Trauma 3 120 36 RLFC 50 ACI-C 16/02/01 32 26 P vs C
122 38 M Trauma 1 54 RLFC 288 ACI-C 13/09/02 63 MACI
vs
ACI
123 34 F Trauma 1 36 15 RLFC 1200 ACI-C 24/11/00 67 67 76 P vs C
124 15 M Trauma 2 12 58 RLFC 1000 ACI-C + 
osteotomy 
6/12 later
19/04/02 78 comb
125 49 M Trauma 1 20 58 RLFC 345 ACI-C 22/06/99 87 87 88 88 P vs C
126 16 M Trauma 2 17 46 RLFC 300 ACI-C 25/05/01 96 100 P vs C
127 41 F Trauma 1 54 30 RMFC 200 ACI-C 05/03/02 10 MACI
vs
ACI
128 30 F Trauma 3 36 24 RMFC 500 ACI-C 04/09/01 32 24 P vs C
129 26 F Trauma 3 12 15 RMFC 220 ACI-C 26/01/01 58 88 84
130 34 M Trauma 1 14 54 RMFC 360 ACI-C 05/10/99 84 74 79 P vs C
131 39 F Trauma 2 24 62 RMFC 200 ACI-C 13/04/99 84 72 68 86 P vs C
132 34 M Trauma 1 252 50 RMFC 900 ACI-C 21/11/00 88 86 Pvs C
133 18 M Trauma 2 48 80 RMFC 400 ACI-C 26/11/99 96 69 100 P vs C
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134 15 M Trauma 1 36 53 R pat lat 500 ACI-C 07/11/00 95 100
135 20 M Trauma 1 36 54 R pat 
med
1200 ACI-C 27/07/01 71 28
136 47 M Trauma 1 12 45 R pat 
med
280 ACI-C 01/03/02 72 MACI
vs
ACI
137 24 M Trauma 2 24 44 R troch 200 ACI-C + 
drilling of 
defect 
over MFC
11/04/00 75 84 68
138 38 M Trauma 3 180 73 R troch 400 ACI-C 25/02/00 77 87 62 PvsC
139 34 M Trauma 5 36 17 R troch 1050 ACI-C 02/06/00 78 44 46 P vs C
140 18 M Trauma 1 36 46 R troch 500 ACI-C 17/02/99 89 92 94
141 36 M Trauma 
+ failed 
ACI
3 60 54 L pat 
med
300 ACI-C 01/03/02 30 MACI
vs
ACI
142 31 M Trauma 
+ failed 
ACI
5 132 18 RMFC 224 ACI-C 26/07/01 22
143 48 F Trauma 
+ failed 
ACI
2 180 24 LMFC 900 ACI-C 01/11/02 64 MACI
vs
ACI
144 29 F Trauma 
+ failed 
MSP
4 108 26 RMFC 600 ACI-C 20/06/00 50
145 36 M Trauma 
+ failed 
MSP
4 120 16 RMFC 700 ACI-C 10/03/00 89
146 30 F Trauma 
+ failed 
MSP
2 120 24 R pat
med
875 ACl-C 10/03/00 68
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147 28 F Trauma 
+ failed 
MSP
2 60 42 L pat 
multi
800 ACI-C 27/04/01 50
148 28 F Trauma 
+ failed 
MSP
5 84 34 LMFC 525 ACI-C + 
ACL 
recon
28/05/02 42 MACI
vs
ACI,
comb
149 21 M Trauma 
+prev 
ACI to 
LLFC
4 60 42 L pat 
multi
600 ACI-C 01/12/00 24 30
150 38 F Trauma 3 36 30 RLFC 600 ACI-C 20/07/01 86 84
151 46 F Other 1 66 18 RMFC  
+ Rpat 
multi
400
600
ACI-C 20/11/01 12
152 38 M Trauma
+
previous 
failed 
MSP to 
L pat 
(1995)
3 288 14 L pat lat 
+ L pat 
med
300
440
ACI-C 07/09/01 18
153 28 M Trauma 3 108 31 R Troch 
+ R 
MFC
400
150
ACI-C +
mosaic 
plasty to 
supralat 
troch 
ridge
26/03/99 31 17 18
154 41 F Other 2 36 36 RMFC  
+ R pat 
multi
375
700
ACI-C 11/12/01 36
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155 42 M Trauma 1 60 63 LMFC  
+ L pat 
lat
300
250
ACI-C 14/12/01 40
156 38 M Trauma 3 132 56 Rpat 
multi + 
R troch
1250
300
ACI-C 21/12/01 52
157 29 M Trauma 1 12 24 L pat 
med + L 
LFC
500
1200
ACI-C 03/08/01 56 52
158 48 M Trauma 2 24 66 LMFC  
+ L 
troch
100
225
ACI-C 05/02/99 96 78 78 84
159 14 M Other 2 24 62 R pat 
multi + 
RMFC
1000
1200
ACI-C 15/09/00 82 87
160 48 M Trauma 1 180 79 RMFC  
+ R 
troch
500
75
ACI-C 02/03/99 84 77
161 37 M Trauma 3 96 61 L Troch 
+ L pat 
lat
500
160
ACI-C 27/11/01 76
162 38 M Trauma 5 36 30 L pat 
med + L 
pat lat
500
300
ACI-C 24/11/00 62 40
163 43 F Other 1 18 37 Rpat + 
RMFC
500
75
ACI-C 12/09/00 60 58
164 52 M Trauma 2 324 72 Rpat
multi
989 ACI-C 01/02/02 82 MACI
vs
ACI
165 34 M Trauma 2 36 65 LMFC 600 MACI 17/10/03 83
166 40 F Trauma 5 120 50 RMFC 225 MACI 23/09/03 56
167 34 M Trauma 6 108 74 RMFC 300 MACI 18/09/03 26
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168 37 F Trauma 1 24 61 LMFC 400 MACI 25/07/03 82
169 42 M Trauma 2 72 67 Rpat 
multi + 
R Troch
300
225
MACI 24/06/03 70
170 40 M Trauma 3 192 66 LMFC 400 MACI 22/05/03 72
171 37 F Trauma 2 18 51 LMFC 300 MACI + 
ACL
13/05/03 61
172 46 M Trauma 1 30 68 LMFC 500 MACI 09/05/03 56
173 33 F Trauma 2 204 20 L Pat 
multi
500 MACI 08/05/03 32
174 35 M Chond
pat
3 36 40 R Pat 
multi
375 MACI 06/05/03 80
175 45 F OCD 1 17 38 LMFC 875 MACI 26/04/03 48
176 50 F Trauma 1 24 34 RPat 200 MACI 15/04/03 55
177 21 F Chond
pat
3 60 42 R Pat + 
R Troch
100
100
MACI 28/03/03 70
178 42 M Trauma 1 24 35 RMFC 750 MACI 28/03/03 82
179 26 F Trauma 4 192 26 R Pat 
med
300 MACI 21/03/03 60
180 34 F Trauma 3 120 36 RMFC 320 MACI 14/03/03 66
181 47 M Trauma 2 12 62 RMFC 630 MACI 01/03/03 96
182 44 F Chond
pat
1 17 42 R Pat 
med
200 MACI 01/03/03 73
183 19 M Trauma 1 36 74 RPat
med
400 MACI 28/02/03 98
184 47 M Trauma 1 42 56 RMFC 50 MACI 26/02/03 60
185 21 M Trauma 9 72 67 RMFC  
+ LFC
1575
700
MACI 26/02/03 81
186 17 M Trauma 1 36 58 LPat
sing
750 MACI 25/02/03 76
187 37 M Trauma 1 120 64 LMFC 630 MACI 14/02/03 54
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188 31 F Trauma 2 132 50 LMFC 450 MACI 13/02/03 30
189 30 M Trauma 2 168 28 LMFC 450 MACI 11/02/03 68
190 23 M Trauma 1 48 58 LMFC 200 MACI 06/02/03 30
191 38 M Other 1 456 68 LMFC 525 MACI 22/01/03 96
192 21 F Chond
pat
2 120 56 LPat
multi
700 MACI 17/01/03 58
193 28 M Trauma 2 11 50 RLFC 875 MACI 10/01/03 84
194 22 F OCD 4 120 52 RMFC 875 MACI 20/12/02 77
195 30 M Chond
pat
4 54 60 LLFC 700 MACI 20/12/02 97
196 35 F Trauma 3 24 22 LMFC 450 MACI 17/12/02 70
197 33 M Trauma 2 240 32 R Troch 750 MACI 11/12/02 83
198 36 M OCD 1 108 88 LMFC 320 MACI 03/12/02 94
199 38 F Other 2 60 30 RMFC 96 MACI 29/11/02 83
200 37 F Trauma 1 72 36 LMFC 600 MACI 22/11/02 50
201 27 M Other 1 156 42 LMFC 875 MACI 22/11/02 55
202 33 M Trauma 2 24 44 RMFC
*2
500
48
MACI 29/10/02 57 MACI
vs
ACI
203 26 F Other 1 9 46 LMFC
♦2
500
10
MACI 29/10/02 69
204 38 M Early
OA
1 456 62 LLFC 300 MACI + 
micro# tib 
plateau
29/10/02 80 MACI
vs
ACI
205 41 M Trauma 1 48 66 LMFC 750 MACI + 
HTO
17/10/02 63 comb
206 30 F Trauma 1 144 34 LMFC 375 MACI 08/10/02 12 MACI
vs
ACI
207 29 M Trauma 1 24 40 RPat
multi
375 MACI 07/09/02 72 MACI
vs
ACI
SPECIAL NOTE
THIS ITEM IS BOUND IN SUCH A
MANNER AND WHILE EVERY
EFFORT HAS BEEN MADE TO
REPRODUCE THE CENTRES, FORCE
WOULD RESULT IN DAMAGE
Pat
no.
Age
(yrs)
Sex Cause No. of 
opera 
tions
Dur. Of 
symp.
Gin Pre 
Op
Site Size
(mm*)
Surg
Proc
Date of
2nd
Stage
Gin 
1 yr
Gin
2
yrs
Gin
3
yrs
Gin
4
yrs
Notes
208 35 M Trauma 2 60 30 RMFC 100 MACI + 
ACL 
recon
30/08/02 34 MACl
vs
ACI
209 26 F Chond
pat
5 108 36 L Pat 
multi
525 MACl 16/08/02 64 MACl
vs
ACI
210 42 F Other 1 48 48 R pat lat 350 MACl 13/08/02 76 MACI
vs
ACI
211 19 F Chond
pat
2 54 29 RMFC 375 MACI 13/08/02 65
212 23 M Chond
pat
1 72 50 RMFC 484 MACl
sandwich
06/08/02 75 MACl
vs
ACI,
comb
213 32 M Chond
pat
7 60 28 R Pat 
med
528 MACl 02/08/02 38
214 45 F Chond
pat
1 60 51 RPat
multi
875 MACl 20/06/02 46
215 43 M Trauma 3 36 32 LMFC 300 MACl 18/06/02 12 MACI
vs
ACI
216 38 M Trauma 1 156 57 LPat 
med + L 
Troch
330
216
MACI 11/06/02 52 MACI
vs
ACI
217 46 F Chond
pat
2 66 40 RPat
med
220 MACl 31/05/02 26 MACI
vs
ACI
218 32 M Trauma 3 150 45 LMFC 200 MACI + 
ACL 
recon
24/05/02 74 MACI
vs
ACI,
comb
SPECIAL NOTE
THIS ITEM IS BOUND IN SUCH A
MANNER AND WHILE EVERY
EFFORT HAS BEEN MADE TO
REPRODUCE THE CENTRES, FORCE
WOULD RESULT IN DAMAGE
Pat
no.
Age
(yrs)
Sex Cause No. of 
opera 
tions
Dur. Of 
symp.
Gin Pre 
Op
Site Size
(mm*)
Surg
Proc
Date of 
stage
Gin 
1 yr
Gin
2
^rs
Gin
3
yrs
Gin
4
yrs
Notes
219 21 M Trauma 1 48 41 LMFC 250 MACI + 
ACL 
recon
14/05/02 95 MACI
vs
ACI,
comb
220 44 M Other 4 54 42 LLFC 750 MACI 03/05/02 81 MACI
vs
ACI
221 31 M Trauma 4 156 56 LMFC 600 MACI + 
ACL 
recon
22/04/02 56 MACI
vs
ACI,
comb
222 22 F Trauma 7 48 62 L Pat lat 
+ med, 
L Troch 
♦3
1200
150
600
750
150
MACI 17/04/02 85 MACI
vs
ACI
223 21 M Chond
pat
2 42 27 L Pat lat 500 MACI 16/04/02 52 MACI
vs
ACI
224 20 M OCD 1 36 70 LMFC 800 MACl
sandwich
16/04/02 96 MACI
vs
ACI,
comb
225 41 M Trauma 2 84 42 R Pat 
multi
375 MACI 12/04/02 14 MACI
vs
ACI
226 25 F Other + 
failed 
MSP at 
4 years
3 108 14 L Pat 
med
224 MACI
sandwich
12/04/02 82 MACI
vs
ACI,
comb
SPECIAL NOTE
THIS ITEM IS BOUND IN SUCH A
MANNER AND WHILE EVERY
EFFORT HAS BEEN MADE TO
REPRODUCE THE CENTRES, FORCE
WOULD RESULT IN DAMAGE
Pat
no.
Age
(yrs)
Sex Cause No. of 
opera 
tions
Dur. Of 
symp.
Gin Pre 
Op
Site Size
(mm*)
Surg
Proc
Date of 
stage
Gin 
1 yr
Gin
2
yrs
Gin
3
yrs
Gin
4
yrs
Notes
227 34 M Trauma 
+ failed 
Mosaic 
plasty to 
MFC
4 60 44 RMFC 540 MACl 22/03/02 46
228 27 F Chond
pat
2 180 34 R Pat 
multi
300 MACl 19/03/02 90
229 30 F Other 2 42 41 RMFC 300 MACI 15/03/02 62 MACI
vs
ACI
230 44 F Chond
pat
2 96 43 RPat
sing
645 MACI 15/03/02 42 MACI
vs
ACI
231 31 F Chond
pat
1 48 70 R Pat 300 MACI 08/03/02 68
232 46 ^  F Chond
pat
2 336 40 LMFC 600 MACI + 
bone graft
05/03/02 52 MACI
vs
ACI,
comb
233 43 F Trauma 1 24 46 R Pat lat 
+ Troch
625
300
MACI 01/03/02 66 MACI
vs
ACI
234 21 M OCD 2 36 43 LLFC 875 MACI 02/10/02 81
235 73 F Other 1 24 20 R Pat 400 MACI 13/02/02 72
236 32 F Trauma 2 24 29 LPat 600 MACI 25/03/02 50
237 20 M Other 1 36 51 LPat 360 MACI 27/03/02 90
238 51 F Other 2 12 73 LMFC 375 MACI 27/03/02 89
239 25 F Trauma 1 36 32 L Pat 400 MACl 13/05/02 64
240 24 M Trauma 1 9 40 LLFC 600 MACl 24/06/02 87
241 40 F Trauma 1 24 18 RPat 150 MACl 18/07/02 22
242 40 M Trauma 2 40 52 L Troch 300 MACl 18/07/02 63
SPECIAL NOTE
THIS ITEM IS BOUND IN SUCH A
MANNER AND WHILE EVERY
EFFORT HAS BEEN MADE TO
REPRODUCE THE CENTRES, FORCE
WOULD RESULT IN DAMAGE
Pat
no.
Age
(yrs)
Sex Cause No. of 
opera 
tions
Dur. Of 
symp.
Gin Pre 
Op
Site Size
(mm*)
Surg
Proc
Date of
2nd
Stage
Gin 
1 yr
Gin
2
yrs
Gin
3
yrs
Gin
4
yrs
Notes
243 35 F Other 2 36 36 R Pat + 
LFC
400
7
MACI 07/12/02 53
244 45 M Trauma 3 30 35 L Pat 700 MACI 18/01/03 84
245 28 M Other 1 24 62 RLFC 750 MACI 07/12/02 74
246 34 M Trauma 3 36 4 RLFC 200 MACI 05/02/03 68
247 37 F Trauma 1 16 63 LMFC 50 MACI 17/04/02 42
248 36 M Trauma 3 28 ^ 26 RMFC 800 MACI 27/05/02 32
249 36 M Other 1 36 62 RMFC 450 MACI 29/05/02 80
250 31 M Trauma 2 48 43 RMFC 200 MACI 24/06/02 87
251 24 F OCD 2 36 16 LMFC 400 MACI 12/08/02 36
252 38 M Trauma 1 24 30 LMFC 60 MACI 04/09/02 44
253 50 M Trauma 1 36 59 RMFC 400 MACI 21/09/02 38
254 42 M Trauma 2 30 50 RMFC 300 MACI 23/09/02 29
255 33 M Trauma 1 16 46 RMFC 150 MACI 28/09/02 44
256 40 F Trauma 1 18 44 LMFC 500 MACI 28/09/02 60
257 38 M Other 2 24 62 LMFC 150 MACI 30/09/02 90
258 36 F Other 3 60 58 RPat 400 MACI 23/11/02 72
259 39 F Trauma 1 36 46 LPat 225 MACI 27/11/02 72
260 37 F Other 0 24 20 LMFC 112.5 MACI 01/10/02 77
261 51 M Other 1 18 24 RMFC 120 MACI 26/02/03 44
262 63 M Trauma 3 60 38 LLFC 375 MACI 29/03/03 78
263 26 M Trauma 3 108 ^ 44 LLFC 900 MACI 28/05/03 72
264 35 M Trauma 1 20 58 RMFC 200 MACI 10/05/03 84
265 29 M Trauma 4 120 69 R Pat 144 MACI 31/05/03 82
266 38 M Other 2 36 22 RLFC 300 MACI 07/06/03 56
267 40 M Trauma 4 108 26 RMFC 450 MACI 09/06/03 53
268 28 M Trauma 3 30 47 RLFC 200 MACI 04/06/03 48
269 39 M Other 2 36 65 RMFC 1000 MACI 07/06/03 72
270 46 M Trauma 2 36 33 RMFC 400 MACI 09/07/03 32
271 36 M Trauma 5 54 16 L Troch 
+ MFC
600
1200
MACI 06/08/03 62
SPECIAL NOTE
THIS ITEM IS BOUND IN SUCH A
MANNER AND WHILE EVERY
EFFORT HAS BEEN MADE TO
REPRODUCE THE CENTRES, FORCE
WOULD RESULT IN DAMAGE
Pat
no.
Age
(yrs)
Sex Cause No. of 
opera 
tions
Dur. Of 
symp.
Cin Pre 
Op
Site Size
(mm*)
Surg
Proc
Date of2nd
Stage
Cin 
1 yr
Cin
2
yrs
Cin
3
yrs
Cin
4
yrs
Notes
272 28 M Trauma 1 12 40 L pat 
multi
500 MACI 02/11/02 87 MACI
vs
ACI
273 20 M Other 4 97 22 L pat lat 1600 MACI 18/06/02 22 MACI
vs
ACI
Abbreviations:
Cin: Cincinnati score.
Surg Proc: Surgical procedure.
OCD: Osteochondritis Dissecans.
Chond pat: Chondromalacia Patellae.
MSP: Matrix Support Prosthesis.
HTO: High Tibial Osteotomy.
Micro#: Microfracture
P vs C: Patients recruited for the prospective, randomised study comparing two techniques of Autologous 
Chondrocyte implantation for osteochondral defects in the knee: Periosteum covered versus type I/Ill collagen 
covered.
MACi vs ACI: Patients recruited for the prospective, randomised study comparing two techniques of Autologous 
Chondrocyte implantation for osteochondral defects in the knee: MACI vs ACI.
comb: Patients reviewed who had Chondrocyte implantation in the knee combined with other surgical procedures.
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